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The expression of the Drosophila melanogaster morphogen Hedgehog (Hh) plays a 
key role in co-ordinating proliferation and differentiation during animal 
development. Tight spatial and temporal regulation of Hh expression is essential for 
its correct function in these essential processes. Both mis-expression of its 
mammalian orthologue Sonic Hedgehog (Shh) and aberrant stimulation of the 
associated signalling pathway occur in a wide range of human tumours. Although 
there is extensive knowledge of the signal transduction pathway that is activated in a 
Hh-stimulated cell, very little is known about pathways governing the expression of 
the morphogen itself.  
 
The Drosophila tumour suppressor protein Hyperplastic Discs (Hyd), an E3 ubiquitin 
ligase, negatively regulates hedgehog (hh) expression and Hh pathway activity by 
independent mechanisms in the developing Drosophila eye. Genetically generated 
hyd mutant clones in the eye mis-express hh and the transcriptional activator of Hh 
target genes, Cubitus interruptus (Ci), and cause overgrowth of the surrounding wild-
type tissue. However, the underlying molecular mechanism(s) by which Hyd 
regulates these morphogen regulatory pathways is not known. Hyd may be involved 
in ubiquitylating target proteins in these pathways, which could have degradative or 
non-degradative outcomes. In order to elucidate Hyd’s molecular role in potential 
morphogen regulatory pathways, I applied a proteomics-based approach to identify 
novel Hyd binding partners and ubiquitylated substrates. Tandem affinity 
purification in combination with mass spectrometry was used to purify and identify 
Hyd and its complexed binding partners from Drosophila cells. Binding and 
ubiquitylation assays were subsequently used to verify and characterize the 
interactions. In addition, a biased, literature-guided approach was applied to identify 
likely Hyd binding partners based on their involvement in morphogen signalling and 
conservation across species. Finally, to assess the functional consequences of a 
newly identified interaction, I used a Drosophila in vivo model to determine whether 
the novel binding partner was capable of modifying the hyd mutant phenotype. For 
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this purpose, the Mosaic Analysis with a Repressible Cell Marker (MARCM) 
technique was used to generate hyd mutant clones in the developing larval eye, 
which were expressing transgenes resulting in either the over-expression or RNAi-
mediated knockdown of the gene of interest. 
 
My results indicate that Hyd is involved in regulating both Hh and Wg morphogen 
signalling in the Drosophila eye, and that the molecular mechanism of action may, at 
least in part, involve the protein kinase Shaggy (Sgg). Hyd interacts with the Hh and 
Wg transcriptional activator proteins Ci and Armadillo, respectively, as well as the 
Sgg kinase. Sgg is a negative regulator of both the Hh and Wg pathways, and acts to 
direct the proteolytic processing or degradation of the transcriptional effectors of 
these morphogen pathways. Sgg and its mammalian orthologue GSK3β were 
ubiquitylated in vitro, and GSK3β ubiquitylation was negatively regulated by the 
mammalian homologue of Hyd, EDD. Knockdown of sgg in eye disc cells mutant for 
hyd resulted in a dramatic rescue of the overgrowth phenotype. Loss of hyd in clones 
located in the anterior region of the eye disc resulted in low levels of the full-length 
Hh transcriptional activator protein Ci. This effect was reversed completely as a 
result of sgg knockdown. Furthermore, loss of hyd in eye disc clones resulted in 
elevated Hh and Wg morphogen expression. Mis-expression of hh in hyd mutant 
clones was significantly reduced upon over-expression of a constitutively active Sgg 
kinase. Hence sgg appears to genetically act downstream of hyd to regulate hh gene 
expression and Ci expression. 
 
In summary my results identify Sgg as a novel regulator of hh gene expression, 
whose activity may be regulated by ubiquitylation, and which may be acting 
downstream of Hyd in a ubiquitin-regulated manner to control both hh gene 
expression and Hh pathway activity in the developing Drosophila eye. Hyd may also 
regulate Hh pathway activity by directly interacting with Ci and affecting its activity. 
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The results also indicate that Hyd may be a master regulator of both Hh and Wg 
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1.1 The Ubiquitin Code 
 
1.1.1 Ubiquitin and transfer of ubiquitin to substrates 
 
Ten years ago, Avram Hershko, Aaron Ciechanover, and Irwin Rose discovered the 
functions of a small, highly conserved eukaryotic protein called ubiquitin. They were 
awarded the 2004 Nobel Prize in Chemistry for their work on ubiquitin, which 
increasing evidence suggests is involved in regulating almost every process in a cell 
[reviewed in (Welchman et al. 2005)].  
 
Ubiquitin is a highly stable, 76-amino acid (aa) protein, which is almost structurally 
invariant from yeast to man. The high structural conservation of ubiquitin’s compact 
β-grasp fold among eukaryotes suggests that it plays an important and central role in 
a cell’s processes (Vijay-Kumar et al. 1987). Ubiquitin is covalently attached to 
substrate proteins through the action of a series of enzymes, a process known as 
ubiquitylation (Figure 1.1). Importantly, the modification of target proteins with 
ubiquitin is both reversible and dynamic, making it comparable to phosphorylation. 
Although ubiquitylation has classically been found to direct substrate protein 
degradation through a multi subunit protease called the 26S proteasome, more recent 
advances in the field have found that ubiquitylation can also affect protein 
conformation, activity, and interactions (Z. J. Chen & L. J. Sun 2009). 
 
Ubiquitin is transferred to substrate proteins in a three-step mechanism involving 
three key enzymes: E1 activating enzymes, E2 conjugating enzymes and E3 ligase 
enzymes (Figure 1.1) (Deshaies & Joazeiro 2009; Schulman & Harper 2009; Ye & 
Rape 2009). In the first step, the E1 enzyme activates ubiquitin via its catalytic 
cysteine residue in an adenosine triphosphate (ATP)-dependent reaction, forming a 
high-energy thiol ester intermediate. The activated ubiquitin is then transferred to a 
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cysteine residue in the E2 enzyme, which interacts with different E3 ligase enzymes. 
The E3 ligase ultimately confers the specificity of the ubiquitylation reaction, as it is 
involved in recognizing the substrate protein. In humans, there are two E1 enzymes, 
40 E2 enzymes, and 600 E3 enzymes, effectively increasing the specificity of the 
ubiquitylation cascade from E1 to E3 (Z. J. Chen & L. J. Sun 2009). The E3 ligase, 
in some cases with the help of the E2 enzyme, catalyses the covalent attachment of 
ubiquitin to the substrate in the final step. This involves the formation of an 
isopeptide bond between the carboxy-terminal of ubiquitin to the epsilon amino 
(NH2)-group of an internal lysine residue of the substrate protein. In some cases, the 
isopeptide bond can also be formed at the extreme amino-terminal of the protein, 
effectively forming a covalent ubiquitin-Met1 linkage (also known as linear 
ubiquitylation) (Rieser et al. 2013). 
 
Figure 1.1: Transfer of Ubiquitin to substrates and degradation via the proteasome. Ubiquitin is 
activated by the E1 in an ATP-dependent reaction (1). The E1 then transfers ubiquitin to the E2 (2). In 
most cases, the E2 enzyme and the protein substrate both bind specifically to the E3 ligase, which 
transfers the activated ubiquitin moiety to the substrate (3). The E3 conjugates successive ubiquitin 
moieties to the substrate, which targets the substrate for degradation via the 26S proteasome (4). The 
substrate is degraded into peptides (5), and reusable ubiquitin is removed by deubiquitylating enzymes 
(DUBs) (6). Pi, inorganic phosphate; PPi, pyrophosphate; Ub, ubiquitin. Figure taken from 
(Welchman et al. 2005). 
 
Ubiquitination can result in the attachment of a single ubiquitin moiety, as well as 
multiple ubiquitin moieties, which can form polymeric chains (Figure 1.2). A 
substrate is monoubiquitylated if a single lysine residue is modified with ubiquitin, or 
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multi-monoubiquitylated if multiple lysine residues in the substrate protein are 
modified. Conversely, a substrate is polyubiquitylated if successive ubiquitin 
moieties are attached to internal lysine residues in the substrate-bound ubiquitin, 
resulting in the formation of polyubiquitin chains ranging from two to >10 ubiquitin 
moieties in length. Similarly, the substrate is multi-polyubiquitinated if multiple 
lysine residues in the substrate are modified with polyubiquitin chains [reviewed in 
(Komander & Rape 2012)]. Ubiquitin has seven lysine residues (K6, K11, K27, K29, 
K33, K48, and K63), which cover the surface of ubiquitin. Conjugation to these sites 
can result in polymeric chains of numerous topologies, composed of homogenous 
and/or mixed lysine linkages (Figure 1.2). In homogenous chains, the same ubiquitin 
residue is used for attachment of subsequent ubiquitin molecules during chain 
elongation. This results in the generation of, for example, Met1- (linear), Lys48- and 
Lys63-linked chains. Conversely, chains with mixed topology are generated if 
different lysine residues in the pre-attached ubiquitin are used for attachment of 
subsequent ubiquitin molecules during chain elongation. Consequently, polyubiquitin 
chains can adopt different structural conformations which are distinguished by 
ubiquitin-binding proteins that translate the different modifications into distinct 
cellular outcomes (Komander & Rape 2012; F. Ikeda & Dikic 2008). Although all 
possible linkages have been detected in cells, it is currently not known whether all 
have a physiological function (Peng et al. 2003; P. Xu et al. 2009). For example, the 
function of Lys6, Lys27, Lys29, and Lys33 chains is poorly understood.   
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Figure 1.2: Ubiquitylation topologies. Distinct forms of ubiquitin (red balls) can be attached at 
multiple locations on a substrate. (a) Monoubiquitylation. (b) Multimonoubiquitylation. (c) 
Homogenous ubiquitin chain. (d) Mixed ubiquitin chain. (e) Branched ubiquitin chain. (f) Unanchored 
ubiquitin chain. Figure adapted from (Komander & Rape 2012). 
1.1.2 Types of E3 ubiquitin ligases 
 
E3 ligase enzymes determine the specificity of the ubiquitin modification by 
selectively binding and ubiquitylating a specific substrate protein. They can be 
broadly categorized into two subfamilies: HECT (homology to E6AP C-terminus) 
domain E3 ligases (Rotin & S. Kumar 2009), and RING (really interesting new gene) 
domain E3 ligases (Joazeiro & Weissman 2000; Tyers & Willems 1999). 
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Additionally, each subfamily can be further classified into monomeric/homomeric 
and multi-protein complex E3 ligases. 
1.1.2.1 HECT domain E3 ligases 
 
HECT domain E3 ligases contain a 350-amino acid carboxy terminal domain with 
high homology to E6AP, the founding member of this subfamily (Huibregtse et al. 
1993; Huibregtse et al. 1995). The defining feature of the HECT domain is a highly 
conserved, catalytic cysteine residue, which directly accepts the activated ubiquitin 
moiety from the E2, forming a HECT-ubiquitin intermediate. The E3 then directly 
binds the substrate, presumably through its amino terminal, and catalyses the transfer 
of ubiquitin to an acceptor lysine on the substrate, or pre-existing ubiquitin chains on 
the substrate (Scheffner et al. 1995; Huang et al. 1999). One example of a HECT 
domain E3 ligase is the Drosophila protein Hyperplastic Discs (Hyd) (Mansfield et 
al. 1994), and its human homologue E3 in Differential Display (EDD) (Honda et al. 
2002), which form the basis of the work presented in this thesis. Although many 
HECT domain E3 ligases are thought to act as monomers, EDD can form a multi-
protein complex with DNA-damage binding protein 1 (DDB1), Vpr-binding protein 
(VPRBP), and dual-specificity tyrosine-phosphorylation-regulated kinase 2 
(DYRK2) to ubiquitylate the mitotic microtubule ATPase protein katanin p60 
(Maddika & J. Chen 2009). 
1.1.2.2 RING domain E3 ligases 
 
In contrast to HECT domain E3 ligases, RING domain E3 ligases do not form an E3-
ubiquitin intermediate. Instead, these E3 ligases bind different E2s via the RING 
domain, as well as interacting with the substrate. They therefore act as scaffolds that 
bring the E2 and the substrate into sufficient proximity, and position both proteins 
optimally for ubiquitylation to take place (Jackson et al. 2000). In this case, it is the 
E2 that catalyses the transfer of ubiquitin to the substrate (Lorick et al. 1999). The 
RING domain is characterized by a structural pattern of conserved cysteine and 
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histidine residues, which facilitates the binding of Zn2+ cations (N. Zheng et al. 
2000).  
 
RING domain E3 ligases can be further sub-divided into two groups. The first group 
consists of RING domain E3s that function as either monomers or homodimers, and 
that contain both the RING finger domain (i.e. the E2 binding domain) and a 
substrate recognition motif. Examples of members of this group include Mdm2 
(Boyd et al. 2000; Geyer et al. 2000) and Parkin (Shimura et al. 2000). The second 
group consists of RING E3s that function as part of multi-subunit complexes, such as 
the APC complex, involved in the degradation of cell cycle regulators (Page & 
Hieter 1999), and the von-Hippel Lindau-Elongins B and C (VBC)-Cul2-RING 
finger complex, involved in the degradation of HIF1-alpha (Kamura et al. 2000; 
Maxwell et al. 1999). These E3 complexes are modular, and are based on a core 
scaffold that binds interchangeable substrate-targeting subunits, and different RING 
domain E3s to recruit the E2 (Figure 1.3). Members of the Cullin (CUL) protein 
family typically fulfill the role of the scaffold protein, and form the backbone of most 
E3 ligase complexes. Each Cullin protein associates with specific substrate adaptors 
and RING E3 ligases, generating a large possibility of different combinations with 
different substrates, as well as ubiquitin linkage specificities (Petroski & Deshaies 
2005). 
1.1.2.3 SCF ligase complexes 
 
As mentioned above, many modular E3 ligases are based on a cullin scaffold, and are 
collectively referred to as cullin-RING ligase (CRL) family complexes (Figure 1.3). 
Of these, the CRL1 ligases, also known as the S-phase kinase-associated protein 1 
(SKP1)-cullin 1 (CUL1)-F-box protein (SCF) complexes, are the best characterized. 
They specifically recognise phosphorylated signal- and cell cycle-induced proteins, 
mostly resulting in the degradation of the target protein (Petroski & Deshaies 2005; 
Skaar et al. 2013).  
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Figure 1.3: Members of the cullin–RING ligase (CRL) family. Cullin–RING ligase (CRL) 
complexes are modular multi-protein complexes, with variable substrate adaptors. The Cullin (CUL) 
proteins (green) form the backbone, and form a complex with  RING-box protein 1 (RBX1; red), the 
E2 enzyme (orange), variable substrate adaptors (blue and purple), and the substrate (yellow). SKP1, 
S phase kinase-associated protein 1. SCF, SKP1–CUL1–F-box protein complex. DDB1, DNA 
damage-binding protein 1. DCAF, DDB1- and CUL4-associated factor. SOCS, suppressor of cytokine 
signalling. BTB, bric-a-brac-tramtrack-broad. FBXW8, F-box and WD40 domain 8. Figure taken 
from (Skaar et al. 2013). 
The core component of SCF complexes is the scaffold protein CUL1. The CUL1 
carboxy terminus binds the small RING-box protein 1 (RBX1), which recruits the 
E2. The amino terminus of CUL1 interacts with S-phase kinase-associated protein 1 
(SKP1), which recruits various F-box proteins (Figure 1.3). These different F-box 
proteins dictate the substrate specificity of SCF ligase complexes, and bind to SKP1 
via their conserved F-box domain (Petroski & Deshaies 2005). There are sixty-nine 
F-box proteins in humans, and their interchangeability in SCF complexes enables 
these to target hundreds of different substrates (Jin et al. 2008; Skaar et al. 2009). 
The activity of SCF complexes is regulated on multiple levels, which includes 
phosphorylation of its individual components (Glickman & Ciechanover 2002), as 
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well as covalent modification with the ubiquitin-like protein NEDD8 (Skaar et al. 
2013), although these mechanisms remain poorly understood.  
 
F-box proteins typically recognize short degradation motifs, also known as degrons, 
in the substrate protein, and many bind specifically to phosphodegrons (Skaar et al. 
2013). Some phosphodegrons are phosphorylated by a single kinase, whereas others 
require phosphorylation by multiple kinases and/or priming kinases, where one 
kinase must recognize a priming phosphate prior to phosphorylating the substrate. 
For example the F-box protein β-transducing repeat-containing protein (βTrCP) 
recognizes the consensus sequence Asp-Ser-Gly-Xaa-Xaa-Ser, where Xaa is any 
amino acid, and both Ser residues must be phosphorylated (Kitagawa et al. 1999; Lau 
et al. 2012). 
 
1.1.3 Removal of ubiqitin: DUBs 
 
The covalent modification of substrate proteins with ubiquitin is a reversible process. 
Deubiquitylating enzymes (DUBs) prevent the constitutive ubiquitylation of proteins 
by catalyzing the removal of ubiquitin and ubiquitin chains. DUBs can be 
categorized into five different families: ubiquitin-C-terminal hydrolases (UCHs), 
ubiquitin-specific proteases (USPs), Machado-Joseph Disease protein domain 
proteases (MJDs), ovarian tumour proteases (OTUs), and JAMM motif proteases 
(JAMMs) (Nijman et al. 2005). With the exception of JAMMs, which are 
metalloproteases, all DUBs are cysteine proteases that hydrolyse the penultimate 
amide bond at the ubiquitin carboxy terminus (Z. J. Chen & L. J. Sun 2009). UCHs 
remove short peptide chains from the carboxy terminus of ubiquitin, whereas USPs 
cleave the isopeptide bond between ubiquitin molecules, or between ubiquitin and 
the substrate (Glickman & Ciechanover 2002). 
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Several DUBs are proteasome-bound and play important housekeeping roles 
removing and recycling ubiquitin from substrates targeted for degradation. DUBs 
thereby protect ubiquitin from degradation and help maintain levels of free cellular 
ubiquitin (Finley 2009). Most USP family DUBs disassemble chains independently 
of the linkage, but instead recognize a specific set of substrates (Komander et al. 
2009). Some DUBs, on the other hand, are linkage specific; for example JAMMs 
tend to be Lys63 specific, and several OTUs display specificity towards Lys48, 
Lys11, Lys29 and Lys33. Unlike non-linkage specific DUBs (e.g. USPs), linkage 
specific DUBs may not be able to remove the last ubiquitin on the substrate, possibly 
generating a monoubiquitylated substrate with distinct signaling properties and/or 
activity (Komander & Rape 2012). Finally, DUBs can be involved in the 
replacement of an existing ubiquitin chain with another ubiquitin chain that differs in 
topology, a process known as ubiquitin chain editing. During this process, DUBs and 
E3 ligases can form complexes, allowing them to act sequentially (Sowa et al. 2009). 
Interestingly, some proteins have both DUB and E3 activities - an example being the 
A20 protein, which is involved in the regulation of the transcription factor NF-κB 
(Wertz et al. 2004).      
 
1.1.4 Ubiquitin-like proteins 
 
Covalent modification of substrate proteins by small proteins such as ubiquitin is not 
unique to ubiquitylation. Several ubiquitin-like (UBL) proteins can also be 
conjugated to substrate lysine residues and utilise an analogous set of enzymes, 
which are mechanistically and structurally similar to E1, E2, and E3 proteins 
(Kerscher et al. 2006). UBLs increase the diversity of small-protein post-translational 
modifications and consequently the number of downstream effector proteins 
translating those modifications into specific cellular outcomes. Some UBL proteins 
share a very limited degree of sequence homology with ubiquitin, but all share the 
characteristic and highly conserved β-grasp ubiquitin superfold (Welchman et al. 
2005).  
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At least eleven UBL proteins have been identified to date. Perhaps the most 
intensively studied UBL proteins include neuronal-precursor-cell-expressed 
developmentally downregulated protein-8 (NEDD8) and Small Ubiquitin-like 
Modifier (SUMO). NEDD8 is activated by the heterodimeric E1 APPBP1-UBA3 
(Alzheimer-precursor-protein-binding protein-1-ubiquitin-activating enzyme-3), and 
transferred to substrates by the E2 UBC12 and the E3 ligase Mdm2 (mouse double 
minute-2) (Welchman et al. 2005; Xirodimas et al. 2004). NEDD8 is mainly 
involved in the regulation of E3 ligase proteins and complexes (Hori et al. 1999). For 
example, NEDD8 regulates SCF activity through modification of CUL1, which 
prevents the association of CUL1 with an inhibitor of SCF activity, CAND1 (cullin-
associated and neddylation-dissociated-1). Conversely, deneddylation of CUL1 by 
the COP9 signalosome complex negatively regulates the activity of the SCF complex 
as it allows the binding of CAND1 and prevents the binding of the SKP1-F-box 
heterodimer (Cope & Deshaies 2003). 
 
Another UBL protein, SUMO, mainly targets proteins involved in transcription, 
chromatin remodelling and DNA repair. The modification of proteins with SUMO 
mostly affects protein activity and localization (Gill 2004; Matunis et al. 1996). 
SUMO uses the E1 AOS1-UBA2, the E2 UBC9, and several E3 ligases, including 
RanBP2 (Ran-binding protein-2) for conjugation to target proteins. Interestingly, it 
has been suggested that protein sumoylation may oppose the function of 
ubiquitylation, as SUMO and ubiquitin can compete to modify the same site in some 
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1.1.5 Functional outcomes of ubiquitination 
 
Once a protein has been ubiquitylated, effector proteins with ubiquitin-binding 
domains (UBDs) translate the ubiquitin modification into specific cellular outcomes 
(Dikic et al. 2009). Different linkage topologies present different binding surfaces to 
effector proteins, and as a result affect the outcome of ubiquitylation. Classically, it 
is generally believed that K48-linked chains direct degradation of the modified 
protein, whereas K63-linked chains have various non-proteolytic functions, such as 
regulation of the protein’s activity or sub-cellular localization (Figure 1.4). 
However, this view may be too simplified, as emerging evidence suggests that these 
chain types can both have proteolytic as well as non-proteolytic functions. In 
addition, the functional outcome of ubiquitylation is not solely dependent on chain 
topology, as it is also affected by several other factors such as timing, sub-cellular 
localization, reversibility of the modification, and cross-talk between E3s and 
effector proteins (Komander & Rape 2012). 
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Figure 1.4: Cellular Outcomes of Ubiquitylation. Ubiquitylation can have both degradative and 
non-degradative outcomes. Ubiquitin-directed degradation occurs via the proteasome or the lysosome, 
whereas non-degradative ubiquitylation can positively (black arrows) or negatively (black circles) 
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1.1.5.1 Degradation via the proteasome 
 
Historically, protein ubiquitylation was solely linked to protein degradation via the 
26S proteasome, a large multi-subunit protease that is highly conserved among all 
eukaryotes (Finley 2009). This 2.5 MDa complex is composed of two sub-
complexes: a 20S core particle (CP) and a 19S regulatory particle (RP) (Figure 1.4). 
The 20S CP harbours the catalytic protease activity and forms a barrel-shaped 
structure. The protease active sites face inward into the so-called proteolytic 
chamber, and degrade proteins into small peptides. One or two 19S regulatory 
particles can attach to either end of the 20S CP barrel to form the complete 26S 
proteasome. The function of the 19S RP is to recognize ubiquitylated proteins, 
partially unfold proteins destined for degradation, and to direct them into the 20S CP 
proteolytic chamber. Following protein degradation, small peptides as well as 
reusable ubiquitin are released from the 26S proteasome (Glickman & Ciechanover 
2002). 
 
Several ubiquitin linkages can result in protein degradation via the 26S proteasome. 
K48-linked ubiquitin chains were the first ubiquitin linkage found to direct protein 
degradation (Chau et al. 1989). Considering the importance of protein turnover in 
living cells, it is not surprising that quantitative proteomic analyses have revealed 
that K48-linked chains are the most abundant linkage type, and that inhibition of the 
26S proteasome results in rapid accumulation of proteins modified with K48-linked 
ubiquitin chains (Kim et al. 2011; Kaiser et al. 2011). However, emerging evidence 
implicates other ubiquitin linkages in protein degradation via the 26S proteasome. 
For example, K11-linked chains conjugated by the E3 complex APC/C direct the 
degradation of cell cycle regulators during mitosis (Jin et al. 2008; Matsumoto et al. 
2010), and, in some cases, K29- and K63-linked chains were also found to direct 
protein degradation (E. S. Johnson et al. 1995; Saeki et al. 2009). 
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Finally, proteins can also be targeted to the lysosome for degradation. The lysosome 
is a membrane-bound cellular compartment containing several proteases, in which 
proteins are engulfed and degraded. For example, membrane proteins are targeted to 
the lysosome through monoubiquitylation or K63-linked chains, which involves 
endocytosis of membrane proteins and fusion of endocytic vesicles with the 
lysosome (Mukhopadhyay & Riezman 2007).    
 
1.1.5.2 Non-degradative outcomes of ubiquitylation 
 
Ubiquitylation of proteins can also have many non-proteolytic outcomes, including 
the regulation of protein interactions, activity, and localization, all of which can 
affect various signalling pathways in the cell. These non-proteolytic functions of 
ubiquitin are most frequently associated with monoubiquitylation or linear (Met1) 
and K63-linked chains (Z. J. Chen & L. J. Sun 2009; Rieser et al. 2013; Komander & 
Rape 2012). 
 
Ubiquitylation can both promote and inhibit protein interactions. For example, 
during the DNA damage response, monoubiquitylation of PCNA promotes its 
association with several DNA repair-specific DNA polymerases (Hoege et al. 2002; 
Bienko et al. 2010). K63-linked chains often play an important role in scaffolding, 
such as in the recruitment of several E3s to sites of DNA damage by K63-linked 
histone proteins (Al-Hakim et al. 2010). Conversely, ubiquitylation can also 
negatively affect interactions. For example, the transcription factor Smad4 is 
monoubiquitylated, which blocks its interaction with the transcriptional co-factor 
Smad2. De-ubiquitylation of Smad4 by USPX9 results in association with Smad2 
and subsequent transcriptional activation (Dupont et al. 2009). In this example, 
ubiquitylation also affects protein activity indirectly. 
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Ubiquitylation can also direcly regulate protein activity by directing the proteolytic 
cleavage, or the partial proteolytic degradation of a protein. One such example is the 
Hh pathway transcriptional effector protein Cubitus interruptus (Ci), which is 
ubiquitylated and partially processed by the 26S proteasome, resulting in the removal 
of the transcriptional activation domain (Smelkinson & Kalderon 2006; J. Jiang & 
Struhl 1998; J. Jia et al. 2005; Noureddine et al. 2002). This generates a truncated, 
repressor protein, which translocates to the nucleus to inhibit the transcription of Hh 
pathway target genes (Méthot & Basler 1999). Changes in protein activity can also 
be the result of allosteric regulation through conformational changes following 
ubiquitylation (Ditzel et al. 2008). 
 
Finally, ubiquitylation can regulate proteins by affecting their subcellular 
localization. As mentioned earlier, monoubiquitylation of plasma membrane proteins 
can result in their internalization into endosomes, as well as further re-routing to 
proteolytic lysosomes (Terrell et al. 1998; Stringer & Piper 2011). Additionally, the 
multimonoubiquitylation of the transcription factor p53 was shown to result in its 
nuclear export (M. Li et al. 2003).  
 
1.2 Hedgehog (Hh) signalling in development and 
disease 
 
When Christiane Nüsslein-Volhard and Eric Wieshaus performed a genetic screen to 
identify genes that are involved in the development of the fruit fly larval body plan in 
1980, they came across Drosophila larvae that displayed disorganized bristles 
reminiscent of hedgehog spines (Nüsslein-Volhard & Wieschaus 1980). The 
distinctive phenotype was a result of a null allele of one gene, which they named 
hedgehog (hh), unknowingly establishing the Hedgehog signalling field and 
initiating a flood of research in developmental and cancer biology. Now, we know 
that the hh gene gives rise to a secreted protein that acts as a morphogen, diffusing 
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over relatively large distances to direct tissue patterning during development, and 
acting in a gradient-dependent manner to activate a signalling cascade in target cells 
(Figure 1.5). The ultimate target of the Hh signalling pathway is the regulation of the 
transcription factor Cubitus interruptus (Ci), which controls Hh target gene 
transcription and thus orchestrates a breadth of cellular outcomes depending on the 
concentration of Hh ligand and tissue type (Ingham & McMahon 2001).  
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Figure 1.5: Hedgehog (Hh) signalling. (Upper panel) Hh ligand is expressed in, and secreted by, 
Hh-producing cells, and binds to its receptor Patched (Ptc) on Hh-responsive cells. (Left panel) This 
relieves inhibition of the trans-membrane protein Smoothened (Smo) by Ptc, which then initiates 
downstream signalling, and involves the phosphorylation of the Smo cytoplasmic tail by the kinases 
Gprk2, PKA, and CKI. This, in turn, results in the recruitment of the Hh signalling complex (HSC) to 
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the Smo cytoplasmic tail, consisting of the scaffold protein Costal 2 (Cos2), Fused (Fu), Supressor of 
fused (Sufu), and the transcriptional activator protein Ci155. Fu phosphorylates the negative regulators 
of Ci155, Cos2 and Sufu, resulting in the release of Ci155 from the complex, and its subsequent 
translocation into the nucleus to activate target gene expression. The Ci target gene rdx/hib (Hs SPOP) 
encodes a Cul3-based E3 ligase, which is responsible for the complete degradation of Ci155, forming a 
negative feedback loop to control Hh pathway activity. (Right panel) In the absence of Hh ligand, Ptc 
inhibits Smo, which prevents its association with the HSC. Instead, Ci155 is retained by the HSC in the 
cytoplasm, which results in its sequential hyper-phosphorylation by multiple kinases that associate 
with the HSC, and include PKA, Sgg (Hs GSK3β), and CKI. Phosphorylated Ci155 is recognised by 
the Cul1-based E3 ligase Slimb (Hs βTrcP), which directs proteolytic processing of Ci155 via the 26S 
proteasome, resulting in the generation of a truncated Ci75 protein that lacks the transcriptional 
activation domain. Instead, Ci75 translocates to the nucleus to repress the transcription of target genes.  
 
Hh signaling is largely conserved between flies and mammals, and plays a key role 
in embryonic development, as well as adult stem cell maintenance and tissue 
homeostasis (Wilson & Chuang 2010; Ingham & McMahon 2001; Beachy et al. 
2004). Expression of hh and the resulting activation of the Hh pathway, which I will 
collectively refer to as Hh signalling, must therefore be tightly regulated in both a 
spatial and temporal manner. As a result, it is not surprising that defects in Hh ligand 
expression have been linked to tumour formation and maintenance in adults (L. L. 
Rubin & de Sauvage 2006; Scales & de Sauvage 2009). Although many components 
of the Hh pathway have been discovered using Drosophila and mouse genetics 
(Wilson & Chuang 2010; Forbes et al. 1993), the molecular mechanisms governing 
Hh ligand expression remain somewhat elusive.  
 
The field of Hh signalling in Drosophila and vertebrates is vast, and thus beyond the 
scope of this thesis. As I am using the Drosophila eye as a developmental model 
system to determine the role of Hyd in the regulation of hh expression and the Hh 
pathway, I will concentrate on the molecular mechanisms underlying Hh ligand 
expression and Hh pathway transduction in the fruit fly, with a particular focus on 
the function of Hh signalling in the developing eye. Additionally, I will elaborate on 
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the pathological roles of Hh signalling in human cancer biology, to highlight the 
translational potential of the research presented in this thesis. 
 
1.2.1 Expression and secretion of Hh ligand from Hh-
producing cells 
 
1.2.1.1 Transcriptional and epigenetic regulation 
 
During Drosophila embryonic development, the homeodomain transcription factor 
Engrailed (En) positively regulates hh transcription in the posterior of each larval 
segment (Tabata et al. 1992). Similarly, En regulates hh expression in the posterior 
compartments of the larval leg and wing imaginal discs (Tabata et al. 1995; Zecca et 
al. 1995). The mechanism by which En regulates hh transcription is indirect, and 
involves the negative regulation of ci expression (Domínguez et al. 1996; Eaton & 
Kornberg 1990; Schwartz et al. 1995). The full-length Ci protein, Ci155, is normally 
processed to the Ci75 transcriptional repressor form, which directly represses hh 
transcription in the wing disc (Domínguez et al. 1996; Méthot & Basler 1999). As a 
result, En-mediated repression of ci expression allows hh expression in the posterior 
compartment. Similarly, in the absence of En in the anterior compartment, Ci75 
represses hh expression (Domínguez et al. 1996; Méthot & Basler 1999). 
Additionally, another target gene of Ci155, master of thickveins (mtv), encodes a 
protein that, together with the co-repressor Groucho (Gro), represses hh and en 
expression in anterior cells (Bejarano et al. 2007; de Celis & Ruiz-Gómez 1995). 
However, En function is not required for hh expression in the eye-antennal disc 
(Strutt & Mlodzik 1996). Instead, the transcription factor Pointed, which is activated 
downstream of the Epidermal growth factor receptor (Egfr)/Ras pathway, binds an 
eye specific enhancer in the hh gene to drive expression of hh in the posterior 
compartment of the eye disc (Rogers et al. 2005). 
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Finally, hh expression in the wing disc is also controlled by an epigenetically 
regulated chromosomal element upstream of the hh gene known as a Cellular 
Memory Module (CMM) (Maurange & Paro 2002). The Trithorax-group (trxG) and 
Polycomb-group (PcG) proteins are epigenetic regulators that interact with CMMs, 
and act to maintain the active or silenced states of transcrption, respectively (Francis 
& Kingston 2001). Once activated or repressed in the respective compartments, hh 
expression in the wing disc is maintained through the action of trxG and PcG 
regulators on its CMM (Maurange & Paro 2002; Chanas & Maschat 2005). 
 
1.2.1.2 Post-translational processing and modification 
 
Following hh gene transcription and translation, the immature 45kDa Hh protein 
undergoes autoproteolytic cleavage and lipidation, which is mediated by the carboxy-
terminal region of the protein (Hh-C). This involves recruitment of cholesterol by the 
Hh-C moiety, and subsequent covalent attachment of cholesterol to the amino-
terminal (Hh-N) (Perler 1998; Mann & Beachy 2004). Following cleavage, Hh-C is 
degraded by the proteasome (X. Chen et al. 2011). Hh-N is then further post-
translationally modified by the acyltransferase skinny hedgehog (SKI), which 
catalyses the attachment of a palmitic acid group to Hh-N (Chamoun et al. 2001), 
and this has been shown to increase Hh-N protein activity (F. R. Taylor et al. 2001; 
M.-H. Chen et al. 2004). This generates a dually lipid-modified 19kDa Hh-N protein 
that is cholesterol-modified at its carboxy-terminus and palmitoylated at its amino-
terminus. As a result, Hh-N readily associates with sterol-rich microdomains on the 
plasma membrane (Rietveld et al. 1999), and its cholesterol modification in 
particular restricts Hh-N diffusion as it promotes its retention in the plasma 
membrane (Peters et al. 2004). The secretion of Hh-N requires the action of the 
multipass transmembrane protein Dispatched (DISP), which binds to the cholesterol 
moiety on Hh-N and promotes its release from the cell surface (Tukachinsky et al. 
2012). 
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1.2.2 Activation of the Hh pathway in Hh-responsive cells 
 
The secreted Hh ligand binds to its receptor, the transmembrane protein Patched 
(Ptc) (Nakano et al. 1989), on Hh-responsive cells, resulting in the activation of the 
Hh signaling cascade, and the transcription of tissue-specific Hh target genes by Ci 
(Figure 1.5). The transmembrane proteins Interference Hedgehog (Ihog) and Brother 
of Ihog (Boi) are thought to act as co-receptors (Camp et al. 2010; X. Zheng et al. 
2010). Hh does not directly interact with Ptc, however it does directly interact with 
Ihog and Boi, suggesting that these co-receptors are required for the indirect binding 
of Hh to Ptc (McLellan et al. 2006; Yao et al. 2006). Hh signalling is also potentiated 
by glypicans on the plasma membrane, as their association with Hh enhances ligand 
stability and promotes the internalization of the Hh-Ptc complex (Yan & X. Lin 
2009). 
 
In the absence of bound Hh ligand, Ptc constitutively represses Hh pathway activity 
by inhibiting the action of the G-protein coupled receptor (GPCR) protein 
Smoothened (Smo) (Nakano et al. 1989; Hooper & Scott 1989). This triggers the 
removal of Smo from the plasma membrane, which is thought to occur through 
degradation and/or internalization of Smo into intracellular vesicles (Xia et al. 2012; 
S. Li et al. 2012). However, the molecular mechanism underlying Ptc-mediated Smo 
inhibition remains unclear.  
 
The target of Ptc-mediated repression, Smo, is an orphan GPCR with no known 
ligand. However, Ptc may control the influx and/or efflux of a naturally occurring 
sterol-like ligand that controls Smo activity (Taipale et al. 2002), as several agonists 
and antagonists have been shown to control vertebrate Smo activity by binding to its 
membrane-integrated heptahelical domain (Mas & Ruiz i Altaba 2010). Ptc may 
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regulate Smo’s potential sterol-ligand through its sterol-sensing domain (SSD) 
(Nikaido	  2011).  
 
Hh binding to Ptc relieves Ptc-mediated Smo inhibition, and initiates the intracellular 
signaling cascade (Figure 1.5). Smo accumulates at the plasma membrane, which is 
thought to be a result of increased trafficking from intracellular vesicles and/or an 
increase in Smo protein stability (Denef et al. 2000). Smo activation occurs through 
the phosphorylation of several residues on its cytoplasmic carboxy terminal tail by 
the sequential action of Protein Kinase A (PKA), Casein Kinase Iα (CKIα), and Gpcr 
Kinase 2 (GPRK2) (Y. Chen et al. 2010; H. Jia et al. 2010; J. Jia et al. 2004). This 
results in a conformational switch within the cytoplasmic region of Smo, which is 
required for Smo translocation to the plasma membrane and subsequent signalling 
activity (Zhao et al. 2007; Y. Chen et al. 2010). Interestingly, the level of Smo 
phosphorylation appears to be directly related to the strength of its signalling activity 
(J. Jia et al. 2004). Conversely, a group of protein phosphatases, including Pp1, Pp2a 
and Pp4, reverse Smo phosphorylation, thereby regulating the extent of Smo 
signalling activity (Y. Su et al. 2011b; H. Jia et al. 2009).  
 
Phosphorylation of the Smo carboxy-terminal tail promotes its association with the 
normally microtubule-bound Hh signaling complex (HSC), which consists of the 
scaffold protein Costal 2 (Cos2), Fused (Fu), Suppressor of Fu (SuFu), and the 
transcription factor Cubitus interruptus (Ci) (Figure 1.5) (Kalderon 2004). The 
function of the HSC is to regulate the transcriptional activity of the zinc-finger 
protein Ci, which has the bi-functional ability to activate or repress target gene 
expression. In humans, a gene duplication event has given rise to three Ci 
orthologues, GLI1-3. In contrast to Ci, the GLI proteins have designated functions, 
where GLI1 acts as the transcriptional activator, whereas GLI3 is a transcriptional 
repressor; with GLI2 exhibiting both properties (Hui & Angers 2011). Ci consists of 
a zinc finger DNA binding domain, a C-terminal activation domain, and an N-
terminal repressor domain (Figure 1.6). Importantly, Ci activity is regulated by three 
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key mechanisms: proteolytic processing, nuclear translocation, and degradation (J.	  
Jiang	  2006).    
 
Figure 1.6: Domain structure of the full length Ci155 protein. Degrons represent 
binding/recognition sites for the Cul1-based Slimb/βTrcP E3 ligase complex, which targets Ci155 for 
partial proteolyic processing. Adapted from (Briscoe & Thérond 2013). 
1.2.3 Proteolytic processing of Ci 
 
In the absence of Hh pathway activation, the HSC associates with the kinases: 
protein kinase A (PKA), casein kinase Iα (CKIα), and glycogen synthase kinase 3β 
(GSK3β), also known as Shaggy in Drosophila melanogaster. This promotes the 
sequential phosphorylation of Ci on multiple residues of its carboxy terminus 
(Figure 1.6). PKA initially phosphorylates certain residues, also known as priming 
sites, which then serve as recognition sites for GSK3β and CKIα, resulting in further 
phosphorylation of nearby residues (J. Jiang 2002; Price & Kalderon 2002; J. Jia et 
al. 2005). The hyper-phosphorylation of Ci promotes its recognition by the F-box-
containing protein Slimb [also known as β-transducing repeat-containing protein 
(βTrCP) in humans], which recruits an SCF E3 ubiquitin ligase complex, containing 
the S phase associated protein kinase 1 (SKP1) and Cullin 1 (CUL1), to catalyse Ci 
ubiquitylation. This, in turn, triggers the recognition, and subsequent partial 
proteolytic processing of Ci by the 26S proteasome, resulting in the removal of the 
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carboxy-terminal transcriptional activation domain (Figure 1.7) (Smelkinson & 
Kalderon 2006; J. Jiang & Struhl 1998; J. Jia et al. 2005; Noureddine et al. 2002). 
This processing event therefore gives rise to a truncated Ci transcriptional repressor 
protein (Ci75), which translocates to the nucleus and represses Hh target gene 
transcription (Méthot & Basler 1999). 
	  
Figure 1.7: Dual regulation of Ci155 by ubiquitylation. In the absence of Hh ligand, Ci155 is 
ubiquitylated by the Cul1-based Slimb E3 ligase complex, resulting in its partial proteolytic 
processing to a truncated Ci75 repressor protein via the 26S proteasome (left). In the presence of Hh 
ligand, the Cul3-based Rdx/Hib E3 ligase complex regulates Hh pathway activity by ubiquitylating 
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1.2.4 Ci: Nuclear translocation, Hh target gene transcription, 
and degradation 
 
In the presence of Hh ligand, the activation of Smo and downstream signaling events 
prevent the phosphorylation and proteolytic processing of Ci, which in turn permits 
the translocation of full-length Ci to the nucleus to activate transcription of Hh target 
genes (Figure 1.6). Ci is tethered to the cytosolic HSC through its interaction with 
the scaffold protein Cos2, which retains Ci in the cytoplasm and mediates 
interactions with both its positive and negative regulators (Robbins et al. 1997; W. 
Zhang et al. 2005). As a result, Cos2 is itself a negative regulator of Ci, in addition to 
the kinases that promote hyperphosphorylation and subsequent proteoytic processing 
of Ci (PKA, CKIα, and GSK3β). In addition, the cytoplasmic protein SuFu also 
binds Ci and prevents its translocation to the nucleus (Farzan et al. 2008). 
Conversely, Ci is positively regulated by the kinase Fu. Following Hh binding to Ptc, 
the stabilization and dimerisation of phosphorylated Smo at the plasma membrane 
results in the recruitment of the HSC to the Smo cytoplasmic tail, and the 
autoactivation of Fu, which is thought to involve dimerisation. Once activated, Fu 
phosphorylates Cos2, which results in the release of full-length Ci from the HSC 
(Ruel et al. 2007; Shi et al. 2011; Y. Zhang et al. 2011). Fu is also thought to 
antagonize SuFu, although the mechanism is unclear and does not appear to involve 
phosphorylation by Fu (Q. Zhou & Kalderon 2011). Instead, it has been suggested 
that Fu and other proteins may modify Ci directly to prevent its interaction with 
SuFu (Briscoe & Thérond 2013). Once full length Ci (Ci155) is released from Cos2 
and SuFu, it translocates to the nucleus and activates gene expression. There are 
many tissue specific Ci target genes, but the most ubiquitously expressed target gene 
is ptc (Ohlmeyer & Kalderon 1998). Another Ci target gene is rdx/hib, which 
encodes the Cul3-based E3 ubiquitin ligase Roadkill (Rdx)/ Hh-induced MATH and 
BTB domain-containing protein (Hib) (Hs Speckle-type PPZ; SPOP), and 
ubiquitylates Ci155 to target it for complete degradation via the 26S proteasome 
(Figure 1.7) (Q. Zhang et al. 2009; Kent et al. 2006; Q. Zhang et al. 2006). Both 
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expression of ptc and ubiquitylation of Ci155 by Rdx/Hib, as a result of nuclear 
accumulation of Ci155, therefore confer negative feedback to the pathway. 
 
1.2.5 Function of Hh signaling in Drosophila Eye 
development 
 
1.2.5.1 Eye Development in Drosophila 
 
Drosophila lends itself to studying eye development as flies can be genetically 
manipulated in a relatively simple and quick way. In addition, the fly eye-antennal 
(EA) imaginal disc (Figure 1.8) allows the simultaneous visualisation of spatial and 
temporal gene expression during the course of development, making it the ideal 
model organism for studying signalling pathways that contribute to the development 
of complex tissues. Furthermore defective adult eyes do not significantly impair the 
animals’ viability.  
 
The Drosophila adult compound eye is a highly organised lattice structure consisting 
of up to 800 independent subunits known as ommatidia. Each ommatidium is 
composed of 20 specialized cells, which include eight photoreceptor (PR) neurons, 
six pigment cells, 4 cone cells, and two mechanosensory bristles. The photoreceptors 
(PRs) form the core of the ommatidium and are further subdivided into six outer (R1-
R6) and two inner PRs (R7 and R8) (Ready	  et	  al.	  1976). 
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Figure 1.8: Development of the adult Drosophila eye and head from the larval eye-antennal 
(EA) imaginal disc. (A) Distinct regions of the EA disc give rise to specific structures that make up 
the adult head and retina. Figure taken from (Held 2005). (B) Expression of growth factors and 
morphogens that contribute to photoreceptor differentiation as the MF moves from the posterior to the 
anterior of the EA disc. A1-A3 (antennal segments 1-3), Ar (arista), Fr (frons; parallel grooves ≈ a 
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human fingerprint), MF (morphogenetic furrow), n (nerve = optic stalk), Oc (ocelli; oval = lateral 
ocellus; half-oval = median ocellus), Palp (palpus).  
During larval development, a monolayered epithelium called the eye-antennal disc 
gives rise to all ommatidial cells, and eventually the adult compound eye, head and 
antennae (Figure 1.8 A), as a result of various stages of patterning, determination 
and differentiation. The disc is derived from a cluster of 20 cells (Garcia-­‐Bellido	  &	  
Merriam	  1969) and is subdivided into distinct anterior and posterior regions early 
on during embryogenesis, which will eventually give rise to the antenna, and the 
retina, the vertex and the ocelli, respectively (Figure 1.8 A) (Tsachaki	  &	  Sprecher	  
2012). Following initial proliferation, eye disc cells are sequentially committed to 
becoming PRs or support cells during a wave of differentiation that is marked by a 
visible trough known as the morphogenetic furrow (MF). The MF moves across the 
disc from posterior to anterior, leaving differentiated cells behind it (i.e. posterior to 
the MF) (Figure 1.8 B) (Ready	  et	  al.	  1976;	  Wolff	  &	  Ready	  1991). During 
embryogenesis, all cells destined to give rise to the eye-antennal disc are marked by 
expression of the transcription factors Eyeless (Ey) and Twin of eyeless (Toy). 
During the early second instar larval stage, the disc begins to be separated into the 
posterior region, which mainly expresses Ey, and the anterior region, which mainly 
expresses the homeodomain transcription factor Cut (Kenyon	  et	  al.	  2003). The 
subdivision of the disc also involves two major signaling pathways: the Epidermal 
Growth Factor Receptor (EGFR) pathway, which results in the activation of the 
Ras/Raf/MEK/ERK signalling cascade, and the Notch (N) pathways, which continue 
to play diverse roles throughout subsequent stages of eye development (J.	  P.	  Kumar	  
&	  Moses	  2001a;	  Dominguez	  et	  al.	  2004;	  Kenyon	  et	  al.	  2003). 
 
In order to generate a sufficient number of cells that will follow a retinal fate, 
controlled cell proliferation has to take place during the initial growth phase of the 
disc, and this is mainly regulated by Notch signaling (Domínguez	  &	  de	  Celis	  1998). 
Notch signaling in turn activates the Janus tyrosine kinase/signal transducer and 
activator of transcription (JAK/STAT) pathway (Chao	  et	  al.	  2004;	  Ekas	  et	  al.	  2006;	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Reynolds-­‐Kenneally	  &	  Mlodzik	  2005;	  Tsai	  &	  Y.	  H.	  Sun	  2004), which is initiated by 
the cytokine-like ligand Unpaired (Upd) (Harrison	  et	  al.	  1998). 
 
Once sufficient proliferation has taken place and the region of the eye-antennal disc 
that will give rise to the eye field has been determined, undifferentiated precursor 
cells are sequentially committed to adopt a retinal fate as a result of a wave of 
differentiation starting at the posterior edge and ending within the anterior region of 
the disc. This wave of differentiation is associated with the MF, which moves across 
the disc over a two-day period (Tsachaki	  &	  Sprecher	  2012). The MF is visible as a 
narrow channel resembling a trough, its morphological appearance being the result of 
cellular contraction. Several signaling pathways, including the Notch, EGFR, 
Wingless (Wg), Hh and Dpp signaling pathways, work in concert to initiate the MF 
at the posterior margin of the eye disc early during the third larval instar stage (J.	  P.	  
Kumar	  &	  Moses	  2001b). As the MF moves towards the anterior region of the disc, 
it causes cells to arrest at the G1 phase of the cell cycle, marking the onset of 
differentiation, and this requires both Hh and Dpp signaling (Escudero	  &	  Freeman	  
2007;	  Firth	  &	  Baker	  2005). 
 
The first PR to be specified at the centre of each ommatidium is the R8 PR, which 
then recruits the remaining PRs in a stereotypic pattern (Tomlinson	  &	  Ready	  1987). 
The first PRs to join PR8 are R2 and R5, followed by R3 and R4, and finally R1 and 
R6, and R7. The R8 PR expresses the EGFR ligand Spitz, which activates the Ras 
pathway and specifies the fate of the recruited PRs (Freeman	  1994). Once all PRs 
have been specified, they undergo terminal differentiation, which involves the choice 
to express a specific rhodopsin gene, encoding photosensitive GPCRs, which are 
sensitive to a certain wavelength of light (Terakita	  2005). Finally, ommatidial 
development is completed during the pupal stage, where pigment cells and 
mechanosensory bristles are added at the periphery of the ommatidia. 
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1.2.5.2 The Role of Hh and other signalling pathways in Drosophila eye 
development 
 
Hh is the main signal that directs differentiation during the movement of the MF 
across the eye disc. Hh is secreted by cells posterior to the furrow (Figure 1.9, panel 
a), and signals to cells anterior to the MF, prompting them to withdraw from the cell 
cycle. As a result, ectopic expression of Hh anterior to the MF results in the 
generation of ectopic furrows (C.	  Ma	  et	  al.	  1993). Some functions of Hh signaling 
during retinal differentiaton are direct, whereas others are indirect and a result of Hh-
mediated expression of Dpp ligand (Figure 1.8 B) and subsequent stimulation of 
Dpp signalling (Heberlein	  et	  al.	  1993). Hh initiates the expression of the proneural 
transcription factor Atonal (Ato) in a transient strip anterior to the MF (Figure 1.8 B) 
(Jarman	  et	  al.	  1994). Ato is required for the specificiation of the R8 PR, the first PR 
that differentiates and forms the centre of the ommatidium.  This in turn results in the 
activation of EGFR/Ras signalling, which directs the recruitment and differentiation 
of the remaining PRs (Roignant	  &	  Treisman	  2009). Ato mutants are defective in 
the specification of eye disc cells, and, as a result, lack eyes completely (Jarman	  et	  
al.	  1995). EGFR/Ras signalling also ensures that the Hh pathway is no longer active 
in differentiated cells by promoting the expression of Rdx/Hib (Baker	  et	  al.	  2009). 
Rdx/Hib is only expressed in the posterior region of the disc (Figure 1.9, panels e 
and g), and ubiquitylates full-length Ci155, targeting it for degradation by the 
proteasome (Ou	  et	  al.	  2002).  
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Figure 1.9: Morphogen and Hh pathway component expression patterns in L3 EA discs. (a) X-
gal staining of β-gal expression from a hh enhancer trap (hhP30), indicating the expression pattern of 
hh in the EA disc (J. J. Lee et al. 1992). (b) and (c) X-gal staining of β-gal expression from wg (b) 
and dpp (c) lacZ reporters (A. Mukherjee et al. 2000). (d) Immunofluorescence image of Ptc 
antibody staining, indicating Ptc protein expression (Shyamala & Bhat 2002). (e) X-gal staining of β-
gal expression from an rdx lacZ reporter, indicating rdx/hib expression (Kent et al. 2006). (f) and (g) 
Expression patterns of slimb/cul1 (f) and rdx/cul3 (g) as determined by in situ hybridization with 
antisense probes of Cul1 and Cul3, respectively (Ou et al. 2002). 
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Antagonising Hh-regulated events, Wg signalling acts to suppress progression of the 
MF. During the third larval instar, Wg is expressed in the anterior-lateral margins of 
the disc (Figure 1.9, panel b), where it acts to promote head capsule development 
and inhibit retinal differentiation (Legent & Treisman 2008). 
1.2.6 Hh signalling in cancer 
 
Although Hh signalling plays a vital role during embryogenesis and development, it 
also occurs in the adult, mostly associated with stem/progenitor cell populations, at a 
few specialized sites, such as CNS neural stem cells and the gut epithelium, where it 
is required for tissue maintenance and repair (L. L. Rubin & de Sauvage 2006; Scales 
& de Sauvage 2009). Unsurprisingly, inappropriate activation of Hh signalling in 
humans is linked to cancer. Aberrant Hedgehog signalling encompasses both 
activating mutations in Hh pathway components, as well as mis-expression of Hh 
ligand that leads to activation of the Hh pathway in the same (autocrine) and/or 
neighbouring cells (paracrine or juxtacrine) (Scales & de Sauvage 2009). Regardless 
of method, activation of the Hh pathway has various outcomes which are context 
and/or cell type-dependent (Scales & de Sauvage 2009), but include upregulation of: 
cyclins and cyclin-dependent kinases, resulting in proliferation (Duman-Scheel et al. 
2002; Yoon et al. 2002); anti-apoptotic proteins such as B-cell lymphoma 2 (Bcl2), 
promoting cell survival (Bigelow et al. 2004; Regl et al. 2004); vascular endothelial 
growth factor (VEGF) and angiopoietins, which promote angiogenesis (Pola et al. 
2001); and the Zinc finger protein SNAI1 (also known as SNAIL), which initiates 
the epithelial-mesenchyme transition during tumour metastasis (Feldmann et al. 
2007). All of these Hh –associated outcomes contribute to tumourigenesis through 
driving cell proliferation, resistance to cell death and metastasis.  
Three models, known as Type I to III/IIIb, have been proposed for Hh pathway 
activity in human cancers (Figure 1.8A) (L. L. Rubin & de Sauvage 2006). Type I 
cancers are Hh ligand independent and harbour activating mutations in Hh pathway 
Hyd regulates morphogen signalling in the developing eye 
Chapter 1: Introduction   34 
components, such as Ptc. By contrast, type II and type III cancers are Hh ligand 
dependent and are chracterised by mis-expression of Hh ligand by cancer cells. Hh 
ligand secreted by the tumour epithelium either signals to the same (autocrine) or 
neighbouring cells (juxtacrine) in type II tumours, or to more distant stromal cells 
(paracrine) surrounding the tumour. Type III tumours respond to Hh stimulation by 
secreting other extracellular signalling molecules that, in turn, signal back to the 
tumour cell to promote its growth and survival (L. L. Rubin & de Sauvage 2006).  
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Figure 1.10: Hh signalling in human cancer. (A) Three models of Hh signal activation that promote 
tumour growth and survival. (B) Hh signalling is de-regulated in human cancer. Cancers with 
mutations in the Hh signal transduction pathway (e.g. Ptc and Smo), leading to constitutive activation 
of the pathway, are shown in blue boxes. Cancers with an autocrine requirement for Hh ligand are 
shown in brown boxes. (L. L. Rubin & de Sauvage 2006) 
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1.2.6.1 Type I tumours 
 
The first indication that aberrant Hh signalling plays a role in cancer came with the 
discovery that the rare genetic condition called Gorlin syndrome (also known as 
basal cell nevus syndrome) is caused by inactivating mutations in PTCH1 (Hahn et 
al. 1996; R. L. Johnson et al. 1996). This leads to constitutive activation of the Hh 
pathway even in the absence of Hh ligand (Figure 1.10). Gorlin patients are 
therefore predisposed to numerous types of cancer, and develop basal cell 
carcinomas (BCCs), a skin tumour of keratinocytes, in addition to medulloblastomas 
(cancer of the cerebellum) and rhabdomyosarcomas (a rare form of muscle cancer) 
during the early stages of their lives (L. L. Rubin & de Sauvage 2006; Scales & de 
Sauvage 2009). 
 
In addition, the majority (>85%) of sporadically occurring BCCs also harbour 
inactivating mutations of PTCH1 or loss of heterozygosity, and in some cases 
contain activating mutations in SMO that prevent its inhibition by PTCH1 (Unden et 
al. 1996; Gailani et al. 1996; Reifenberger et al. 1998; Reifenberger et al. 2005; Xie 
et al. 1997). In all cases, this leads to increased Hh signaling in the tumour cells. 
Rhabdomyosarcoma and medulloblastoma are mainly paediatric cancers that are 
associated with loss of heterozygosity or mutations in the negative Hh pathway 
regulators PTCH1 or SUFU (Raffel et al. 1997; Pietsch et al. 1997; Vorechovsky et 
al. 1997; M. D. Taylor et al. 2002; Tostar et al. 2006). Although cell autonomous 
activation of the Hh pathway activity is well established in these tumours, there is 
little evidence that suggests this particular mechanism occurs in other tumour types 
(L. L. Rubin & de Sauvage 2006). 
1.2.6.2 Type II tumours 
 
In type II tumours, the tumour cells mis-express and secrete Hh ligand, which then 
signals to the same cells or neighbouring tumour cells to stimulate their proliferation 
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and/or survival (Figure 1.10), ultimately leading to tumour growth (Scales & de 
Sauvage 2009). Hh over-expression as a tumour promoting factor was first identified 
in small cell lung cancer (SCLC) (Watkins et al. 2003). Since then several tumours 
that over-express Hh have been identified, including non-small cell lung cancer 
(nSCLC) (Yuan et al. 2007), pancreatic cancer (Thayer et al. 2003; Berman et al. 
2003), upper gastrointestinal tract cancer (Berman et al. 2003; X. Ma et al. 2006), 
colorectal cancer (Qualtrough et al. 2004), prostate cancer (Karhadkar et al. 2004; 
Sanchez et al. 2004), breast cancer (S. Mukherjee et al. 2006) and melanoma (Stecca 
et al. 2007) tumours. Although there is much evidence for Hh over-expression 
occurring in tumour biopsies and cancer cells in culture, type II Hh signaling has not 
yet been conclusively demonstrated in vivo (L. L. Rubin & de Sauvage 2006). 
 
1.2.6.3 Type III tumours 
 
In contrast to autocrine/juxtacrine Hh signaling observed in type II tumours, type III 
tumours involve paracrine Hh signaling between the tumour and the surrounding 
stromal cells (Figure 1.10), which includes fibroblasts, endothelial cells and immune 
cells (Scales & de Sauvage 2009). Human prostate, pancreatic and metastatic colon 
tumours express Hh in the tumour epithelium, which results in increased GLI1 
expression (i.e. Hh pathway activation) in the surrounding stromal cells (Fan et al. 
2004; Bailey et al. 2008; H. Tian et al. 2009). The stromal cells in turn send growth 
and/or survival signals back to the tumour, creating a favourable microenvironment 
for tumour growth (Scales & de Sauvage 2009). In addition, a ‘reverse paracrine’ 
model (Type IIIb) has been proposed, in which Hh is secreted by stromal cells 
instead and signals to tumour cells. However, this has only been observed in B-cell 
lymphoma, multiple myeloma and leukemia so far, where Hh secreted from the bone 
marrow stroma appears to be essential for the survival of cancer cells in vitro (Dierks 
et al. 2007; Hegde et al. 2008). 
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1.2.6.4 Therapeutics 
 
Hh pathway inhibitors (HPIs) that block Hh signaling at or below the level of Smo 
could theoretically be used to treat both Hh ligand independent (type I) and Hh 
ligand dependent (type II and III) cancers. Ptch1+/- heterozygous mice develop 
spontaneous medulloblastomas and are often used as a model system for testing HPIs 
(Romer et al. 2004; Sanchez & Ruiz i Altaba 2005). Cyclopamine and jervine were 
the first HPIs to be identified and were originally isolated from corn lilies (Bryden et 
al. 1971). Both inhibit the Hh pathway by binding to SMO, which is thought to 
involve a conformational change in the SMO protein (Cooper et al. 1998; J. K. Chen, 
Taipale, Cooper, et al. 2002a). However, several factors, such as their low binding 
affinity, poor oral bioavailability and unfavourable pharmacokinetics (Lipinski et al. 
2008), led to the generation of more potent and/or soluble derivatives of cyclopamine 
(J. K. Chen, Taipale, Young, et al. 2002b; Tremblay et al. 2008). In addition, several 
screens identified novel synthetic HPIs, including HhAntag (Frank-Kamenetsky et al. 
2002), SANT1–SANT4 (J. K. Chen, Taipale, Young, et al. 2002b), Cur-61414 
(Williams et al. 2003) and GDC-0449 (Scales & de Sauvage 2009). Some HPIs also 
act upstream of SMO by blocking the interaction of Hh with Ptc, and examples of 
these include the Hh-blocking antibody 5E1 (Ericson et al. 1996) and the small 
molecule inhibitor robotnikinin (Stanton et al. 2009). Notably, although several drugs 
and antibodies that inhibit Hh binding to Ptc are being developed, no compounds are 
known to exist that inhibit Hh over-expression at the source, which is the underlying 
cause of tumour growth in the more common type II and type III Hh ligand 
dependent cancers (Scales & de Sauvage 2009). 
 
Only HPIs inhibiting SMO have been tested in humans so far. Cyclopamine, applied 
topically in a cream formulation, resulted in the regression of BCC tumours (Tabs & 
Avci 2004), and the orally available SMO inhibitor GDC-0449 (Genentech and 
Curis) promoted tumour regression in phase I clinical trials with patients that had 
various metastatic or advanced tumours. As a result, GDC0449 has since entered 
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phase II trials for several cancers. Finally, the HPIs IPI-926 (Infinity 
Pharmaceuticals) and BMS-833923 (also known as XL139; Bristol Myers Squibb 
and Exelixis) are also currently used in phase I clinical trials (Scales & de Sauvage 
2009).  
 
1.3 The Wg/Wnt Pathway and its regulation by the 
kinase Shaggy(Sgg)/GSK3β 
 
Wg/Wnt signalling plays an important role in cellular proliferation and 
differentiation during development (van Amerongen & Nusse 2009). The wingless 
(wg) gene was originally identified as a regulator of segment polarity during larval 
development in Drosophila (Nüsslein-Volhard & Wieschaus 1980). Its mammalian 
homologue Wnt (Rijsewijk et al. 1987), which is expressed by one of 19 different 
genes in humans, is a proto-oncogene that produces a secreted, cysteine-rich protein 
(Tanaka et al. 2002). Wnt proteins are lipid modified (Willert et al. 2003), which is a 
requirement for Wnt signalling and is thought to be important for Wnt secretion 
(Franch-Marro et al. 2008; Kurayoshi et al. 2007; Willert et al. 2003). Although 
Wnts are often thought of as classical morphogens, forming a gradient that 
determines cell fate in a concentration-dependent manner over relatively large 
distances (endocrine signalling) as seen in the Drosophila wing imaginal disc (Zecca 
et al. 1996), they mediate juxtacrine (contact-dependent) or paracrine (short-range) 
signalling over a short distance in most tissues (Clevers & Nusse 2012). 
 
1.3.1 Wg/Wnt activates the Wg/Wnt pathway in target cells 
 
Wnt proteins activate the Wnt signaling pathway by binding to a heterodimeric 
receptor complex on target cells (Figure 1.11). The Wnt receptor complex contains 
the seven-transmembrane (7TM) receptor Frizzled, which interacts directly with Wnt 
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proteins through its large extracellular amino terminus (Bhanot et al. 1996; Dann et 
al. 2001; Janda et al. 2012), and the single-pass transmembrane protein LRP5/6, 
which is also known as Arrow in Drosophila (Pinson et al. 2000; Tamai et al. 2000; 
Wehrli et al. 2000).  
 
Binding of Wg/Wnt ligand to the Frizzled-LRP6 receptor complex induces a 
conformational change of the latter, resulting in phosphorylation of its cytoplasmic 
tail by the kinases GSK3β and CK1γ (X. He et al. 2004; Tamai et al. 2004). This 
results in the recruitment of the Wg/Wnt pathway protein Axin, which interacts with 
LRP6 (Mao et al. 2001). However, relatively little is known on how GSK3β and 
CK1γ are recruited and/or activated as a result of Wg/Wnt pathway activation, and 
the role of the Frizzled receptor component in pathway transduction remains unclear. 
Frizzled interacts with the cytoplasmic protein Dishevelled (Dsh) (W. Chen et al. 
2003), which is thought to promote the interaction between Axin and the LRP tail. 
 
The major molecular outcome of Wg/Wnt pathway transduction is the regulation of 
the stability of the transcriptional effector protein β-catenin by the APC/Axin 
destruction complex. The destruction complex consists of β-catenin, the tumour 
suppressor protein APC, the serine-threonine kinases GSK3β and CK1γ, and the 
scaffold protein Axin, which also interacts with the LRP tail (Figure 1.11) (reviewed 
in (Clevers & Nusse 2012)). In the absence of Wg/Wnt ligand binding to the 
Frizzled-LRP6 receptor, CK1γ and GSK3β sequentially phosphorylate β-catenin at 
multiple serine and threonine residues. The phosphorylated β-catenin is subsequently 
recognized by the F box/WD repeat protein Slimb/β-TrCP, which forms part of a 
multi-subunit E3 ubiquitin ligase complex, leading to ubiquitylation and degradation 
of β-catenin via the proteasome (Aberle et al. 1997). Phosphorylated β-catenin 
dissociates from the APC/Axin/GSK3β/CK1γ complex and is bound by cytoplasmic 
β-TrCP to be degraded by the proteasome. Conversely, Wg/Wnt pathway activation 
promotes the association of Axin with the LRP6 tail, resulting in the dissociation of 
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the complex and releasing β-catenin, which translocates to the nucleus to activate 
transcription of Wg/Wnt pathway target genes (Figure 1.11). 
 
Figure 1.11: The Wg/Wnt signalling pathway. (left panel) Wg binding to target cells results in the 
heterodimerisation of the Frizzled and LRP/Arrow receptors. This results in LRP/Arrow 
phosphorylation and subsequent sequestration of Axin and Dishevelled (Dvl). Cytoplasmic Armadillo 
(Arm)/β-catenin (βcat) translocates to the nucleus and binds DNA-bound T cell factor (TCF) 
transcription factors to activate target gene transcription. (right panel) In the absence of Wg ligand, 
the Frizzled and LRP/Arrow receptors dissociate, and Axin forms a multi-protein complex with APC, 
Arm/βcat, and the kinases CKI and Sgg/GSK3β. CKI and Sgg/GSK3β phosphorylate Arm/βcat at 
multiple sites, which results in its recognition and ubiquitylation by the Cul1-based E3 ligase 
Slimb/βTrcP, and its subsequent degradation via the proteasome. Target gene transcription is 
repressed by the binding of the co-repressor protein Groucho (Gro) to TCF transcription factors. 
Adapted from (Clevers & Nusse 2012). 
Once in the nucleus, β-catenin interacts with DNA-bound T cell factor (TCF) 
transcription factors, also known as Pangolin in Drosophila, to initiate Wnt/Wg 
target gene transcription (Figure 1.11) (Behrens et al. 1996; Molenaar et al. 1996). 
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TCF transcription factors recognize the highly conserved consensus motif 
AGATCAAAGG in both vertebrates and Drosophila (van de Wetering et al. 1997). 
The pTOPflash Wnt/TCF reporter, which contains various repeats of the consensus 
sequence, is a widely used experimental tool, which exploits the high affinity of TCF 
for this motif (Korinek et al. 1997). Two other proteins, Bcl9/Legless and Pygopus, 
which were first identified in Drosophila, are also thought to associate with the β-
catenin/TCF complex to activate gene transcription, although their exact roles in the 
process are less clear (Kramps et al. 2002; Parker et al. 2002; Thompson et al. 2002). 
In the absence of Wg/Wnt pathway activation, and thus the absence of nuclear β-
catenin, the transcription of Wg/Wnt target genes is prevented as a result of the 
interaction of TCF with the transcriptional repressor protein Groucho (Figure 1.11) 
(Cavallo et al. 1998; Roose et al. 1998). Many Wg/Wnt target genes exist, including 
the well-known Wnt target gene AXIN2 (Lustig et al. 2002), however most are tissue 
and/or developmental stage specific (Clevers & Nusse 2012). 
 
1.3.2 Wg/Wnt Signaling in Cancer 
 
Human tumours frequently harbour Wnt pathway mutations. Notably, the vast 
majority of colorectal cancers contain mutations in the APC tumour suppressor gene 
(Wood et al. 2007). Loss of APC leads to stabilization of β-catenin and constitutive 
activation of Wnt target genes (Korinek et al. 1997). APC gene mutations can be 
inherited, causing a hereditary cancer syndrome known as familiar adenomatous 
polyposis (FAP) (Kinzler et al. 1991; Nishisho et al. 1991). FAP is caused by 
heterozygous APC mutation, which promotes the growth of benign colon adenomas 
and polyps. However, the additional mutation of the second APC allele (Kinzler & 
Vogelstein 1996), or other genes such as KRAS, P53, and SMAD4, results in 
malignant tumour formation. In rare cases of colorectal cancer where APC is not 
mutated, loss-of-function mutations in Axin (W. Liu et al. 2000), as well as 
activating point mutations in β-catenin (Morin et al. 1997) have been reported. In 
addition, similar mutations have also been identified in hepatocellular carcinomas 
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and melanomas, as well as other tumours (Rubinfeld et al. 1997; Reya & Clevers 
2005). 
 
1.3.3 The multiple cellular functions and regulation of the 
kinase GSK3β 
 
1.3.3.1 Cellular functions of GSK3β 
 
Although glycogen synthase kinase 3 β (GSK3β) was originally identified as a key 
enzyme involved in glycogen metabolism, many other functions for this versatile 
serine/threonine kinase have since come to light, including its involvement in various 
signalling pathways, such as insulin, growth factor, Wg/WNT and Hh/SHH 
pathways, as well as the control of the cell cycle, apoptosis and microtubule function 
(reviewed in (Cohen	  &	  Frame	  2001)). 
 
GSK3β is a negative regulator of both glycogen and protein synthesis. GSK3β 
phosphorylates and thereby inactivates the enzyme glycogen synthase, which 
catalyses the final step in glycogen synthesis, and the eukaryotic initiation factor 2B 
(eIF2B). Insulin-induced signaling results in the activation of protein kinase B, which 
in turn phosphorylates and inhibits GSK3β (Cross	  et	  al.	  1995), resulting in the 
desphosphorylation and activation of glycogen synthase and eIF2B (Hughes et al. 
1992; Welsh & Proud 1993). GSK3β is also thought to negatively regulate cell cycle 
entry and cellular proliferation by phosphorylating cyclin D1 (Alt et al. 2000; Diehl 
et al. 1998) and c-myc (Sears et al. 2000), promoting their subsequent ubiquitylation 
and degradation via the proteasome. Growth factor signalling results in the inhibition 
of GSK3β and therefore promotes stabilization of cyclin D and c-myc and cell 
growth and proliferation.  
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Interestingly, GSK3β also plays a key role in morphogen signalling, including the 
Wg/WNT and Hh/SHH pathways. Within WNT signalling, GSK3β has dual, 
switchable roles: (i) in the presence of WNT it promotes pathway activation at the 
receptor level by phosphorylating the LRP6 cytoplasmic tail and; (ii) in the absence 
of WNT ligand it negatively regulates pathway activity by phosphorylating the 
transcriptional effector β-catenin and promoting its proteasomal degradation (Clevers 
& Nusse 2012).  
 
In Drosophila, the Wg pathway is crucial in the determination of the pattern of 
segment polarity during larval development, which is characterized by alternating 
rows of bristles, and regions lacking bristles called naked cuticles. Loss of function 
(LOF) mutations in the wg gene result in the loss of naked cuticle, whereas LOF 
mutations in the fly homologue of GSK3β, Shaggy (Sgg)/zeste-white 3 (zw3), 
completely reversed this phenotype, leading to the loss of bristles, suggesting that 
Sgg negatively regulates the Wg pathway (Siegfried et al. 1992). Sgg/GSK3β 
negatively regulates Arm/β-catenin by phosphorylating it, which leads to its 
recognition and ubiquitylation by the Cul-1 based E3 ligase Slimb/βTrcP, and 
subsequent degradation (Figure 1.11) (Aberle et al. 1997). Similarly, Sgg/GSK3β 
negatively regulates Hh pathway activity by phosphorylating Ci155, leading to Ci 
ubiquitylation by Slimb/βTrcP and subsequent partial proteolytic processing to a 
transcriptional repressor form, Ci75 (Figure 1.5) (J. Jia et al. 2002). 
 
1.3.3.2 Substrate specificity and regulation of GSK3 activity 
 
GSK3β’s substrate specificity is defined by the requirement for a ‘priming 
phosphorylation’ on many of its substrates as a prerequisite to recognition and 
phosphorylation. GSK3β typically phosphorylates a substrate containing a priming 
phosphate on a serine/threonine residue located four residues carboxy terminal to 
another serine/threonine (Figure 1.12 A) (Fiol et al. 1987). For example, the 
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phosphorylation of Armadillo/β-catenin in the Wg/Wnt pathway by SGG/GSK3β 
requires a priming phosphorylation by casein kinase 1 (CK1) (C. Liu et al. 2002; 
Yanagawa et al. 2002). 
 
Figure 1.12: GSK3β substrate specificity and regulation. (A) GSK3β recognises a priming 
phosphate four residues carboxy terminal of its phosphorylation target site. (B) GSK3β activity is 
negatively (-) regulated by phosphorylation on Ser9 and treatment with LiCl, and positively (+) 
regulated by phosphorylation on Tyr216 (Tyr 214 for Sgg). Mutation of Ser9 to Ala generates a 
constitutively active kinase mutant. 
 
GSK3β is itself regulated by phosphorylation (Figure 1.12 B). GSK3β is considered 
to be constitutively active as a result of high levels of phosphorylation on a tyrosine 
residue present in the activation loop (Tyr214), which is incidentally equivalent to 
the mechanism of activation seen in MAPKs (Hughes et al. 1993). However, unlike 
MAPKs, an additional requirement for full GSK3β activation is the induction of the 
active kinase conformation through binding of the priming phosphate. 
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Phosphorylation of a serine residue at the extreme amino terminal of GSK3β (Ser9) 
is also used to negatively regulate its activity. The phosphorylation results in the 
recognition of this phosphoserine as a ‘pseudosubstrate’ by the GSK3β binding 
pocket that normally binds the priming phosphate on target substrates. This 
effectively prevents substrates from binding GSK3β, as well as sterically blocking 
access to the catalytic site (Frame et al. 2001). This serine residue is phopshorylated 
by different kinases in response to different stimuli, such as by PKB/AKT in 
response to insulin signalling (Cross et al. 1995). Finally, lithium ions were also 
shown to specifically inhibit GSK3β activity (Klein & Melton 1996; Stambolic et al. 
1996).  
 
Importantly, in the Wg/Wnt pathway, Sgg/GSK3β is not regulated via 
phosphorylation on Ser9 or Tyr214/216. Wg pathway transduction does not alter 
inhibitory Ser9 or activating Tyr214 phosphorylation levels of Sgg (Papadopoulou et 
al. 2004). In the Wg/Wnt pathway, Sgg/GSK3β is sequestered into the APC/Axin/β-
catenin destruction complex rather than diffusing freely in the cytoplasm. The 
inhibition of Sgg/GSK3β activity following Wg/Wnt pathway activation is thought to 
involve the disruption of the interaction of GSK3β with Axin by another protein 
complex. This protein complex is believed to contain at least two proteins, including 
Dishevelled and FRAT (frequently rearranged in advanced T- cell lymphomas) (L. 
Li et al. 1999), the mammalian homologue of the GSK3-binding protein (GBP) first 
identified in Xenopus (Yost et al. 1998). Additionally, recent findings have led to the 
proposal of two new models of GSK3β regulation in Wnt signalling (Metcalfe & 
Bienz 2011). One involves the negative regulation of GSK3β activity following 
phophorylation of a serine residue in the LRP receptor cytoplasmic tail, which acts as 
a ‘pseudosubstrate’ and binds to the GSK3β binding pocket, preventing the 
interaction with β-catenin. Another model proposes that Wnt pathway activation 
triggers the uptake of GSK3β into multivesicular bodies (MVBs), thus physically 
sequestering GSK3β and preventing phosphorylation of β-catenin (Metcalfe & Bienz 
2011). 
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1.3.4 Wingless signaling in Drosophila eye development 
 
Wg plays a crucial role in Drosophila eye development by defining head tissue and 
retinal tissue boundaries, as well as regulating eye disc growth (reviewed in (Legent 
& Treisman 2008)). The eye antennal disc gives rise to both the retina and he 
surrounding head tissue (see Section 1.2.5 and Figure 1.8 A). Wg is mainly 
expressed in the anterior lateral margins of the eye disc (Figure 1.9, panel b), which 
will eventually give rise to the head capsule, where it acts to promote head capsule 
differentiation and restrict eye development (Treisman & G. M. Rubin 1995; Heslip 
et al. 1997; C. Ma & Moses 1995; Royet & Finkelstein 1996). Additionally, Wg 
contributes to the subdivision of the two tissue types by antagonizing the action of 
posteriorly expressed signalling molecules including Hh and Dpp, and thus defines 
the boundaries of the retinal field. As would be expected, inhibition of Wg activity 
using a temperature-sensitive allele or removal of the downstream signalling effector 
Dishevelled (Dsh) results in invasion of the eye field into the lateral regions of the 
dorsal head tissue (C. Ma & Moses 1995; Royet & Finkelstein 1996; Heslip et al. 
1997). Conversely, loss of negative regulators of Wg signaling, such as Shaggy (Sgg) 
or Axin (Axn), results in the expansion of head tissue at the expense of the retinal 
field (Treisman & G. M. Rubin 1995; Heslip et al. 1997; Baonza & Freeman 2002; J. 
D. Lee & Treisman 2001). Finally, Wg is also a regulator of eye disc growth, as 
clones over-expressing Wg or lacking the negative regulator Axin cause dramatic 
overgrowth of the eye disc (Treisman & G. M. Rubin 1995; Baonza & Freeman 
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1.4 Hyperplastic Discs (Hyd) and its mammalian 
orthologues 
 
Hyperplastic Discs (Hyd) is a Drosophila HECT-domain bearing E3 ubiquitin ligase 
protein (Callaghan et al. 1998). The hyd gene was first identified in a genetic screen 
for temperature sensitive mutations, which caused overgrowth of imaginal discs in 
mutant hyd larvae raised at restrictive temperatures (Martin et al. 1977). Further 
genetic evidence identified Hyd as a tumour suppressor following the isolation of 
twenty new mutant hyd alleles in a screen for mutations causing imaginal disc 
overgrowth (Mansfield et al. 1994). Homozygous mutation of the hyd gene is 
generally lethal, with most alleles causing lethality between the second larval instar 
and the pupal stages, although the null phenotype is predicted to be lethal at or before 
the second larval instar. In most cases, any temperature sensitive alleles of hyd that 
give rise to viable adults at permissive temperatures result in sterility, defects in germ 
tissue morphology and reduced lifespan (Mansfield et al. 1994). In agreement with 
this observation, hyd mutants display various spermatogenesis defects, including 
defects in chromosome condensation, spindle attachment and centrosome behaviour 
during meiosis (Pertceva et al. 2010).  
 
Mosaic genetic screens using homozygous mutant hyd clones in the eye imaginal 
disc later implicated Hyd in the regulation of Hh signalling (J. D. Lee et al. 2002). In 
developing Drosophila larvae, anterior eye disc clonal cells containing homozygous 
mutations of the hyd gene mis-express the morphogens hedgehog (hh) and 
decapentaplegic (dpp). This results in non-autonomous premature photoreceptor 
differentiation and ectopic proliferation of surrounding wild type tissue, giving rise 
to overgrown (i.e hyperplastic) and/or deformed eyes in adult flies (Figure 1.13 A) 
(J. D. Lee et al. 2002).  
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Furthermore, Hyd negatively regulates hh gene expression and Hh pathway activity 
through independent mechanisms (Figure 1.13 B), as these findings show that (i) 
Hyd regulates dpp expression downstream of hh expression, as well as (ii) regulating 
hh expression independently of Ci.  
 
dpp is transcribed in response to Hh pathway activation at the morphogenetic furrow 
(MF) (Penton et al. 1997). However, in hyd and hh double mutant clones, dpp is still 
mis-expressed, suggesting that ectopic dpp expression was not a consequence of Hh 
pathway activation, and that Hyd regulates dpp expression independently of its 
regulatory effects on hh expression. Additionally, loss of hyd in hyd and hh double 
mutant clones also caused full-length Ci155 to accumulate in anterior clones, 
suggesting that Hyd reduces Ci155 levels independently of Hh pathway activity, and 
that Hyd regulates Hh pathway activity upstream or at the level of Ci (Figure 1.13 
B).  
 
On the other hand, over-expression of a ci75 transgene, encoding the Ci75 
transcriptional repressor, in hyd mutant clones blocked dpp expression, but not hh 
expression. Ci75 normally represses the transcription of dpp, and also represses the 
transcription of hh in anterior cells in the wing disc (see Section 1.2.1.1) 
(Domínguez et al. 1996; Méthot & Basler 1999). However, these findings suggest 
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Figure 1.13: hyd mutant phenotype, role in Hh signalling and domain structure. (A) hydmt clones 
in the eye disc cause non-autonomous overgrowth of eye tissue and hyperplasia in adult eyes. (J. D. 
Lee et al. 2002) (B) Hyd regulates Hh signalling via two independent mechanisms. (C) Hyd domain 
structure. Hyd contains five functional domains: the ubiquitin-associated (UBA) domain, the regulator 
of chromatin condensation (RCC) domain, the UBR-type zinc finger domain, the poly(A)-binding 
protein C-terminal (PABC) domain, and the catalytic E6AP-type E3 ubiquitin-protein ligase (HECT) 
catalytic domain. 
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Although genetic evidence implicates Hyd in the regulation of Hh signaling and 
morphogen gene expression, the molecular mechanism underlying its role in these 
processes is unknown.  
 
The Hyd protein was found to be both cytoplasmic and nuclear, whereas its potential 
localization in the plasma membrane was excluded (Mansfield et al. 1994). At the 
time of commencing this project, there was only one potential interaction for the Hyd 
protein described in the literature. Lewis et al. performed a mass spectrometry co-
purification experiment on fractionated Drosophila embryo extracts, which 
demonstrated the existence of a large, multi-protein complex, the Myb-
MuvB/dREAM complex, which is involved in regulating DNA replication and gene 
transcription during development. In this experiment, Hyd was co-purified with two 
of the core complex components, Mip120 and Mip130 (Lewis et al. 2004). The Myb-
MuvB/dREAM complex was shown to epigenetically regulate gene transcription in 
vivo, in particular the expression of polo kinase 1 (PLK1), a regulator of spindle pole 
assembly, and components of the spindle assembly checkpoint (SAC) (Wen et al. 
2008). An interaction with the Myb-MuvB/dream complex would therefore implicate 
Hyd in the regulation of the cell cycle and mitosis. Since then, large-scale co-affinity 
purification mass spectrometry screens with Drosophila proteins have produced a 
wealth of protein-protein interaction data (Guruharsha et al. 2011; Friedman et al. 
2011), in which a number of potential Hyd interacting proteins were identified. This 
data is publicly accessible on the Drosophila Interactions Database (DroID; 
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1.4.1 Structure and function of the Hyd protein 
 
A vital source of information with regards to the molecular function of the Hyd 
protein lies in its amino acid sequence. Hyd is a relatively large protein (319 kDa) 
and contains five distinct domains, as well as two nuclear localization signals 
(Figure 1.13 C). Hyd shares up to 40% sequence identity with its mammalian 
homologues UBR5 (Mus musculus) (Saunders et al. 2004) and E3 in Differential 
Display (EDD) (Homo sapiens) (Callaghan et al. 1998). Remarkably, sequence 
identity between the three homologues rises up to 90% across individual domains, 
suggesting that they may also share evolutionarily conserved functions (Figure 
1.14). 
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Figure 1.14: ClustalW Alignment of Hyd (D melanogaster), EDD (H sapiens) and UBR5 (M 
musculus) protein sequences. Hyd shares high sequence identity with EDD and UBR5 across 
individual domains: UBA (aa 154-196), UBR (aa 1217-1285), PABC (aa 2484-2561), and HECT (aa 
2782-2885). 
1.4.1.1 Homologous to E6-AP C-terminus (HECT) Domain 
 
The presence of the homologous to the E6-AP carboxyl terminus (HECT) catalytic 
domain at its carboxyl terminus classifies Hyd as a HECT family E3 ubiquitin ligase 
(Huibregtse et al. 1995), and suggests its involvement in the ubiquitylation of its 
target proteins. The HECT domain defines a family of E3 ubiquitin protein ligases in 
which a conserved cysteine residue accepts ubiquitin from an E2 ubiquitin-
conjugating enzyme in the form of a thioester and then directly catalyses the transfer 
of ubiqitin to target substrates (Huibregtse et al. 1995). EDD reversibly binds 
ubiquitin in vitro via the conserved cysteine residue (C2768) in its HECT domain, as 
substitution of this residue completely abrogated the ability to bind ubiquitin 
(Callaghan et al. 1998). Accordingly, EDD ubiquitylates a number of substrates, 
including katanin (Maddika & J. Chen 2009), TopBP1 (Honda et al. 2002), and β-
catenin (Hay-Koren et al. 2011) (see Section 1.4.2 below). Taken together with the 
fact that Hyd’s HECT domain shares high sequence identity with the EDD HECT 
domain, this suggests that Hyd most likely also functions as an E3 ubiquitin ligase. 
 
1.4.1.2 Poly(A)-binding Protein C-terminal (PABC) Domain 
 
Immediately adjacent to the carboxy terminal HECT domain, Hyd contains a highly 
conserved protein-protein binding domain, termed the Poly(A)-binding Protein C-
terminal (PABC) domain. Interestingly, the PABC domain is found exclusively in 
only Hyd (and its homologues), and in the poly(A)-binding protein (PABP) (Deo et 
al. 2001). PABP plays a key role in eukaryotic protein synthesis and mRNA stability. 
It recognizes the 3’ poly(A) mRNA tail and recruits several translation and mRNA 
Hyd regulates morphogen signalling in the developing eye 
Chapter 1: Introduction   58 
processing factors to the mRNA pol(A) tail via its PABC domain(Deo et al. 2001; 
Kozlov et al. 2004). 
 
The EDD and human PABP PABC domains share 56% sequence identity over the 
most highly conserved 60 amino acid region (Deo et al. 2001). The structures of both 
PABC domains from EDD and human PABP have been determined, revealing 
several structural similarities, as well as a conserved binding surface (Deo et al. 
2001; Kozlov et al. 2004). The PABC domain recognizes a conserved sequence 
motif of 12-15 amino acids, known as PAM2 (PABP-interacting motif 2) (Kozlov et 
al. 2001; Kozlov et al. 2004), which is present in several known binding partners of 
human PABP, including the PABP-interacting proteins Paip1 and Paip2, as well as 
eRF3 (Craig et al. 1998; Khaleghpour et al. 2001; Hoshino et al. 1999). Site-directed 
mutagenesis of conserved PABC domain residues revealed essential residues 
required for peptide recognition. Substitution of a conserved phenylalanine residue in 
the human PABP PABC domain (F22) to alanine completely abrogated the binding 
to Paip1 and Paip2, whereas mutation of an additional conserved leucine residue 
(F22A, L40A) prevented the binding of eRF3 (Kozlov et al. 2004). 
 
The high conservation between the PABP and EDD PABC domains suggests that 
they may share one or more interaction partners. As expected, the EDD PABC 
domain also binds PAM2 peptides with high affinity (Lim et al. 2006), and EDD 
interacts with full-length Paip1 (Deo et al. 2001) and the anti-proliferative protein 
transducer of ErbB2 (Tob2) (Lim et al. 2006). Tob2 belongs to the BTG/Tob family 
of proteins, which share a conserved amino terminal B Cell Translocation Gene 
(BTG)/Tob homology domain, and have known functions in cell cycle control 
(Raburn et al. 1995), differentiation (Rodier et al. 1999), and transcriptional 
regulation (Okochi et al. 2005). Additionally, bioinformatics-based sequence analysis 
has identified several PAM2 containing proteins, representing putative EDD binding 
partners, which include ataxin-2, USP10, dNF-x1, TPRD/TTC3 and dMAP205 
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(Albrecht	  &	  Lengauer	  2004). Hence EDD/Hyd’s PABC domain may be involved in 
substrate recognition and recruitment prior to EDD/Hyd-mediated substrate 
ubiquitylation. Taken together with the high conservation of the PABC domain, this 
makes it an interesting domain to investigate in order to shed light on Hyd/EDD’s 
mechanism of action in the cell. 
 
1.4.1.3 UBR-type Zinc Finger Domain 
 
The UBR box motif is a zinc finger fold that is found in a unique family of E3 
ubiquitin ligases that target substrates as part of the N-end rule pathway(Tasaki et al. 
2005). It consists of two conserved zinc finger motifs: a Cys2 His2 motif containing 
a zinc ion, and a Cys6 His1 motif containing two zinc ions. The N-end rule relates 
the half-life of a cellular protein to the identity of its amino terminal residue 
(reviewed in (Tasaki et al. 2012). In the N-end rule pathway, a subset of proteins 
containing degradation signals in the form of destabilizing amino terminal residues, 
known as N-degrons, are targeted for ubiquitylation and subsequent degradation by a 
unique class of E3 ubiquitin ligases termed N-recognins, which include 
Hyd/UBR5/EDD. N-degrons are generated by several mechanisms, including 
proteolytic cleavage and posttranslational modification of proteins by conjugation 
(e.g. arginylation, phenylalanylation, etc.), the latter being the major mechanism of 
generating N-degrons in eukaryotes. Conjugation of destabilizing amino terminal 
residues is carried out by evolutionary conserved aminoacyl-tRNA transferases. 
 
UBR5/EDD was classed as a member of the UBR box family of N-recognins, along 
with UBR1, UBR2 and UBR4, in a study that employed an affinity assay for proteins 
that bind to destabilizing amino terminal residues (Tasaki et al. 2005). Beads 
conjugated with Type 1 (Arg) or Type 2 (Phe) N-degron-containing peptides were 
used to pull down endogenous N-recognins from mouse tissue extracts. This revealed 
that UBR5/EDD, unlike UBR1, UBR2 and UBR4, bound exclusively to Type 1 
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(Arg) N-degron beads (Tasaki et al. 2005). Interestingly, Hyd’s isolated UBR 
domain also interacts with cleaved, Arg-bearing Drosophila Inhibitor of Apoptosis 1 
(DIAP1) (Ditzel et al. 2008). This experiment was successfully replicated in the 
Drosophila melanogaster cell line D.Mel-2, suggesting that both UBR5/EDD and 
Hyd share a conserved N-recognin function and specifically recognize Type 1 (Arg) 
N-degrons in putative substrate proteins (Tasaki et al. 2005).  
 
1.4.1.4 Regulator of Chromatin Condensation (RCC) Domain 
 
The RCC domain is found in the cell cycle regulator protein RCC1, a guanine 
nucleotide-exchange factor for the nuclear Ras homologue Ran (Bischoff & 
Ponstingl 1991). The crystal structure of RCC1 has been solved and reveals a seven-
bladed propeller, which may also bind to DNA (Renault et al. 1998). Hyd and EDD 
both contain an N-terminal RCC1-like domain, two putative nuclear localization 
signals (Callaghan et al. 1998; Dingwall & Laskey 1991), and both proteins are 
localized predominately in the nucleus (Mansfield et al. 1994; Hay-Koren et al. 
2011), suggesting that they may translocate to the nucleus to bind DNA directly via 
the RCC-like domain.  
 
1.4.1.5 Ubiquitin-Associated (UBA) Domain 
 
UBA domains are frequently found in proteins that are involved in ubiquitin-
mediated degradation and regulatory pathways (Hofmann & Bucher 1996). Although 
sequence similarity between UBA domains is relatively low, they generally contain 
structurally conserved surface patches of hydrophobic residues, which form a 
binding platform for protein-protein interactions. Most UBA domains bind ubiquitin 
and proteins containing ubiquitin-like (UBL) folds (Mueller & Feigon 2002).  
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The structure of the EDD UBA domain, which shares 90% sequence identity with 
the Hyd UBA domain, has been solved in complex with ubiquitin (Kozlov et al. 
2007). Several techniques, including isothermal titration calorimetry (ITC), NMR, 
and pull down assays, were used to assess the binding affinity of the EDD UBA 
domain for various ubiquitin linkages. This revealed that, although the EDD UBA 
domain can bind both mono-and poly-ubiquitin molecules, it has a higher binding 
affinity for monoubiquitin (Kozlov et al. 2007). Interestingly, this is in contrast to 
other UBA domains, which generally bind polyubiquitin chains with a higher affinity 
(Raasi et al. 2005; Trempe et al. 2005). While EDD was able to bind both K48- and 
K63-linked ubiquitin chains, it displayed a relatively higher affinity for K63-linked 
chains (Kozlov et al. 2007), suggesting that the ubiquitylation of target proteins by 
EDD may have predominantly nonproteolytic functions (see Section 1.1.5). Finally, 
site-directed mutagenesis was used to assess the functional importance of conserved 
residues involved in ubiquitin binding. A fully folded double point mutant, in which 
two conserved hydrophobic EDD UBA domain residues (Val196 and Leu224) were 
substituted with a hydrophilic residue (Lys), failed to bind both mono- and 
polyubiquitin (Kozlov et al. 2007), indicating that these residues are also likely to be 
crucial for ubiquitin binding in the Hyd UBA domain. 
 
1.4.2 Molecular functions of conserved mammalian Hyd 
orthologues 
 
The Hyd protein is highly conserved in mammalian cells, and shares a large 
proportion of sequence identity and functional domains with its human and murine 
counterparts EDD and UBR5, respectively (Figure 1.14). Over the last few years 
elucidation of EDD’s molecular mechanism has implicated it in diverse roles in 
cancer, cell cycle control, DNA damage repair pathways, gene transcription, Wnt 
signaling, miRNA-mediated gene regulation, mRNA translation, glucose 
metabolism, and viral infection (discussed below). Importantly, EDD’s mode of 
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action in these diverse processes could provide clues on Hyd and EDD’s putative 
molecular function in Hh signalling. 
 
1.4.2.1 UBR5-/- mice display severe developmental defects 
 
Analogous to the effects of Hyd deficiency in flies, UBR5 deficient (UBR5-/-) mice 
display severe developmental defects and embryonic lethality at mid-gestation 
(Saunders et al. 2004). Although heterozygous UBR5+/- mice developed normally 
and were fertile, UBR-/- embryos died at or before E10.5. In addition, UBR-/- 
embryos between gestational stages E8.5 and E10.5 were developmentally retarded, 
displaying growth defects and defective yolk sac and allantoic vascular development, 
resulting in defective chorioallantoic fusion and embryonic death (Saunders et al. 
2004). Interestingly, Indian Hedgehog (Ihh) has been reported to play a critical role 
in yolk sac vasculogenesis (Byrd et al. 2002), which suggests that UBR5 and other 
mammalian Hyd orthologues like EDD are likely to play a key role in development 
through regulation of Hh signalling. 
 
1.4.2.2 EDD is frequently over-expressed in human cancers 
 
The human homologue of Hyd, EDD, was first isolated in a screen for progestin-
regulated genes in human breast cancer cells (Callaghan et al. 1998). The EDD gene 
is localized to chromosome 8q22, a locus that is subject to allelic imbalance in 
several human cancers. The EDD locus is most frequently amplified in ovarian 
cancer (Clancy et al. 2003), which correlates with high EDD expression in tumours 
and is associated with a two-fold increased risk of cancer relapse and death in 
ovarian cancer patients who initially responded to chemotherapy (O'Brien et al. 
2008). Amplification of the EDD gene has also been reported in breast cancer, 
hepatocellular carcinoma, squamous carcinoma of the tongue, and metastatic 
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melanoma, and EDD was overexpressed in breast cancer tumours and cell lines 
(Clancy et al. 2003). Interestingly, these findings support an oncogenic role for EDD 
in human cancers, as opposed to the tumour suppressor role for Hyd reported in 
Drosophila imaginal discs (J. D. Lee et al. 2002). 
 
1.4.2.3 EDD plays a role in DNA damage signalling pathways 
 
In order to maintain genomic and cellular integrity, the cellular response to DNA 
damage usually involves the arrest of the cell cycle in G1, S or G2 phases, followed 
by DNA repair and/or cell death. This mechanism prevents the replication of 
damaged DNA, and defects in the associated signalling pathways can lead to 
uncontrolled proliferation and genomic instability, both of which contribute to 
tumourigenesis. DNA damage events lead to the activation of the ATM-CHK2/ATR-
CHK1 kinase signaling networks, which in turn orchestrate cell cycle arrest, DNA 
repair and/or cell death by phosphorylating a number of target proteins (Munoz et al. 
2007). 
  
Several reports implicate EDD in DNA damage signaling. EDD interacts with PMS1 
and PMS2 during mismatch repair, binds calcium- and integrin-binding protein 
(CIB)/DNA-dependent protein kinase-interacting protein, which is potentially 
involved in the DNA damage response (Henderson et al. 2002), and ubiquitinates 
topoisomerase II-binding protein (TopBP1) in vitro (Honda et al. 2002). 
 
EDD coordinates the action of TopBP1 in the DNA damage response by targeting it 
for proteasomal degradation (Honda et al. 2002). TopBP1 is usually degraded by the 
proteasome, but the introduction of DNA damage events by radiation inhibits the 
ubiquitylation of TopBP1 by EDD and results in TopBP1 activation by 
phosphorylation, and subsequent colocalisation with Gamma-H2AX nuclear foci at 
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sites of DNA damage. EDD interacts with the BRCA1 domain containing carboxy 
terminus of TopBP1, a domain commonly found in DNA damage checkpoint 
proteins and cell cycle regulators (Honda et al. 2002). 
 
EDD also interacts with and modulates the activity of the DNA damage checkpoint 
kinase CHK2 (Henderson et al. 2006). EDD acts upstream of CHK2 in the DNA 
damage signaling pathway by promoting the activating phophorylation of CHK2 in 
response to DNA damage. The interaction between EDD and CHK2 is itself 
dependent on EDD phosphorylation, although EDD is not a target of CHK2 
phosphorylation(Henderson et al. 2006). The mechanism of EDD mediated CHK2 
activation may involve non-proteolytic ubiquitination as a trigger for subsequent 
CHK2 phosphorylation, however this remains to be investigated. 
 
In accordance with EDD’s role in modulating CHK2 activity, EDD is required for 
G1/S and intra S phase DNA damage checkpoint activation, and for the maintenance 
of G2/M arrest after DNA damage (Munoz et al. 2007). EDD deficient cells 
displayed radiation-resistant DNA synthesis, premature entry into mitosis, 
accumulation of polyploidy cells, and cell death via mitotic catastrophe, as well as 
altered expression of the cell cycle mediators Cdc25A/C and E2F1 (Munoz et al. 
2007). Taken together, these findings suggest that EDD plays a significant role in the 
DNA damage response and thus the maintenance of genomic stability, which could 
in part explain the link between dysregulated EDD and cancer.  
 
1.4.2.4 EDD, cell cycle control and proliferation 
 
EDD interacts with Dual specificity tyrosine-phosphorylation-regulated kinase 2 
(DYRK2), which results in the formation of an E3 ubiquitin ligase complex that 
directs the ubiquitylation and degradation of the mitotic regulator katanin p60 
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(Maddika	  &	  J.	  Chen	  2009). DYRK2’s name is derived from the unique self-
activation mechanism employed by DYRK kinases. DYRK2 autophosphorylates a 
tyrosine residue within its activation loop during protein sysnthesis, which 
simultaneously results in a loss of its tyrosinekinase activity and activation of its 
function as a serine/threonine kinase. A limited number of DYRK2 substrates have 
been identified, although interestingly these include the Hh pathway transcriptional 
effector protein GLI2 (Varjosalo et al. 2008), suggesting that, analogous to previous 
findings in Drosophila, EDD may be indirectly involved in GLI and Hh pathway 
regulation.  
 
Surprisingly, the Dyrk2 kinase acts as an essential scaffold protein for the formation 
of the E3 ligase complex containing EDD as the catalytic subunit, as well as the 
DDB1 and VPRBP proteins (EDVP-Dyrk2 complex). DDB1 (DNA-damage binding 
protein 1) and VPRBP (also known as CAF1) are adaptor and substrate recognition 
subunits, respectively, of the Cul4-Roc1 E3 ligase complex. However, the EDVP-
Dyrk2 complex appears to be unique as it does not contain Cul4 and Roc1. 
 
Although Dyrk2 kinase activity is not required for EDVP-Dyrk2 complex formation, 
the phosphorylation of katanin by Dyrk2 is a priming event for subsequent 
polyubiquitination and degradation of katanin by EDD and the proteasomal system. 
Katanin is a microtubule AAA-ATPase and plays an important role during mitosis, 
as it severs microtubules at the mitotic spindles, allowing the disassembly of 
microtubules and the segregation of sister chromatids to proceed during anaphase. 
This suggests that EDD is an important regulator of mitotic transition through its 
effects on katanin protein levels (Maddika & J. Chen 2009). 
 
The regulation of katanin levels is dependent on EDD’s ubiquitylation activity. 
However, a recent report proposes an E3 ligase-independent function of EDD during 
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cell cycle progression (Ling	  &	  W.-­‐C.	  Lin	  2011). EDD interacts with the tumour 
suppressor p53, a critical regulator regulator of cell cycle progression during the 
G1/S phase transition. Phosphorylation of p53 by ATM stabilizes p53 and leads to 
cell cycle arrest and apoptosis, however, the interaction with EDD inhibits the 
phosphorylation of p53 by ATM. Interestingly, it was determined that the catalytic 
activity of EDD was not required for the suppression of p53 activity (Ling	  &	  W.-­‐C.	  
Lin	  2011). This suggests that EDD has additional functions in the regulation of cell 
cycle progression that are not dependent on its ubiquitylation activity.  
 
In addition to its role in mitotic progression, there is evidence that EDD is involved 
in other pathways controlling cellular proliferation. EDD interacts with the anti-
proliferative protein Tob2 via its PABC domain (Lim	  et	  al.	  2006). Tob2 inhibits 
cellular proliferation by negatively regulating cyclin D1 expression, whereas Tob2 
itself is subject to negative regulation through ERK1- and ERK2-mediated 
phosphorylation. Interestingly, both EDD (Eblen et al. 2003) and Tob2 (Suzuki et al. 
2002) are substrates for the ERK2 kinase. The extracellular signal-regulated kinase 
(ERK) pathway (also known as the mitogen-activated protein kinase (MAPK)1 
pathway) regulates several important cellular processes, including proliferation, 
differentiation, gene transcription, and cellular migration. Binding of the mitogen 
epidermal growth factor (EGF) to the membrane epidermal growth factor recetpr 
(EGFR) results in activation of the oncogenic Ras GTPase, and subsequent activation 
of the Raf protein kinases. The Raf kinases phosphorylate and activate MAPK kinase 
or ERK kinases (MEK) 1 and 2, which in turn phosphorylate and activate the ERK1 
and ERK2 kinases, prompting these to migrate to various cellular locations to 
phosphorylate specific effector proteins (Eblen et al. 2003). Interestingly, ERK2 is 
ubiquitylated by MEK Kinase 1 (MEKK) via its RING finger-like plant 
homeodomain (PHD), which negatively regulates ERK2 activity (Lu et al. 2002). 
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ERK2 phosphorylation on EDD is thought to occur mainly on serine residues, 
although some threonine phosphorylation was also observed (Eblen	  et	  al.	  2003). 
Several novel EDD phosphorylation sites on EDD have already been identified by 
mass spectrometry, including Ser1018, which was also found to be phosphorylated in 
UBR5, and is predicted to be a putative ERK2 phoshorylation site (Bethard	  et	  al.	  
2011). Phosphorylation of EDD by ERK2 may affect EDD’s ubiquitylation activity, 
which in turn may be involved in positively regulating ERK2 activity, and opposing 
the negative regulation of ERK2 by MEKK ubiquitylation (Lu et al. 2002).  
 
1.4.2.5 EDD function in the Wnt signaling pathway 
 
Wnt signalling plays a crucial role in cellular proliferation and differentiation, and its 
de-regulation is linked to a number of human cancers (see Section 1.3). EDD 
interacts with a number of Wnt pathway’s components, yet conflicting evidence 
identifies it as both a positive and negative regulator of the Wnt signaling pathway. 
EDD directly interacts with GSK3β, which in turn mediates the indirect interaction 
of EDD with β-catenin (Hay-Koren et al. 2011). Over-expression of EDD promoted 
β-catenin K29- and K11-linked poly-ubiquitylation by EDD, and subsequent up-
regulation of β-catenin stability, its nuclear accumulation and activity. Potentially 
paralleling GSK3β-directed Ci ubiquitylation, EDD-mediated β-catenin 
ubiquitylation is GSK3β dependent. Therefore, GSK3β may mediate 
phosphorylation of β-catenin prior to ubiquitylation by EDD. Interestingly, EDD 
does not appear to ubiquitylate GSK3β, but EDD itself is a putative substrate for 
GSK3β phosphorylation on Thr1736 (Bethard et al. 2011). These results suggest that, 
through its interaction with GSK3β, EDD positively regulates the Wnt signaling 
pathway and functions as a putative colorectal oncogene. In addition, this implies 
that GSK3β can act as both a negative and positive regulator of β-catenin, and 
subsequent Wnt pathway activity. 
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However, a different study also identified EDD as a negative regulator of Wnt 
signaling and a potential colorectal tumour suppressor protein (Ohshima et al. 2007). 
EDD co-localised with and up-regulated APC in the cytoplasm, resulting in down-
regulation of β-catenin by the APC/Axin/GSK3β destruction complex(Ohshima et al. 
2007). This is in contrast to previous work, which demonstrated nuclear EDD 
staining, and co-localisation of EDD with β-catenin but not cytoplasmic GSK3β 
(Hay-Koren et al. 2011). The discrepancy between these conflicting results could be 
due to the use of different cell lines and experimental conditions, but could also 
indicate a dual role for EDD in both the positive and negative regulation of the Wnt 
pathway, which is perhaps dependent on other factors such as cellular localization, 
cell type or the phosphorylation state of EDD. 
1.4.2.6 EDD function in gene expression 
 
In addition to its role in post-translational regulation, EDD also regulates gene 
expression at the transcriptional, post-transcriptional and translational stages. Hyd 
and EDD have a putative role in the transcription of Hh/SHH and Wg/WNT pathway 
target genes, as they interact with the respective transcriptional effector proteins Ci 
(Wang et al. 2014) and β-catenin (Hay-Koren et al. 2011). EDD also affects 
transcription of progestin-mediated genes by acting as a transcriptional coactivator 
for the nuclear steroid progesterone receptor (PR). EDD interacts with PR in 
response to ligand binding and enhances its transcriptional activity (Henderson et al. 
2002). EDD has also been reported to interact with the CDK9 kinase subunit of 
positive transcripton elongation factor b (P-TEFb). RNA polymerase II (RNAPII) is 
regulated by several factors, including transcription factor IIS (TFIIS) and P-TEFb 
during elongation of transcription. EDD positively regulates this process by binding 
to bothTFIIS and P-TEFb, resulting in the polyubiquitination of the PTEF-b CDK9 
subunit, which enhances its activity rather than leading to its degradation (Cojocaru 
et al. 2011). 
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These findings indicate that EDD can regulate gene transcription directly at the DNA 
level. However, the reported interaction between EDD and DYRK2 also suggests 
that EDD may be involved in epigenetic gene regulation. In Drosophila, the DYRK2 
homologues dDyrk2 and Minibrain interact with the chromatin remodeling factors 
SNR1 and TRX (Kinstrie et al. 2006), which function in establishing open and 
repressive chromatin states to regulate transcription. SNR1 is a major subunit of the 
Drosophila Brm (Brahma) ATP-dependent chromating remodeling complex, whereas 
TRX is a highly conserved epigenetic regulator involved in maintaining homeotic 
gene expression in association with the Polycomb group genes (Kinstrie et al. 2006).  
 
In addition to regulating gene expression at the transcriptional level, EDD is also 
involved in regulating the translation of transcribed gene products by modulating the 
levels of the translational regulatory molecule Paip2 (Yoshida et al. 2006). Paip2 
inhibits translation by displacing PABP from the mRNA. Both PABP and EDD 
compete for binding of Paip2 via their PABC domains. Binding of EDD to Paip2 
results in Paip2 ubiquitylation and subsequent degradation (Yoshida et al. 2006). 
This indicates that EDD is a positive regulator of translation. 
 
Finally, EDD appears to regulate gene expression at the mRNA level, as both Hyd 
(R. Zhou et al. 2008) and EDD (H. Su et al. 2011a) are implicated in the miRNA 
silencing pathway. A genetic screen in mouse embryonic stem (ES) cells identified 
EDD as a key component of the miRNA silencing pathway, where EDD deficiency 
results in impaired miRNA function and growth defects (H. Su et al. 2011a). 
MicroRNAs (miRNAs) suppress gene expression by destabilising and preventing the 
translation of their mRNA targets. During miRNA biogenesis, the ribonucleases 
Drosha and Dicer process long stem-loop primary RNA transcripts to generate 
miRNA duplexes, which are then loaded onto Argonaute (Ago) proteins to form the 
miRNA-induced silencing effector complexes (miRISCs). miRNAs are partially 
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complementary to their mRNA targets and thus recruit the miRISC to initiate 
silencing of specific mRNAs (H. Su et al. 2011a). 
 
EDD interacts with Ago-miRNA complexes through a PAM2 motif in the GW182 
protein TNRC6A. The interaction between EDD and TNRC6A is mediated through 
both the PABC domain and heterodimersiation of the UBA domains present in both 
EDD and TNRC6A. Interestingly, the PABC domain of EDD was shown to be 
essential for its role in miRNA silencing, whereas its E3 ubiquitin ligase activity was 
not required. Once associated with miRISCs, EDD recruits downstream effectors, 
such as Paip2, ATXN2, eRF3a, eRF3b and Tob1/2, via its PABC domain. For 
example, Tob1/2 recruits CCR4-CAF1 complexes which promote the target mRNA 
deadenylation, destabilization and subsequent decoupling from translation (H. Su et 
al. 2011a). 
1.4.2.7 Other reported functions of EDD 
 
In addition to its diverse functions in DNA damage signalling, cell cycle control, 
Wnt signaling and gene expression, EDD also regulates cellular metabolism. EDD 
ubiquitylates the metabolic enzyme phosphoenolpyruvate carboxykinase (PEPCK1), 
which leads to its subsequent degradation via the proteasome (W. Jiang et al. 2011). 
PEPCK1 catalyzes the first committing and rate-limiting step of gluconeogenesis, 
and plays a central role in maintaining glucose homeostasis. It has been linked with 
type II diabetes as increased levels of PEPCK1 elevate blood glucose levels. 
Normally, high glucose levels stimulate the acetylation of PEPCK1 by the P300 
acetyltransferase, which destabilizes PEPCK1 by promoting the interacton with 
EDD, resulting in ubiquitylation and degradation of PEPCK1. Interestingly, 
inhibition of EDD activity results in increased glucose production, suggesting that 
loss of EDD may also be linked to type II diabetes (W. Jiang et al. 2011). 
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Finally, a role for EDD in the cellular response to viral infection was proposed as 
EDD was shown to regulate the Human Papillomavirus Type 18 E6/E6AP Ubiquitin 
Ligase Complex(Tomaic et al. 2011). Human papillomaviruses (HPVs) are small 
double-stranded DNA viruses that cause hyperproliferative lesions in epithelial 
tissues, and infection with high-risk HPV types, such as 16 and 18, has been linked 
to tumourigenesis, especially in cervical cancer. Viral oncoproteins, such as the E3 
ligases E6 and E7, interact with cellular proteins that are involved in the cell cycle 
and apoptosis, such as p53, and induce their proteasomal degradation, effectively 
leading to cellular immortalization and transformation. EDD interacts with the viral 
E3 ligase complex containing E6 and E6AP, and regulates its expression level. 
Increased EDD expression led to down-regulation of E6/E6AP expression and 
activity, suggesting that EDD acts as a tumour suppressor in the context of HPV-18-




Based on previous findings in Drosophila, and its close similarity to EDD, as 
discussed above, Hyd regulates hh gene expression, Hh pathway activity and 
potentially Wg pathway activity. However, the molecular mechanisms behind Hyd-
mediated regulation of these processes, and how they may involve Hyd’s 
ubiquitylation activity, are unknown. 
 
The principal aims of this project were to understand the molecular mechanisms Hyd 
employs to regulate (i) hh gene expression, (ii) Ci levels and/or activity and (iii) Wg 
pathway activity.  
 
In order to achieve this, the following questions were addressed: 
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1. What are Hyd’s protein binding partners, and are they also ubiquitylated 
substrates of Hyd? 
2. Do these Hyd interactors have a role in the regulation of hh expression, Hh 
pathway activity, or other morphogen pathways, such as the Wg pathway? 
3. To what degree are the proteins, complexes and/or molecular pathways that 
Hyd is associated with conserved across species/phyla (e.g. mammals)? 
 
Experimentally, this involved the mass spectrometric and biochemical identification 
of novel binding partners and ubiquitylated substrates of Hyd, and their subsequent 
placement in the context of putative signal transduction pathways regulating 
morphogen expression, using bioinformatics and Drosophila genetics.  
 
The detailed molecular analysis of Hyd’s role in morphogen regulatory pathways, 
and their molecular components, is an important step in the development of more 
efficacious treatments for Hh ligand dependent cancers. Evolutionary analysis of 
Hyd, its closely related human orthologue EDD, and newly identified pathway 
components, would significantly further the development of therapeutic compounds 
that could target morphogen regulatory pathways and correct morphogen mis-
expression in humans. Increased knowledge of morphogen regulatory pathways 
would also improve screening for associated diagnostic markers, which would allow 
determination of the appropriate treatment regime in cancer patients. 
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2.1 Bacterial methods 
 
2.1.1 Generation of competent bacteria 
 
DH5alpha cells from a frozen glycerol stock were streaked onto an LB agar plate 
without antibiotics and grown at 37°C overnight. A single colony was inoculated into 
20 mL Super Optimal Broth with Catabolite repression (SOC) medium [2% (w/v) 
tryptone, 0.5% (w/v) yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 20 
mM glucose] in a 250 mL conical flask and grown overnight in a 37°C shaker at 200 
rpm. 5 mL of the culture was split and diluted into two 1 L conical flasks, containing 
250 mL 2xYT medium (16 g/L tryptone, 10 g/L yeast extract, 5 g/L NaCl) each, and 
grown in a 37°C shaker until an OD600 of 0.5 was reached. The bacteria were 
pelleted in a Sorvall centrifuge at 5,000 rpm (4°C) for 10 minutes. All subsequent 
steps were carried out in a cold room at 4°C. The supernatant was removed and each 
pellet was resuspended in 83 mL Buffer RF1 [166 mL total; 100 mM RbCl, 50 mM 
MnCl2, 30 mM CH3CO2K, 10 mM CaCl2, 15% (w/v) glycerol, pH 5.8] until no 
clumps were visible. The cell suspension was incubated on wet ice for 1 hour, before 
being spun at 5,000 rpm (4°C) for 10 minutes. The supernatant was removed, and 
each pellet was resuspended in 20 mL Buffer RF2 [40 mL total; 10 mM MOPS, 10 
mM RbCl, 75 mM CaCl2, 15% (w/v) glycerol] until no clumps were visible. The cell 
suspension was incubated on wet ice for 15 minutes, and aliquoted (200 µL) into 
eppendorff microcentrifuge tubes on dry ice. The aliquots of competent DH5alpha 
cells were submerged in liquid nitrogen in a Dewar flask, and stored at -80°C.   
2.1.2 Bacterial transformation 
 
0.1-1 µg DNA was added to 80 µL competent bacterial cells and incubated on ice for 
30 minutes. The bacteria were heat-shocked at 42°C for 1 minute and cooled on ice 
for 10 minutes. 1 mL of Lysogeny Broth (LB; 10 g/L tryptone, 5 g/L yeast extract, 
10 g/L NaCl) without antibiotics was added, and the bacteria were incubated at 37°C 
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with shaking for 1 hour. The cells were then pelleted at 3,000 rpm for 2 minutes in a 
microcentrifuge. Most of the supernatant (~1 mL) was removed, and the remaining 
mixture was resuspended and spread onto an LB agar plate containing the 
appropriate antibiotic (ampicillin or kanamycin at a final concentration of 50 µg/mL). 
The plate was incubated overnight at 37°C or 32°C (for large plasmids and/or 
plasmids prone to recombination). 
2.1.3 Bacterial culture conditions 
 
Bacteria were generally grown in LB or 2xYT medium containing the appropriate 
antibiotic (ampicillin or kanamycin at a final concentration of 50µg/ml) in a shaking 
incubator at 37°C and 200 rpm. 
2.1.3.1 Isolation of plasmid DNA 
 
For small-scale DNA preparations, a single colony was inoculated into 6 mL LB 
containing the appropriate antibiotic and grown in a shaker at 37°C or 32°C 
overnight. The cells were pelleted in a large tabletop centrifuge at 4,000 rpm for 10 
minutes, and the DNA was isolated using the QIAprep Spin Miniprep Kit (QIAGEN, 
Cat. No. 27104) and resuspended in 30-40 µL dH2O. 
For large-scale, transfection quality DNA preparations, a single colony was 
inoculated into 200-500 mL LB containing the appropriate antibiotics and grown in a 
shaker at 37°C or 32°C overnight. The cells were pelleted in a Sorvall centrifuge at 
4,500 rpm for 15 minutes. The DNA was isolated using the QIAGEN Plasmid Midi 
or Maxi Kit (QIAGEN Cat. No. 12143, 12162), and resuspended in 0.1-1 mL dH2O, 
depending on the amount of DNA. 
2.1.3.2 Production of recombinant protein 
 
BL21(DE3) competent cells (Novagen/Merck Millipore, Cat. No. 69450) were 
transformed with pGEX vector expression constructs (Table 2.1) and grown 
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overnight at 37°C on an LB/Ampicillin agar plate. A single colony was inoculated 
into 50 mL LB containing ampicillin, and grown in a shaker at 37°C overnight. The 
culture was diluted 10-fold and incubated at 37°C with shaking until an OD600 of 0.6 
was reached. The culture was then moved to an 18°C shaking incubator and protein 
expression was induced with 1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) 
overnight. The cells were pelleted in a Sorvall centrifuge at 4,500 rpm (4°C) for 10 
minutes prior to lysis and isolation of the recombinant protein (see 2.4.4). 
Table 2.1: pGEX vector expression constructs allow expression of Glutathione S-transferase 





Dm FL Hyd 
pGEX 6P-1 
Bacterial expression of recombinant full-length Drosophila Hyd 
protein containing an amino terminal GST tag (expected MW ~347 
kDa) 
Ampicillin 
Dm Hyd large 
HECT pGEX 
6P-1 
Bacterial expression of recombinant partial carboxy-terminal 
region of the Drosophila Hyd protein, consisting of the PABC and 
HECT domains, and containing an amino terminal GST tag 
(expected MW ~92 kDa) 
Ampicillin 
 
2.2 Molecular biology 
 
2.2.1 General cloning procedure 
 
2.2.1.1 Cloning Strategy 
 
An amino terminally (NT) HA-Strep (HSP)-tagged Hyd pMT expression construct 
had previously been cloned in the lab. In order to facilitate the generation of S2 cells 
stably expressing HSP-Hyd and HSP-Hyd C>A, the inserts were sub-cloned into the 
pMT-PURO vector, which contains an integrated puromycin resistance gene (Iwaki 
& Castellino 2008), in a two-step process. First, the HSP fragment was lifted out of 
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the original vector and ligated into pMT-PURO using the KpnI-EcoRV sites flanking 
the tag. Following the successful generation of an NT HSP pMT-PURO vector, the 
Hyd inserts were sub-cloned using the NotI sites flanking the inserts, generating the 
following constructs: Dm NT HSP-Hyd pMT-PURO and Dm NT HSP Hyd C>A 
pMT-PURO. 
Potential Hyd binding partners were cloned into a pMT vector containing a carboxy 
terminal (CT) FLAG-V5 (F/V) tag. Cloning primers were generally designed to 
include at least one pair of restriction sites that cut only once within the multiple 
cloning site of the destination vector, as well as being absent from the open reading 
frame (ORF) sequence of the gene in question. In addition, a Kozak consensus 
sequence (AAA CAC ACA), which plays an important role in the process of 
translation initiation (De Angioletti et al. 2004), prior to the ATG start codon was 
included, whereas the stop codon at the end of the ORF was omitted to allow 
expression of the CT F/V tag. 
2.2.1.2 Polymerase Chain reaction 
 
DNA containing the coding sequence of the gene of interest was amplified by 
polymerase chain reaction (PCR) from cDNA clones or expressed sequence tags 
(ESTs), purchased from the Drosophila Genomics Resource Centre (DGRC), and 
using the relevant primers (Table 2.2).  













sites used for 
sub-cloning 










Real-time GH05975 F: GGTACCAAACACACAA 
TGGTGCAAAAATTCCAGTCACC
pMT CT KpnI-NotI 
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PCR reactions were carried out using the KOD Hot Start DNA Polymerase kit 
(Novagen/Merck Millipore, Cat. No. 71086), and reaction components and cycling 
conditions are summarized in Table 2.3. Following PCR amplification using the 
KOD polymerase, 1 µL Taq DNA Polymerase (Sigma, Cat. No. D1806) and 1 µL 
dNTPs (2mM each, from KOD kit) were added directly to the PCR reaction, and an 
additional extension step (93°C for 2 minutes, 72°C for 10 minutes) was carried out. 
Since the KOD DNA polymerase produces blunt-ended DNA products, this 
additional extension step, which adds T or A overhangs to the DNA ends, is 
necessary to allow subsequent cloning into the pGEM® T-Easy Vector (Promega, 
Cat. No. A1360). 
Table 2.3: KOD Hot Start Polymerase PCR reaction set-up and cycling conditions. 
PCR Reaction Setup Cycling Conditions 
Reaction 
Component 
Amount Step Temperature (°C) Time 
10X Reaction 
Buffer 
5µl 1 95 2 min 
25mM MgSO4 3µl 2 95 20 sec 
dNTPs (2mM 
each) 
5µl 3 Tm-5°C (Tm based on primer sequence identical 
to target sequence only) 
10 sec 
DNA template  10ng 4 70 Variable* 
Forward primer 
(10µM) 
1.5µl 5 Go to step (2) for 6 cycles 
Reverse primer 
(10µM) 
1.5µl 6 95 20 sec 
KOD polymerase 1µl 7 Tm-5°C (Tm based on entire primer sequence) 10 sec 
dH2O Xµl 8 70 Variable* 
TOTAL 50µl 9 Go to step (6) for 30 cycles 
*Depends on size of amplified fragment - see manufacturer’s protocol. 
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2.2.1.3 Agarose gel electrophoresis and gel extraction 
 
DNA was separated on a 0.8% or 1% (w/v) agarose gel, prepared in 
Tris/Borate/EDTA (TBE) buffer (89 mM Tris, 89 mM boric acid, 2 mM EDTA) and 
containing 0.5 µg/mL Ethidium bromide, alongside a 1 kb DNA ladder (Hyperladder 
I, Biogene, Cat. No. BIO-33053). Bands were visualized by ultraviolet (UV) 
radiation and excised using a scalpel. DNA was extracted from the agarose chunks 
using the QIAquick Gel Extraction Kit (QIAGEN. Cat. No. 28704), and purified 
DNA was eluted in 30 µL dH2O. 
2.2.1.4 pGEM T-Easy cloning 
 
Purified DNA fragments were ligated into the pGEM® T-Easy Vector using the 
pGEM® T-Easy Vector System I kit (Promega, Cat. No. A1360). A molar ratio of 3 
parts of insert DNA to 1 part of vector DNA was maintained, according to the 
formula: [(Amount vector DNA (ng) x size of insert (kb)) / size of vector (kb)] x 3 = 
Amount of insert DNA. The reactions were set up according to the manufacturer’s 
protocol and incubated at 18°C overnight. The ligation reaction was then transformed 
in competent DH5alpha cells, and DNA from at least 4 independent colonies was 
prepared (miniprep) for restriction digest and sequencing, confirming the integrity of 
the construct prior to sub-cloning into an expression vector. 
2.2.1.5 Sequencing 
 
Sequencing of miniprep DNA was carried out by the MRC HGU Human Genetics 
Unit sequencing service (Edinburgh) using the standard T7 and Sp6 primers for the 
pGEM® T-Easy Vector, as well as a number of custom gene specific sequencing 
primers that were designed to cover the entire region of the inserted sequence in 500 
bp increments. 
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2.2.1.6 Restriction digest and alkaline phosphatase treatment 
 
Once the sequence integrity of a particular construct and miniprep was confirmed, 
the insert was lifted out of pGEM® T-Easy by restriction digest, using the restriction 
sites flanking the insert as designed in the original cloning primers (see Table 2.2). 
The destination vector (e.g. CT F/V pMT) was also digested with the same enzymes, 
ready to receive the insert. Briefly, 0.5 µL of each enzyme (various from New 
England BioLabs and Roche), 0.5 µL BSA (New England BioLabs), and 2 µL of the 
appropriate 10X reaction buffer (New England BioLabs 10X reaction buffers 1-4; 
refer to New England BioLabs website for enzyme compatibility) were combined 
with 1 µg DNA and dH2O to a final volume of 20 µL. The reaction was incubated at 
37°C for 1 hour. To minimize re-ligation of the destination vector, 1 µL Alkaline 
Phosphatase (AP) and 2 µL 10X AP reaction buffer (New England BioLabs, Cat. No. 
M0371S) were added directly to the restriction digest mix and incubated for a further 
20 minutes at 37°C. The restriction digests for both insert and vector were then 
separated on an agarose gel, and the relevant DNA fragments were excised and 
purified using the QIAquick Gel Extraction Kit (QIAGEN. Cat. No. 28704).  
2.2.1.7 Ligation 
 
The insert DNA was ligated into the destination vector using the T4 DNA Ligase 
enzyme. 1 µL of 10X T4 Ligation Buffer and 1 µL T4 DNA Ligase (both New 
England BioLabs, Cat. No. M0202S) were combined with the purified insert and 
vector DNA, and dH2O to a total volume of 10 µL. A molar ratio of 3 parts of insert 
DNA to 1 part of vector DNA was maintained (see 2.2.1.4). The reaction was 
incubated at 18°C overnight, transformed, and DNA from at least 4 independent 
colonies was prepared (miniprep) for restriction digest, confirming the integrity of 
the construct prior to preparation of a transfection quality DNA master stock 
(maxiprep). 
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2.2.2 Site-directed mutagenesis 
 
Site-directed mutagenesis (SDM) was used to introduce up to two missense amino 
acid mutations into a given construct. SDM was carried out using custom designed 
primers, containing the desired coding sequence base pair mutation flanked by 
regions complementary to the template DNA, to amplify the mutagenised plasmid by 
PCR. The non-mutagenised template plasmid is removed via DpnI restriction 
enzyme treatment prior to purification of the mutagenised plasmid DNA. The DpnI 
restriction enzyme recognizes methylated adenine in plasmids purified from bacteria 
expressing the Deoxyadenosine (Dam) methyltransferase (J. Tian et al. 2010). 
Briefly, the PCR reaction mix was set up as detailed in Table 2.3, and cycling 
conditions were identical to steps 1 to 4 as outlined in (New England BioLabs, Cat. 
No. ) , which were repeated for 16 cycles. 2 µL of DpnI enzyme (New England 
BioLabs, Cat. No. ) was then added directly to the PCR reaction mix, and incubated 
for 2 hours at 37°C. The mutagenised plasmid DNA was purified using the QIAquick 
PCR Purification Kit (QIAGEN, Cat. No. 28104), and eluted in 30 µL dH2O. 10 µL 
of the purified plasmid DNA was used to transform competent DH5aplha cells for 
the preparation of miniprep DNA and sequencing. Once satisfactory incorporation of 
the desired mutation was confirmed by sequencing, a large-scale, transfection quality 
master stock of the plasmid DNA was prepared (maxiprep). All mutagenised 
constructs and the relevant SDM primers used are summarized in Table 2.4. 


















C2854>A Had already been generated in the lab (Mark Ditzel). 
HSP Hyd 
PABC double 
Y2509>A tac>gcc NT HSP F1: CAAATTGGGGAACGTCTT 
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2.2.3 dsRNA production 
 
dsRNA was produced for RNAi treatment of endogenous mRNAs, resulting in knock 
down of target gene expression, in Drosophila Schneider (S2) cells and/or 
transfection of other Drosophila cultured cells. dsRNAs were synthesized by 
amplifying a DNA template encoding a T7 RNA polymerase consensus site from 
cDNA using primers specific for EGFP (RNAi control), Hyd, and the 3’UTR region 
of the hyd gene. The MEGAscript® T7 Transciption Kit (Life Technologies, Cat. 
No. AM1333) was then used to synthesize ssRNA from the DNA templates for 6 
hours at 37°C, following to the manufacturer’s protocol. RNA was precipitated by 
adding 2 μL 3M sodium acetate (C2H3NaO2) and 40 μL ethanol pre-cooled to -20°C 
to the reaction mix. The tubes were then spun at 13,000 rpm for 5 minutes, and the 
RNA pellets were air dried for 5 minutes before being resuspended in 40 μL RNAse 
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free dH2O. ssRNA was annealed by heating at 65°C for 5 minutes, and left to cool 
slowly overnight. dsRNA was stored at -20°C . 
Table 2.5: Primers used to generate dsRNA DNA templates by PCR. 
dsRNA DNA template Parent DNA 
template (plasmid) 
Forward (F) and reverse (R) primers 

















2.2.4 Isolation of genomic DNA from Drosophila 
 
Single flies were frozen individually in eppendorff tubes at -20°C. Flies were mashed 
in 50 µL “Squishing Buffer” (10 mM Tris HCl pH 8.2, 1 mM EDTA, 25 mM NaCl, 
200 µg/mL Proteinase K) and incubated at 37°C for 30 minutes, before Proteinase K 
activity was inactivated by heating to 95°C for 2 minutes. The crude genomic DNA 
was stored at 4°C and was used at a 1 in 10 dilution in PCR reactions.  
 
 
Hyd regulates morphogen signalling in the developing eye 
Chapter 2: Materials and methods   85 
2.2.4.1 Sequencing of mutant hyd strains 
 
The following fly tocks were used for sequencing hyd mutant alleles:  
FRT82B, hydK7.19/TM6B 
FRT82B, hydK3.5/TM6B  
hyd15/TM6B GFP 
FRT82B, hydWC461/TM6B 
Sb/TM3 GFP (hydWT control) 
Heterozygous adult flies were collected and genomic DNA was extracted as 
described in Section 2.2.4. 1 µL of the crude genomic DNA extract, diluted 1 in 10, 
was used in PCR reactions (see section 2.2.1.2 for general PCR reaction set up) to 
amplify the hyd gene region prior to sequencing. Due to the size of the hyd extended 
gene region, the hyd gene region was amplified in two parts, designated “hyd front 
end” and “hyd back end”, using specifically designed primers (see Table 2.6). PCR 
reactions were separated on a 0.8% agarose gel, and the generated fragments were 
excised and purified using the QIAquick Gel Extraction Kit (QIAGEN. Cat. No. 
28704). Purified DNA was eluted in 30 µL dH2O and pooled for each hyd allele, 
before being sent to The GenePool Sequencing facility (University of Edinburgh, 
Edinburgh), along with a set of custom hyd sequencing primers designed to cover the 
hyd front and back ends in 500-800 bp overlapping increments (see Table 2.6). 
Mutations were identified by scanning for the presence of a double trace in the 
chromatogram (i.e. DNA extracted from heterozygote animals). 
Table 2.6: Primers used for amplification and sequencing of hyd alleles. 
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GATAATGATATGCCGGACCATGATCTGGAGC hyd back 
end 
Sequencing 
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CGACTGCGAATACTTGTATCTCTCGG hyd back 
end 
Sequencing 
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2.3 Cell culture and cell biology methods 
 
2.3.1 Mammalian tissue culture conditions 
 
HEK293 cells were maintained at 37°C with 5% CO2 in Dulbecco’s Modified 
Eagle’s Medium (DMEM; Life Technologies) containing 10% heat inactivated fetal 
bovine serum (FBS; Life Technologies).  
2.3.2 Drosophila tissue culture conditions 
 
S2 cells were grown at room temperature in Schneider’s Drosophila Medium (Lonza) 
containing 10% heat inactivated fetal bovine serum (FBS; Life Technologies). Clone 
8 (Cl8+) cells were grown at room temperature in M3 medium (Sigma) 
supplemented with 0.05% KHCO3 (Sigma), 2.5% fly extract (see 2.3.2.1 below), 5 
µg/ml insulin (Sigma), and 2% fetal bovine serum (FBS; Life Technologies).  
2.3.2.1 Generation of fly extract 
 
Adult flies of any genotype were collected in 50 mL tubes and frozen at -20°C for 45 
minutes. Frozen flies were weighed and transferred to a glass homogeniser on ice. 
6.8 mL M3 medium supplemented with 0.05% KHCO3 was added per 1 g of flies. 
Flies were homogenised thoroughly on ice until completely mashed. The mixture 
was then transferred to a centrifuge tube and spun at 1,500 x g at 4°C for 15 minutes. 
The resulting supernatant was transferred to a fresh tube and incubated at 60°C in a 
waterbath for 5 minutes. Finally, the extract was spun at 1,500 x g at 4°C for 90 
minutes. The resulting supernatant is the fly extract, which was filter sterilized 
through a 0.2 µM filter, aliquoted, and stored at -20°C. 
 
 
Hyd regulates morphogen signalling in the developing eye 
Chapter 2: Materials and methods   89 
2.3.3 Transfection of tissue culture cells 
 
Cells were seeded the day before transfection. Transfections were performed using 
Effectene Transfection reagent (QIAGEN, Cat. No. 301425) according to the 
manufacturer’s protocol. Optimised transfection conditions are summarised in Table 
2.7. Briefly, the required amount of DNA was diluted in Buffer EC. Enhancer was 
added and the transfection mix was incubated for 5 minutes at room temperature, 
before Effectene was added and the mix was incubated for a further 10 minutes at 
room temperature. The transfection mix was then added directly to cultured cells in a 
drop-wise manner, and the plates were gently rocked to mix. If necessary, protein 
expression was induced in Drosophila cells by adding 5 µL 140 mM CuSO4 to the 
cell culture medium 12 hours post-transfection. Cells were incubated for 48 hours 
prior to lysis and/or analyis. 
Table 2.7: Optimised Transfection Conditions for HEK293, S2 and Cl8+ cells. 
Cell type HEK293 S2/Cl8+ 
S2/Cl8+ 
(Luciferase assays) 
Plate format 10 cm (10 mL) 6-well plate (6 x 2 mL) 
96 well plate 
(100 µL per well) 
Seeding density (1 day 
before transfection) 3 x 10
6 ~50-60% confluency ~50-60% confluency 
Total amount of DNA 
per well/plate 2 µg 0.4 µg 
0.1 µg (+ 200 ng 
dsRNA – optional) 
Total volume of EC 
buffer used to dilute 
DNA 
300 µL per plate 100 µL per well 50 µL per well 
Volume of Enhancer to 
add per well/plate 16 µL per plate 3.2 µL per well 0.8 µL per well 
Volume of Effectene to 
add per well/plate 60 µL per plate 10 µL per well 2.5 µL per well 
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2.3.3.1 dsRNA treatment of S2 cells 
 
S2 cells were seeded into 6-well plates at ~50-60% confluency the day before 
dsRNA treatment in complete growth medium. On the day of dsRNA treatment, the 
complete medium was removed and cells were washed gently in serum-free medium 
(no FBS). dsRNA was added to the cells suspended in serum-free medium at 15 µg 
per well. The cells were incubated for 1 hour with the dsRNA in serum-free medium, 
before an additional 2 mL of complete growth medium was added. Cells were 
incubated for 24 to 48 hours prior to lysis and/or analysis. 
2.3.3.2 Generation of stably transfected S2 cells 
 
S2 cells were transfected with NT HSP pMT-PURO expression constructs. 
Alternatively, S2 cells were transfected with the expression construct of choice and a 
separate puromycin resistance plasmid at a 7 to 1 molar ratio. 48 hours post-
transfection, cells were harvested carefully and spun down at 1,200 rpm for 3 
minutes. The cells were then resuspended in 5 mL of complete medium containing 6 
µg/mL puromycin, and transferred to a T25 tissue culture flask. Cells were observed 
regularly to monitor cell death. Stably transfected cells were maintained in complete 
growth medium containing 6 µg/mL puromycin. 
2.3.4 Luciferase assays with S2 and Cl8+ cells 
 
S2 or Cl8+ cells were seeded into 96-well plates at ~50 to 60% confluency and 
transfected in triplicate with 200 ng dsRNA against EGFP or Hyd,10 ng Renilla 
Luciferase, 50 ng ptcΔ136-luciferase or ptcΔ136-mutant, and 40 ng Hh-N DNA per 
well (see Table 2.7). Cells were harvested after 5 days, and luciferase activity was 
measured using the Dual-Luciferase® Reporter Assay System (Promega, Cat. No. 
E1910) following the manufacturer’s protocol. 
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2.3.5 Immunofluorescence with cultured cells 
 
Cells were seeded and transfected in plates containing sterile, round glass cover slips. 
Transfected cells were washed gently in Phosphate Buffered Saline (PBS) and fixed 
with 4% paraformaldehyde (PFA) in PBS for 15 minutes at room temperature. The 
cells were washed again in PBS before being permeabilised with 0.1% Triton X-100 
in PBS for 5 minutes at room temperature. The cells were then washed in PBS and 
the slides blocked in blocking solution [1% (w/v) BSA, 1% (v/v) FBS, PBS] for 30 
minutes at room temperature. The primary antibody was diluted in blocking solution 
and was generally used at a dilution 10-fold more concentrated than if used for 
Western blotting. 50 µL of the primary antibody solution per cover slip was 
dispensed onto a sheet of parafilm, and cover slips were carefully placed face down 
onto the solution using tweezers. The cover slips were incubated with the primary 
antibody for 1 hour at room temperature in a damp incubation chamber. Following 
the primary antibody incubation period, the cover slips were washed twice briefly in 
PBS pre-dispensed onto parafilm sheets, before being incubated with 50 µL (per 
cover slip) of the secondary antibody diluted in blocking buffer on a fresh parafilm 
sheet for 1 hour at room temperature in a dark incubation chamber. The cover slips 
were then washed briefly twice, and again for 10 minutes in PBS, before being 
mounted cell-side down onto glass microscope slides using 5-10 µL mounting 
medium (Vectashield Mounting Medium with DAPI, Vector Laboratories, Cat. No. 
H-1200). Images were captured on a Nikon A1R confocal microscope at 100X 
magnification. 
2.4 Protein methods 
 
2.4.1 Cell lysis 
 
Cells were harvested 48 hours post-transfection, washed once in ice-cold PBS, and 
lysed with approximately 10 pellet volumes of Triton lysis buffer (50 mM Tris pH 
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7.5, 100 mM NaCl, 2 mM EDTA, 1% Triton X-100, 1X Roche protease inhibitor 
mix, 1X Roche phosphatase inhibitor mix). The lysates were clarified by 
centrifugation at 13,000 rpm for 15 minutes at 4°C.  
2.4.2 Co-immunoprecipitation and pulldown assays 
 
HA-Strep (HSP)-tagged Hyd/EDD was pulled down using StrepTactin sepharose 
(GE Healthcare) for 1 hour at 4°C with rotation. Samples were washed three times 
with Triton lysis buffer, and protein complexes were eluted with one bead volume of 
1X NuPAGE LDS Sample Buffer (Life Technologies, Cat. No. NP0008) containing 
100 mM dithiothreitol (DTT). To immunoprecipitate endogenous Hyd protein, 5 µL 
anti-M19 antibody (200 µg/mL; Santa Cruz) was added to the lysate and incubated at 
4°C with rotation for 2 hours, followed by Protein A-Agarose (Sigma, Cat. No. 
P2545) for 30 minutes with rotation at 4°C. Samples were washed and eluted as 
described. 
 
2.4.3 Tandem affinity purification (TAP) for mass 
spectrometry analysis 
 
Stable S2 cells expressing HSP-Hyd, HSP-Hyd C>A or HSP only were lysed as 
described in Section 2.4.1. HA-Strep (HSP)-tagged Hyd was pulled down using 
StrepTactin sepharose (GE Healthcare) for 1 hour at 4°C with rotation. Samples were 
washed four times with Triton lysis buffer, and protein complexes were eluted with 
five bead volumes of Desthiobiotin Elution Buffer (50 mM Tris pH 7.5, 100 mM 
NaCl, 2 mM EDTA, 1% Triton X-100, 2.5 M d-Desthiobiotin) for 30 minutes at 4°C 
with rotation. The eluted HSP-Hyd complexes were then immunoprecipitated using 
anti-HA antibody conjugated agarose for 1 hour at 4°C with rotation. Samples were 
washed four times with Triton lysis buffer, and a further two times with lysis buffer 
lacking Triton X-100 detergent. The protein complexes were then eluted with two 
bead volumes of 8 M Urea. Samples were run on pre-cast 4-12% Bis-Tris gels (Life 
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Technologies) until the samples had completely entered the gel (i.e. advanced 1-2 cm 
from the well). Gels were fixed and stained with Coomassie, and gel sections 
containing the eluted proteins were excised. The following procedure was performed 
by Flavia Alves at the Rappsilber Lab, University of Edinburgh: Coomassie stained 
gel sections containing the eluted proteins were reduced in 10 mM DTT for 30 
minutes  at 37°C, alkylated in 55 mM iodoacetamide for 20 minutes at room 
temperature in the dark, and digested overnight at 37°C with 12.5 ng/µL trypsin 
(Proteomics Grade, Sigma T6567). The solution was then acidified to 0.1% 
Trifluoroacetic acid (TFA) and spun onto StageTips, before peptides were eluted in 
20 µL of 80% acetonitrile in 0.1% TFA and concentrated to 4 µL using Eppendorf 
concentrators. The eluted peptide sample was then diluted to 5 µL using 0.1% TFA 
for LC-MS/MS analysis in a Velos LTQ-Orbitrap mass spectrometer (Thermo Fisher 
Scientific) coupled to a Waters Nano AQUITY UPLC (Waters). Mascot searches 
were conducted against a database containing Drosophila melanogaster sequences, 
and the search parameters were as follows: MS accuracy, 6 ppm; MS/MS accuracy, 
0.6 Da; enzyme, trypsin; allowed number of missed cleavages, 2; fixed modification, 
carbamidomethylation on cysteine; variable modifications, oxidation on methionine 
and double glycine (GlyGly) fragment on lysine. 
2.4.4 Purification of recombinant proteins from bacterial cells 
 
Bacterial cells expressing the protein of interest were grown and harvested as 
described in Section 2.1.3.2. Harvested cells were resuspended in 10 mL ice cold 
Bacterial Lysis Buffer (1X PBS, 300 mM NaCl, 1 mM DTT, 1X Roche protease 
inhibitor mix) and sonicated five times for 10 seconds. Lysates were cleared by 
spinning at 4,500 – 10,000 rpm at 4°C for 30 minutes. Lysates were then incubated 
with Glutathione Sepharose (GE Healthcare) for 1 hour at 4°C with rotation. 
Samples were washed three times with 10 mL cold Tris-buffered saline (TBS; 50 
mM Tris, 150 mM NaCl, pH 7.6), and recombinant GST-tagged proteins were eluted 
with two bead volumes of Glutathione (GSH) Elution Buffer (50 mM Tris-HCl pH 8, 
12.5 mM GSH) for 30 minutes at room temperature with occasional agitation. Eluted 
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proteins were dialysed overnight at 4°C against Dialysis Exchange Buffer (50 mM 
Tris pH 8, 100 mM NaCl, 1 mM EDTA, 0.02% Triton X-100, 5% glycerol), and 
stored in 50% glycerol at -80°C.  
2.4.4.1 Peptide ELISA 
 
Peptide array slides were blocked in 3 mL of 5% BSA/TBS-T [5% BSA (w/v), 50 
mM Tris pH 7.5, 150 mM NaCl, 0.05% Tween 20] for 1 hour at room temperature. 
Slides were rinsed twice in TBS-T (50mM Tris pH 7.5, 150mM NaCl, 0.05% Tween 
20), and incubated with the recombinant protein (1-2 µM per slide), diluted in 0.5% 
BSA/TBS-T [0.5% BSA (w/v), 50 mM Tris pH 7.5, 150 mM NaCl, 0.05% Tween 
20], overnight at 4°C. Slides were washed three times for 10 minutes each, before 
being incubated with the primary antibody (anti-EDD M19, 1:1,000; Santa Cruz) 
diluted in 1% BSA/TBS-T [1% BSA (w/v), 50 mM Tris pH 7.5, 150 mM NaCl, 
0.05% Tween 20] for 3 hours at room temperature. The slides were then washed 
twice for 5 minutes each and incubated with the secondary antibody (anti-goat HRP; 
1:10,000; Abcam) diluted in 1% BSA/TBS-T for 1 hour at room temperature. 
Finally, the slides were washed three times for 10 minutes each, before being treated 
with ECL substrate reagent and being exposed to autoradiography film (Amersham). 
2.4.5 Ubiquitylation assays 
 
S2 or HEK293 cells were transfected with His-tagged Ubiquitin, SGG-FLAG and 
dsRNA/RNAi against EGFP or Hyd/EDD. Cells were harvested after 48 h, washed 
once in ice-cold PBS, and lysed in 6 M Guanidinium HCl (GnHCl) Buffer I (6 M 
GnHCl, 0.01 M Tris HCl pH 8, 0.1 M Na2HPO4, 0.1 M NaH2PO4, 5 mM Imidazole, 
10 mM β-Mercaptoethanol). Lysates were sonicated briefly, cleared by 
centrifugation at 4,500 rpm at 4°C for 15 minutes, and incubated with Ni-NTA 
agarose beads (QIAGEN) at room temperature for 3 hours. The beads were washed 
sequentially in the following buffers: GnHCl Buffer II (6 M GnHCl, 0.01 M Tris 
HCl pH 8, 0.1 M Na2HPO4, 0.1 M NaH2PO4, 10 mM β-Mercaptoethanol), Wash 
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Buffer A (8 M Urea, 0.01 M Tris HCl pH 8, 0.1 M Na2HPO4, 0.1 M NaH2PO4, 10 
mM β-Mercaptoethanol), Wash buffer B (8 M Urea, 0.01 M Tris HCl pH 6.3, 0.1 M 
Na2HPO4, 0.1 M NaH2PO4, 10 mM β-Mercaptoethanol, 0.2% Triton X-100), Wash 
Buffer C (8 M Urea, 0.01 M Tris HCl pH 6.3, 0.1 M Na2HPO4, 0.1 M NaH2PO4, 10 
mM β-Mercaptoethanol), and Wash Buffer D (8 M Urea, 0.01 M Tris HCl pH 6.3, 
0.1 M Na2HPO4, 0.1 M NaH2PO4, 10 mM β-Mercaptoethanol, 0.1% Triton X-100). 
His-ubiquitin protein complexes were eluted with one bead volume of His Elution 




2.4.6 SDS-PAGE gel electrophoresis 
 
The protein concentration in cell lysates was measured using the Bradford Protein 
Assay Kit (Thermo Fisher Scientific, Cat. No. 23200) according to the 
manufacturer’s instructions. 15-25 µg of protein per well was prepared for sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) by adding 1X 
NuPAGE LDS Sample Buffer (Life Technologies, Cat. No. NP0008) and DTT to a 
final concentration of 100 mM. The samples were heated at 70°C for 10 minutes 
before loading onto 4-12% Bis-Tris or 3-8% Tris-Acetate gels (Life Technologies), 
and running at 200V for 1-2 hours in 1X MOPS buffer (Life Technologies). 
2.4.7 Western blotting 
 
Proteins separated on SDS-PAGE gels were transferred onto Polyvinylidene fluoride 
(PVDF) membranes using a wet transfer system. Gels, filter paper, and PVDF 
membranes were equilibrated in Transfer Buffer (0.25 M Tris, 1.9 M glycine, 10% 
(v/v) methanol) and transfers were performed overnight in transfer buffer at 30 V at 
4 ºC. Membranes were blocked in 5% Milk/PBS [5% (w/v) dried milk powder, 1X 
Hyd regulates morphogen signalling in the developing eye 
Chapter 2: Materials and methods   96 
PBS] or 5% BSA/PBS [5% BSA (w/v), 1X PBS] for 1 hour at room temperature 
with agitation. The membrane was then incubated with the primary antibody, diluted 
in either 5% Milk/PBS-T [5% (w/v) dried milk powder, 1X PBS, 0.05% Tween 20] 
or 3-5% BSA/PBS-T [3-5% BSA (w/v), 1X PBS, 0.05% Tween 20] for 3 hours at 
room temperature, or overnight at 4°C, with agitation. Membranes were washed 
several times (3 x 10 minutes) in wash buffer [1X PBS, 0.05% Tween 20] and 
incubated with a secondary horseradish peroxidase (HRP)-linked antibody, diluted 
1:10,000 – 1:30,000 in either 5% Milk PBS-T or 3-5% BSA/PBS-T, as above, for 1 
hour at room temperature with agitation. Following a final wash step with wash 
buffer (3 x 5 minutes), before being treated with ECL substrate reagent and being 
exposed to autoradiography film (Amersham). Primary antibodies used were goat 
EDD M-19 (1:1,000; Santa Cruz), mouse HA (1:2,000; Cell Signaling), rabbit FLAG 
(1:2,000; Cell Signaling), mouse Sgg (1:5,000; Euromedex), rabbit GSK3β (1:2,000; 
Cell Signaling), rat Ci 2A1 [1:100; Developmental Studies Hybridoma Bank 
(DSHB)], mouse Armadillo (1:100; DSHB), and mouse tubulin (1:30,000; Cell 
Signaling). 
2.4.8 Coomassie blue and silver staining 
 
SDS-PAGE gels were stained with SimplyBlue™ SafeStain (Life Technologies, Cat. 
No. LC6060) or the Silver Quest™ Silver Staining Kit (Life Technologies, Cat. No. 
LC6070), following the manufacturer’s protocol.  
 
2.5 Drosophila methods 
 
2.5.1 Drosophila melanogaster stocks 
 
These alleles are described in Flybase: hydK7.19, sggS9A.Scer\UAS, sggHMS01751 (RNAi). 
w1118; UAS-sggS9A (5255) and y1 sc* v1; sggRNAi (38293) stocks were obtained from 
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the Bloomington Drosophila Stock Center. hydK7.19 stocks were obtained from 
Jessica Treismann (NYU School of Medicine, New York, NY, USA). Sp//SM6-TM6 
was obtained from Marcos Vidal (Beatson Institute for Cancer Research, Glasgow, 
UK). Flies were maintained on standard medium at 18°C or 25°C.  
2.5.2 Mosaic Analysis with a repressible cell marker 
(MARCM) 
 
The MARCM technique (Lee and Luo, 2001) was used to generate GFP-expressing 
hydK7.19 hh-lacZ clones. Clones were induced by expression of ey-flp3.6. Crosses were 
maintained at 25°C. Two- to three-hour timed L3 larvae collections were made prior 
to dissections of eye discs. The following stocks were used for clonal analysis:  
 
yw ey-flp3.6; act>y+>GAL4, UAS-GFP; FRT82B, tubGAL80//SM6-TM6 
FRT82B, hh-lacZ/TM6B 
FRT82B, hydK7.19 hh-lacZ/TM6B 
UAS-sggS9A; FRT82B, hydK7.19 hh-lacZ//SM6-TM6 
UAS-sggS9A; FRT82B, hh-lacZ//SM6-TM6 
sggRNAi; FRT82B, hydK7.19 hh-lacZ//SM6-TM6 
sggRNAi; FRT82B, hh-lacZ//SM6-TM6 
2.5.3 Wholemount immunofluorescence of eye-antennal 
imaginal discs 
 
Eye-antennal imaginal discs were dissected from L3 stage larvae in PBS as 
previously described (Legent & Treisman 2008) and fixed in 4% paraformaldehyde 
for 30 minutes. The discs were washed three times 5 minutes in PBST [1X PBS, 
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0.1% (v/v) Triton X-100], placed in blocking solution [2% (w/v) BSA, 1X PBS, 
0.1% (v/v) Triton X-100] for 30 minutes, and incubated with primary antibodies 
diluted in blocking solution overnight at 4°C. Discs were washed as described and 
incubated with secondary antibodies diluted in blocking solution for 2 hours at room 
temperature, followed by washing and mounting in Vectashield mounting medium 
containing 4',6-diamidino-2-phenylindole (DAPI) (Vector Laboratories Inc.). 
Primary antibodies used were mouse β-galactosidase (1:100; DSHB), rabbit Hh 
(1:400; a gift from Pascal Thérond), rat Ci 2A1 (1:10; DSHB), mouse Ptc (1:10; 
DSHB), and mouse Wg (1:10; DSHB). Secondary antibodies used were Alexa 594 
and Cy5 (1:500; Life Technologies). Images were captured on a Nikon A1R confocal 
microscope at 20X magnification. 
 
2.5.4 Xgal staining of eye-antennal imaginal discs 
 
Eye-antennal imaginal discs were dissected and fixed as described in 2.5.3. The discs 
were washed two times 10 minutes in PBST [1X PBS, 0.1% (v/v) Triton X-100], and 
incubated in pre-warmed Xgal Staining Solution {0.2% (w/v) Xgal, 7.2 mM 
Na2HPO4, 2.8 mM NaH2PO4, 150 mM NaCl, 1 mM MgCl2, 3 mM K3[Fe(CN)6], 3 
mM K4[Fe(CN)6]} overnight at 37°C. Discs were washed briefly in 1X PBS and 
imaged on a light microscope at 10X magnification. 
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3.1 Introduction 
 
Although Hyd has been functionally implicated in the negative regulation of hh gene 
expression and Hh pathway activity (J. D. Lee et al. 2002), no protein binding 
partners for Hyd had been reported at the time of starting this project in 2010. This 
greatly complicated the task of elucidating the molecular mechanism by which Hyd 
regulates morphogen signalling. In order to facilitate this task, a key objective of this 
project was to identify novel Hyd binding partners, especially those that are already 
known to be involved in morphogen signaling and/or gene expression.  
 
To increase the chances of identifying bona fide Hyd binding proteins, I employed 
several complementary approaches/techniques. As several binding partners have 
been published for Hyd’s human orthologue EDD, I firstly employed a literature-
based approach and selected EDD binding partners that may be involved in Hh 
signaling. Secondly, I performed mass spectrometry on a Hyd pulldown from 
cultured Drosophila cells to identify binding partners, which were then subjected to 
bioinformatics analysis to identify any associations to morphogen signaling. Results 
from both of these approaches were finally subjected to biochemical verification of 
any potential interactions. Lastly, I performed a peptide ELISA to identify specific 
peptide sequences that bind to Hyd with a high affinity, and used this data as an 
alternative approach to identify novel Hyd binding partners.  
 
3.2 Hyd does not interact with members of the 
DYRK2 kinase family 
 
A number of proteins bind to Hyd’s human orthologue, EDD, implicating it in a 
diverse range of pathways and processes (see Chapter 1, Section 1.4.2). However, 
prior to 2014 Hyd had no published binding partners. Therefore, in a biased and 
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literature-guided approach, I selected known EDD binding partners based on their 
potential involvement in pathways regulating morphogen signaling.  
 
EDD interacts with the kinase DYRK2. DYRK2 forms a complex with EDD, and 
members of the Cul4-Roc1 E3 ligase complex DDB1 and VPRBP (Maddika & J. 
Chen 2009). DYRK2 is involved in a number of cellular processes, notably including 
its role in the mammalian SHH pathway, where it contributes to the phosphorylation 
and destabilization of the major transcriptional effector protein GLI2 (Varjosalo et al. 
2008). 
 
Interestingly, the Drosophila DYRK2 homologue, also known as smell-impaired 
(smi35A), interacts with the chromatin remodelling factors SNR1 and TRX (Kinstrie 
et al. 2006), which regulate hh gene transcription (Chanas & Maschat 2005; 
Terriente-Félix et al. 2011).  In addition to directly regulating Hh pathway activity 
through affecting Ci processing, a physical interaction between smi35A and Hyd 
could also epigenetically influence hh gene expression.  However, both these 
hypotheses rely on the conservation of function between human and Drosophila.  
 
3.2.1 Hyd does not interact with smi35A 
 
Assuming that the function of DYRK2 is conserved between humans and 
Drosophila, I first tested whether Hyd can interact with DYRK2 in HEK293 cells. 
An N-terminally Haemaglutinin (HA)- and Streptavidin (Strep)-tagged Hyd 
construct, containing a Precission cleavage site to enable enzymatic removal of the 
tag (collectively termed HSP), had previously been cloned in the lab (Mark Ditzel). 
This epitope tagged construct will be referred to subsequently as HSP-Hyd. In 
addition, a similar HSP-EDD construct, and a DYRK2-FLAG construct had also 
been cloned previously (Mark Ditzel), and were used as a positive binding control. 
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To verify an interaction, HEK293 cells were co-transfected with HSP-Hyd, DYRK2-
FLAG, and HSP-EDD, and Hyd and EDD were pulled down using StrepTactin 
sepharose beads. Additionally, a catalytically inactive Hyd mutant (HSP-Hyd C>A) 
was also included in the binding assay to test whether Hyd’s ubiquitylation activity 
could be required for a potential interaction to take place. Hyd-mediated 
ubiquitylation of DYRK2 could be a prerequisite for the interaction to take place, 
resulting in the generation of a new binding surface, or a conformational change in 
the DYRK2 protein that allows binding of Hyd. In this case, the wild-type Hyd 
protein, but not the C>A mutant Hyd protein would be expected to bind. 
Alternatively, if Hyd normally ubiquitylates and degrades DYRK2, then using this 
mutant in the binding assay would increase the chance of detecting an interaction. In 
the C>A mutant, the catalytic cysteine residue in the HECT domain has been 
replaced with an alanine residue, which prevents both the binding of ubiquitin at the 
active site, and subsequent transfer of ubiquitin to substrates (see Chapter 1, 
Sections 1.1.2.1 and 1.4.1.1). 
 
As expected, DYRK2-FLAG was successfully pulled down with HSP-EDD (Figure 
3.1 A), confirming the published result (Maddika & J. Chen 2009), and ascertaining 
that the epitope tags do not interfere and that the assay is capable of detecting the 
interaction. However, DYRK2-FLAG failed to interact with Hyd (Figure 3.1 A). If 
the potential interaction between DYRK2 and Hyd is not binary, an intermediate 
binding partner could be required for the complex to form. Further to this, if this 
intermediate binding partner is either not conserved between Drosophila and 
humans, or is simply not present in HEK293 cells, this could explain the negative 
binding result. Of course, another possibility is that DYRK2 significantly differs in 
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Figure 3.1: Hyd and EDD interactions with DYRK2 and its homologues. (A) StrepTactin 
pulldown in HEK293 cells. HEK293 cells were transfected with HSP-Hyd WT, HSP-Hyd C>A, HSP-
EDD and DYRK2-FLAG constructs. (B) StrepTactin pulldown in S2 cells. S2 cells were transfected 
with HSP-Hyd WT, HSP-Hyd C>A and smi35A-FLAG constructs. (C) StrepTactin pulldown in 
HEK293 cells. HEK293 cells were transfected with HSP-Hyd WT and smi35A-FLAG constructs. 
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HSP-EDD and DYRK2-FLAG were used as a positive binding control (POS. CTRL.). (D) 
StrepTactin pulldown in S2 cells. S2 cells were transfected with HSP-Hyd WT, HSP-Hyd C>A, and 
Dyrk3-FLAG constructs. 
 
With this in mind, I cloned the Drosophila orthologue of DYRK2, known as smell-
impaired (smi35A). The smi35A construct contains a C-terminal FLAG tag, and was 
cloned into both Drosophila and mammalian expression vectors. Schneider 2 (S2) 
cells, which were originally derived from Drosophila embryos (Schneider 1972) and 
are one of the most commonly used Drosophila cell lines, were co-transfected with 
smi35A-FLAG and HSP-Hyd, and subjected to a StrepTactin pulldown. 
Unfortunately, the expression levels of the smi35A-FLAG construct were sub-
optimal and no binding was detected in S2 cells (Figure 3.1 B). I therefore tried to 
detect a possible interaction in HEK293 cells, as these are known to easily produce 
large amounts of over-expressed proteins, and are therefore ideal for binding assays. 
Smi35A-FLAG and HSP-Hyd were co-transfected into HEK293 cells, followed by a 
StrepTactin pulldown of HSP-Hyd. However, no interaction was detected between 
smi35A-FLAG and HSP-Hyd WT or HSP-Hyd C>A (Figure 3.1 C). This was 
despite the fact that the binding conditions allowed binding of DYRK2-FLAG to 
HSP-EDD in the positive control (Figure 3.1 C). 
3.2.2 Hyd may interact with Dm Dyrk3 and increase its 
expression level 
 
From the previous binding assay results, it appeared that smi35A did not bind Hyd, 
even though DYRK2 readily interacts with EDD. However, the low expression levels 
of smi35A in S2 cells could also account for the lack of an observed reaction. 
Alternatively, this could be due to the divergence of sequence conservation between 
Drosophila DYRK2 homologues and DYRK2. Closer investigation of all existing 
Drosophila homologues of DYRK2 using protein BLAST revealed that smi35A only 
shared 47% sequence identity with DYRK2 (Figure 3.2 B). It also revealed that 
another Drosophila DYRK2 homologue, Dyrk3, is in fact more closely related to 
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DYRK2, sharing a significant 72% sequence identity (Figure 3.2 B).
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Figure 3.2: Sequence identity between DYRK2 and its Drosophila homologues. (A) Amino acid 
sequence alignment of DYRK2, smi35A, Dyrk3 and minibrain (mnb). (B) Schematic summarising 
protein BLAST alignment results of DYRK2 and its closest homologues in Drosophila based on 
sequence conservation. Percentages indicate sequence identity with respect to DYRK2.  
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I therefore reasoned that Dyrk3 may be a better candidate to interact with Hyd and 
cloned a Dyrk3-FLAG construct to test the binding to Hyd. S2 cells were co-
transfected with Dyrk3-FLAG, HSP-Hyd WT and HSP-Hyd C>A, and a binding 
assay was performed using StrepTactin beads. Dyrk3-FLAG did not appear to 
interact with either Hyd WT or Hyd C>A, although a very weak signal was detected 
in the Dyrk3 and Hyd WT binding sample (Figure 3.1 D; upper panel). Interestingly, 
the expression of Dyrk3 was significantly higher in the presence of Hyd WT, 
compared to in the presence of Hyd C>A or when expressed on its own (Fig. 3.1 D; 
third panel from top). This could explain why a small amount of Dyrk3 could have 
been pulled down with Hyd WT.  
3.2.3 Summary 
 
In conclusion, I was unable to establish a positive interactive pairing between Hyd 
and the DYRK kinases. Hyd does not appear to interact with DYRK2 or smi35A, but 
may interact with Dyrk3. The latter result also suggests that Hyd may be involved in 
positively regulating Dyrk3 protein levels through its ubiquitylation activity. 
However, this hypothesis would have to be investigated further. Firstly, the binding 
assay would have to be repeated using a larger amount of transfected S2 cell lysate 
and/or a more sensitive Western blotting detection reagent, such as SuperSignal West 
Femto Chemiluminescent Substrate (Thermo Fisher Scientic Inc.). In addition, I 
would perform a ubiquitylation assay with Hyd and Dyrk3 in S2 cells, to assess 
whether Hyd affects Dyrk3 ubiquitylation levels. Finally, to determine whether Hyd 
regulates Dyrk3 protein levels and by what mechanism, I would assess the effects of 
the presence and absence of Hyd protein in S2 cells (e.g. over-expression and RNAi) 
on Dyrk3 protein levels in the presence of the proteasome inhibitor MG132 and/or 
the protein synthesis inhibitor cycloheximide. 
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3.3 Optimisation of Tandem Affinity Purification 
(TAP) of Hyd for Mass Spectrometry (MS) 
 
One of the key objectives of this project is to identify novel Hyd protein binding 
partners and/or ubiquitylated substrates. In an unbiased proteomics-based approach, I 
employed a specific tandem affinity purification (TAP) protocol in combination with 
mass spectrometry (Gingras et al. 2007) to purify and analyse Hyd complexes from 
Drosophila S2 cells. 
 
The TAP procedure involves a sequential pulldown of Hyd, and its associated 
binding partners, using a StrepTactin affinity resin, followed by elution with 
desthiobiotin, and immunoprecipitation with an anti-HA antibody-conjugated resin 
(Figure 3.3, steps 1 and 2) (Gingras et al. 2007). The Strep-tag fused to Hyd is a 
synthetic peptide that binds with high affinity to StrepTactin, a specifically 
engineered Streptavidin (Schmidt & Skerra 2007). TAP enables the elimination of 
many non-specific contaminants that may bind to the resins, and may otherwise be 
detected as false positives in the final elution (Figure 3.3, step 3). 
 
 
Figure 3.3: HA-Strep Hyd Tandem Affinity Purification (TAP). S2 cells expressing HSP-tagged 
contructs are lysed and are subjected to a two-step purification procedure. First, HSP-Hyd, and 
associated binding partners (e.g. X, Y) are purified using Strep-Tactin sepharose beads (step 1).  HSP-
tagged comlexes are then eluted using desthiobiotin and purified using anti-HA-conjugated agarose 
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beads (step 2). Finally, proteins are eluted from the anti-HA beads for analysis by mass spectrometry 
(step 3). This eliminates most contaminants (red circles) that bind non-specifically to the sepharose or 
agarose resins. 
 
S2 cells were chosen as they endogenously express Hyd (modENCODE project, 
(Celniker et al. 2009), suggesting that they also contain Hyd protein binding partners. 
In addition, S2 cells are easily cultured and express a relatively high amount of 
protein when transfected. In order to produce quality protein material for affinity 
purification, S2 cell lines stably expressing HSP-Hyd constructs were generated 
(Figure 3.4 A). S2 cells were transfected with HSP-Hyd constructs that were cloned 
into the pMT-PURO expression vector, which allows inducible expression of Hyd 
and contains a puromycin resistance gene (Iwaki & Castellino 2008). S2 cells were 
then subjected to puromycin-based selection to obtain cells stably expressing HSP-
Hyd constructs.  
 
Hyd is an E3 ubiquitin ligase, meaning that it may coordinate the ubiquitylation and 
degradation of its binding partners. This would effectively minimize the detection of 
some endogenous binding partners following affinity purification of HSP-Hyd. To 
circumvent this issue, an S2 cell line stably expressing the catalytically inactive 
mutant HSP-Hyd C>A was also generated (Figure 3.4 A). In addition to this, an S2 
cell line expressing the HSP tag only was generated as a negative binding control 
(Figure 3.4 A). Any proteins interacting with the HSP tag would therefore be 
subtracted from those identified as HSP-Hyd interacting proteins.  
 
Next, TAP of Hyd complexes from stable S2 cell lysates was optimized to yield a 
high quality sample for analysis by mass spectrometry (MS). The procedure was 
initially carried out as described previously (Gingras	  et	  al.	  2007) on lysates from 
stable HSP-Hyd WT cells and normal S2 cell lysates. A silver stain of the final 
elution of this pilot experiment revealed that, in addition to exogenous Hyd, there 
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were several unique bands in the Hyd WT elution sample (Figure 3.4 B). The 
complexes were eluted using a denaturing buffer containing 4% SDS, which would 
also denature and detach the heavy and light chains of the HA antibodies conjugated 
to the anti-HA resin. This explains the large background band present in both the 
experimental and control elutions, which is likely to represent the heavy chain of the 
HA antibody (Figure 3.4 B).  
 
In an attempt to obtain a cleaner and higher quality final elution for subsequent mass 
spectrometric analysis, I optimized the final elution step of the procedure. I 
compared three different elution methods: 4% SDS buffer, HA peptide, and 8M 
Urea. In this experiment, both the HA peptide and 8M Urea elutions were cleaner 
than the SDS elutions (Figure 3.4 C). However, in the HSP control sample eluted 
with HA peptide, there was an inexplicably high amount of background. Further to 
this, HA peptide elution would require the removal of the HA peptide prior to mass 
spectrometric analysis of the sample to reduce interference. I therefore chose to 
proceed with the 8M Urea elution method. 
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Figure 3.4: Generation of tools and Optimisation of TAP procedure for identification of Hyd 
binding partners. (A) Expression of WT HSP-Hyd and C>A HSP-Hyd (left panel), and the HSP 
epitope tag (right panel) in stably transfected S2 cell lines. Lysates of non-transfected S2 cells were 
included as a negative control. (B) Silver stain analysis of TAP samples. Non-transfected S2 cells 
(negative control) and S2 cells staby expressing HSP-Hyd WT were lysed and subjected to TAP, prior 
to elution with 4% SDS. Unique bands in the HSP-Hyd eluted fraction are indicated by arrows. (C) 
Silver stain assessment of different elution buffers used for the final elution of the TAP procedure. 
Eluted samples following TAP from non-transfected S2 cells or S2 cells stably expressing the HSP tag 
only (negative controls) were run alongside samples from S2 cells stably expressing HSP-Hyd WT 
and HSP-Hyd C>A. The final elution was performed with either 4% SDS, HA peptide, or 8M Urea. 
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3.4  Mass Spectrometry identifies potential novel Hyd 
binding partners 
 
In an attempt to identify novel Hyd binding partners, I used S2 cells stably 
expressing HSP alone, HSP-Hyd WT and HSP-Hyd C>A to purify complexes as 
described in Section 3.3. The 8M urea-eluted fractions were subsequently loaded into 
individual wells of a pre-cast SDS-PAGE gel, and allowed to run 1-2 cm into the gel. 
Following Coomassie staining, this portion of the gel was then excised in its entirety, 
effectively containing Hyd and all of the complexed material, irrespective of 
molecular weight. The gel fraction was trypsinized, and the sample was analysed by 
mass spectrometry using the search engine Mascot to generate a list of identified 
proteins from the raw peptide mass fingerprint data (carried out by Flavia Alves, 
Rappsilber Lab, Institute of Cell Biology, University of Edinburgh, see Materials 
and Methods, Section 2.4.3 for details of sample preparation, processing and 
analysis).  
 
3.4.1 Mass spectrometry results 
 
All identified proteins also present in the HSP-tag only control were eliminated, and 
the combined results from five independent experiments are summarised in Table 
3.1. From all five experiments, over 100 protein hits were identified. However, a 
large proportion of these hits were proteins, which were unlikely to be involved in 
signalling pathways with Hyd, such as actin, tubulin, and heat shock proteins. The 
simplified list presented in Table 3.1 contains a total of 26 potential novel Hyd 
binding partners chosen from the combined dataset on the basis of their likelihood to 
be involved in processes related to known Hyd/EDD functions (see Section 1.4.2). 
Several proteins were identified that appear to exclusively interact with either Hyd 
WT or Hyd C>A, with the exception of Tcp1 and Gustatory Receptor 97a. This 
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suggests that Hyd’s ubiquitylation activity could be essential for binding to some of 
its binding partners. Unfortunately, most proteins were identified based on the 
presence of a single peptide, with the highest peptide count per protein being five. 
This suggests that the quality of the mass spectrometry data is relatively poor and 
could be due to several factors, including significant protein loss during the relatively 
complex TAP procedure, or insufficient trypsinization of proteins contained within 
the gel chunk. Although I attempted to optimise the experiment during 4 additional 
runs, I was unable to improve the peptide count. However, some protein hits, 
although identified by as little as one peptide, had a good peptide coverage over 
multile experiments. For example, Armadillo, Shab and Copia were identified by 
single, but different, peptides in multiple, independent experiments, which increases 
the confidence level and indicates that these may be genuine Hyd binding partners.  
 
3.4.2 Bioinformatics analysis of mass spectrometry hits 
 
With the intention of identifying novel Hyd binding partners involved in morphogen 
signalling and/or expression, my original plan was to use bioinformatics to narrow 
down a potentially large list of protein hits. Since the list in Table 3.1 is shorter than 
expected, I decided to use a combination of bioinformatics and biochemical 
verification to sift out proteins that are genuine Hyd binding partners and are likely 
to be functionally involved in morphogen pathways.  
The Uniprot database is a central repository of information on protein sequence and 
function. In addition, it integrates the Basic Local Alignment Search Tool (BLAST) 
algorithms, which I used to identify homologous proteins and infer information on 
uncharacterised Drosophila proteins. I identified the closest human orthologue and 
the relevant percentage of sequence identity between the Drosophila and human 
proteins for each MS hit (Table 3.1). This revealed that most of the hits showed very 
close (i.e. >40% sequence identity) sequence homology to a human protein. This is 
important, because the extent of co-evolution among Hyd/EDD binding partners 
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between organisms is a crucial factor in the discovery of conserved biological 
processes in mice and humans, ultimately aiding translational research 
 
Interestingly, analysis of the individual protein hits revealed Armadillo, the 
Drosophila homologue of β-catenin, to be a potential Hyd binding partner (Table 
3.1). Armadillo/β-catenin is the key transcriptional effector in the Wg/Wnt pathway 
(see Chapter 1, Section 1.3.1), suggesting that Hyd may also be involved in 
regulating Wg morphogen signaling.
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Table 3.1: Combined TAP Mass Spectrometry Results. Proteins identified in a total of 5 independent pulldown experiments with both WT HSP-Hyd and C>A 
















Protein Score Closest human orthologue  
(% identity) and predicted function 
1 18 766 132 13,459 
2 123 8,742 177 14,009 
3 103 4,029 191 13,726 




5 83 1,633 - - 
EDD (38%) O95071: Putative E3 ligase 
involved in negatively regulating Hh 
signalling. 
2 - - 1 48 
4 - - 5 179 
Tcp1 (T-cp1) 
P12613 
5 1 30 - - 




5 4 42 - - 
PyK PKM (65%) P14618: Regulation of 
glucose metabolism 
4 1 47 - - Copia (GIP) 
P04146 5 3 32 - - 







4 3 46 - - 
EiF2 (81%) P41091: Protein synthesis 
Akirin 
Q9VS59 4 - - 2 26 
Akirin-2 (40%) Q53H80: Embryonic 
development; Effector of immune 
deficiency pathway 
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Protein Score Closest human orthologue  
(% identity) and predicted function 
3 - - 2 27 Shab 
P17970 4 - - 1 27 
Potassium voltage-gated channel (70%) 
Q14721: Voltage-dependent potassium ion 
permeability 
4 1 38 - - ATP synthase subunit alpha 
(blw) 
P35381 5 2 29 - - 
ATP synthase subunit alpha (81%) 
P25705: ATP production 
Rpn7 
Q9V3G7 4 2 92 - - 
26S proteasome non-ATPase regulatory 
subunit 6 (70%) Q15008: Regulatory 




1 - - 1 27 
Hypoxia-inducible factor 1-alpha (31%) 





2 - - 1 25 
Neurofilament heavy polypeptide (25%) 





homolog 1 (htl) 
Q07407 
2 - - 1 28 
Fibroblast growth factor receptor 3 (40%) 
P22607: May be required for patterning of 
muscle precursor cells 
Tudor (tud) 
P25823 3 - - 1 33 
Tudor domain-containing protein 6 (20%) 
O60522: Formation of primordial germ 
cells 
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Protein Score Closest human orthologue  
(% identity) and predicted function 




Q8IMQ6 3 - - 1 26 





3 - - 1 41 
Glycogen phosphorylase (73%) 




4 1 38 1 26 
Dystrophin (42%) P11532: Anchors the 





4 - - 1 34 
SEC14-like protein 1 (44%) Q92503: 
Unknown function 
APP-BP1 
Q9VTE9 4 - - 1 32 
NEDD8-activating enzyme E1 regulatory 
subunit (45%) Q13564: Regulatory subunit 
of the dimeric Uba3-Ula1 E1 enzyme 
1 1 59 - - 
2 1 97 - - 
Armadillo (arm) 
P18824 
4 1 110 1 102 
Catenin beta-1 (68%) P35222: 
Transcriptional effector protein in the 
Wg/Wnt pathway 
Ran 
Q9VZ23 3 1 67 - - 
GTP-binding nuclear protein Ran (87%) 
P62826: GTP-binding protein involved in 
nucleo-cytoplasmic transport 
Cryptochrome 1 4 1 43 - - Cryptochrome-1 (41%) Q16526: Regulation 
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Protein Score Closest human orthologue  
(% identity) and predicted function 
(cry) 
O77059 




4 1 47 - - 
ATP synthesis 
Flightin (fln) 
P35554 4 1 39 - - 
Possibly involved in the regulation of flight 
muscle contraction 
PERQ 
Q7KQM6 4 1 33 - - 
GIGYF2 (26%) Q6Y7W6: Unknown 
function 
Rpn2 
Q9V3P6 4 1 26 - - 
26S proteasome non-ATPase regulatory 
subunit (62%) Q99460: Regulatory subunit 




5 1 58 - - 
Cysteine desulfurase, mitochondrial (78%) 
Q9Y697: Removal of elemental sulfur from 





5 1 34 - - 
ATP synthase subunit beta (89%) 
P06576: ATP production 
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To gain more insight into potential molecular and/or functional relationships between 
the MS hits, I used additional bioinformatics databases, aiming to identify any shared 
functions and pathway-related interrelationships between the potential binding 
partners. The protein interaction database IntAct was used to identify any shared 
binding partners between the identified proteins, with the aim of identifying potential 
‘nodes’ with shared roles in particular cellular processes. The cytoscape program was 
then used to visualize the network as a node and edge diagram from the list of 
binding partners resulting from the IntAct database query (Figure 3.5). This revealed 
that Ran and Pyruvase kinase interact and may therefore exist in a complex with 
Hyd. Furthermore, the IntAct analysis showed that there are several shared binding 
partners between the potential Hyd binding proteins, which appear to be involved in 
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Figure 3.5: Analysis of mass spectrometry data using bioinformatics databases. Protein Network 
Analysis using the IntAct database. Proteins that have been identified as potential Hyd binding 
partners by mass spectrometry are in red circles; shared binding partners are in blue circles; proteins 
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Table 3.2: Shared binding partners between mass spectrometry hits. Analysis of the mass 
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splicing. 
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homology: enhances replication of 








Essential extracellular matrix 
(ECM) protein that influences cell 
rearrangements. May act by 
modulating metalloproteinases 









Unknown. Inferred function from 
homology: Developmental neurite 
growth regulatory factor with a role 
as a negative regulator of axon-axon 
adhesion and growth, and as a 
facilitator of neurite branching. 






Unknown. Inferred function from 
homology: Histone acetyltransferase 
which may be involved in 
transcriptional activation. 
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Importantly, some binding partners and/or shared binding partners were identified 
that are known to be directly involved in Hh signaling. For example, the potassium 
voltage-gated channel, Shab, interacts with Patched (Ptc), the receptor for the Hh 
ligand on Hh receiving cells (Nakano et al. 1989). Further to this, the protein with 
Uniprot identifier Q7KQM6, also known as PERQ, which has no known function as 
yet, interacts with Suppressor of Fused [Su(fu)]. Su(fu) regulates Ci activity by 
sequestering active Ci155 in the cytoplasm (Méthot & Basler 2000), thus preventing 
translocation to the nucleus and transcription of Hh target genes. This intriguing link 
could support the idea that Hyd negatively regulates Hh pathway activity, whereby 
Hyd exists in a complex with PERQ and Su(fu) and negatively regulates Ci activity. 
Since the function of PERQ is, as of yet, unknown, there is no reason to exclude its 
involvement in the Hh pathway. Finally, the kinase Shaggy (Sgg) is a shared binding 
partner between Cryptochrome (Cry) and Armadillo (Arm). Notably, Sgg plays a key 
regulatory role in both the Hh and Wg pathways, where it negatively regulates the 
respective transcriptional effector proteins and subsequent target gene expression (J. 
Jia et al. 2002; Peifer et al. 1994; Aberle et al. 1997). 
In conclusion, the mass spectrometry-based screen for novel Hyd binding partners 
returned several potential binding partners. Although none of the hits are known to 
be directly involved in Hh signaling, bioinformatics analysis revealed a number of 
interesting links to key Hh and Wg pathway components, which in turn provides a 
starting point for further investigation into the molecular mechanism of Hyd-
mediated Hh pathway regulation. 
 
3.5 Biochemical verification of mass spectrometry 
hits 
 
The TAP of Hyd and subsequent mass spectrometry analysis yielded a list of 26 
potential novel Hyd binding partners. Although bioinformatics analysis of the dataset 
revealed some interesting connections of the binding partners to both Hh and Wg 
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signaling pathway components, there are some limitations to the mass spectrometry 
data that must nonetheless be considered, especially considering the relatively poor 
quality of the mass spectrometry data. No physiological interaction can be inferred 
from mass spectrometry identification alone. Therefore, experimental verification of 
any interaction must be performed, either in cultured cells or in vivo. Importantly, the 
low peptide count obtained for the protein hits complicates the confident selection of 
potential binding partners for further analysis in vivo. Therefore, a screening 
approach was taken to sift out bona fide Hyd binding partners from the generated MS 
hits, whereby expression constructs for each MS hit were either obtained or cloned 
for binding assays in S2 cells. 
 
3.5.1 Binding assays using stable HSP-Hyd S2 cells and 
recombinant substrate expression constructs 
 
Due to time constraints and the limited availability of resources, cloning 27 different 
expression constructs from scratch would have been too ambitious. Fortunately, the 
majority of constructs were available from the Drosophila Genetic Research 
Consortium (DGRC), either as sequence-verified DNA clones that were used for 
sub-cloning, or as HA-FLAG tagged expression constructs in a pMK33 vector 
containing an inducible metallothionein promoter. Obtained cDNA clones were 
subcloned by PCR amplification and ligation into the pGEM vector, followed by 
sub-cloning into a pMT Drosophila expression vector containing a carboxy-terminal 
V5-FLAG epitope tag. Cloning and/or expression testing of the constructs proved 
very time-consuming, hence the complete cloning of some expression constructs was 
not completed within the time-scale of the project. All expression constructs and 
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Table 3.3: Expression construct library for MS hits. 
Expression construct Size (kDa) Status 
GlyP HA-FLAG pMK33 98 Expression construct obtained; stable cell line 
generated 
Tudor HA-FLAG pMK33 110 Expression construct obtained; stable cell line 
generated 
FGFR1 HA-FLAG pMK33 84 Expression construct obtained; Difficulties with 
expression 
Ran HA-FLAG pMK33 25 Expression construct obtained; Expression tested 
ATPsynB HA-FLAG pMK33 54 Expression construct obtained; Expression tested 
blw HA-FLAG pMK33 59 Expression construct obtained; Expression tested 
Arm HA-FLAG pMK33 92 Expression construct obtained; stable cell line 
generated 
bnb HA-FLAG pMK33 46 Expression construct obtained; Expresses but wrong 
size (kDa) 
Cry HA-FLAG pMK33 63 Expression construct obtained; Difficulties with 
expression 
Flightin HA-FLAG pMK33 21 Expression construct obtained; Difficulties with 
expression 
APP-BP1 V5-FLAG pMT 59 cDNA clone obtained; cloning into pMT V5-FLAG 
successful; stable cell line generated 
Tcp1 V5-FLAG pMT 60 cDNA clone obtained; cloning into pMT V5-FLAG 
successful; stable cell line generated 
Akirin V5-FLAG pMT 23 cDNA clone obtained; cloning into pMT V5-FLAG 
successful 
Real-time V5-FLAG pMT 76 cDNA clone obtained; cloning into pMT V5-FLAG 
successful 
PERQ V5-FLAG pMT 170 cDNA clone obtained; cloning into pMT V5-FLAG 
unsuccessful 
Copia 163 cDNA obtained 
 
Following a series of initial expression tests in S2 cells (Data not shown), a sub-set 
of the candidate proteins were screened for their ability to interact with HSP-Hyd. A 
Streptactin pulldown method was chosen for these binding assays, as it most closely 
resembles the TAP procedure used to generate the MS data. The Streptactin 
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pulldown method was chosen over HA immunoprecipitation as most of the 
expression constructs also contained an HA epitope tag. This involved transfection of 
the FLAG-tagged expression constructs into S2 cells stably expressing WT or C>A 
HA-Strep-tagged Hyd. Pulldown assays were performed with Streptactin-sepharose 
and in the same buffer used for the TAP-MS purification, in an attempt to reproduce 
the original binding conditions. This method yielded negative binding results for 
ATP synthase β, Ran, FGFR1, Armadillo, Glycogen Phosphorylase, and Tudor (Data 
not shown).  
 
As an alternative approach, I therefore also employed the reciprocal co-
immunoprecipitation conditions, whereby the candidate binding protein is 
immunoprecipitated using an anti-FLAG agarose resin. Binding to Hyd was then 
assessed by detection of HSP-Hyd (anti-HA antibody) in the immunoprecipitated 
fraction. An example of an experiment performed using this method is shown in 
Figure 3.6 A, where FLAG-tagged GlyP, Tudor, FGFR1, and Flightin were 
transfected into S2 cells stably expressing HA-Hyd, and immunoprecipitated using 
anti-FLAG beads. Unfortunately, this approach also proved uninformative due to a 
high level of background HA-Hyd binding to the anti-FLAG agarose resin (Figure 
3.6 A). In addition, the expression levels of some candidate proteins were poor (e.g. 
FGFR1 and Flightin in Figure 3.6 A) and generally non-reproducible between 
experiments (Data not shown). In summary, difficulties with expression levels, as 
well as lack of reproducibility, represented the biggest obstacles to performing 
binding assays. Therefore, I decided to generate S2 cells stably expressing the 
candidate proteins to try and eliminate this variable. 
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Figure 3.6: Biochemical verification of mass spectrometry protein hits. (A) anti-FLAG 
immunoprecipitation in S2 cells stably expressing HSP-Hyd C>A. Stable HSP-Hyd C>A S2 cells 
were transfected with GlyP-FLAG, Tudor-FLAG, FGFR1-FLAG, and Flightin-FLAG. Positive 
control: Sgg-FLAG. (B) Expression test of S2 cells stably expressing APP-BP1-FLAG, Arm-FLAG, 
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FGFR1-FLAG, Flightin-FLAG, GlyP-FLAG, Tudor-FLAG, Akirin-FLAG, Cry1-FLAG, Sgg-FLAG, 
Ran-FLAG, Tcp1-FLAG. 
3.5.2 Generation of stable S2 cells expressing potential Hyd 
binding partners for use in binding assays 
 
S2 cells stably expressing the candidate proteins were generated by transfecting S2 
cells with the relevant expression construct and a vector containing a puromycin 
resistance gene in a 7:1 molar ratio. The purpose of the 7:1 ratio was to generate a 
population of cells that are more likely to have received the expression construct and 
the puromycin resistance gene, or the expression construct alone, rather than the 
puromycin resistance gene alone. The latter would give rise to unwanted puromycin-
resistant cells, which are not expressing the construct of interest. 
 
With some constructs, I was repeatedly unsuccessful in obtaining a surviving cell 
population following puromycin treatment. However, the remaining puromycin-
resistant cell lines were expression tested (Figure 3.6 B). This revealed that only 
about half of the surviving cell lines were expressing the constructs of interest at 
detectable levels. As a result, S2 cells stably expressing FLAG-tagged APP-BP1, 
Armadillo, GlyP, Tudor, and Tcp1 were successfully generated, whereas the 
generation of stable FGFR1, Flightin, Akirin, Cry1, and Ran cell lines was deemed 
unsuccessful (Figure 3.6 B). 
 
3.5.3 Hyd interacts with Armadillo 
 
The successfully generated S2 stable cells expressing a subset of the Hyd MS hits 
were subsequently used in binding assays in a further attempt to verify a physical 
interaction with Hyd. To maximize expression levels of the candidate binding 
partners, binding assays were performed by combining lysates of HSP-Hyd WT 
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stable cells with lysates of S2 cells stably expressing FLAG-tagged APP-BP1, 
Armadillo, GlyP, Tudor and Tcp1. The lysates were then subjected to a Streptactin 
pulldown, and the eluted material was probed for the candidate binding proteins 
(anti-FLAG) (Figure 3.7 A). As a negative control, lysates expressing the FLAG-
tagged proteins were also incubated with Streptactin resin and S2 cell lysates lacking 
HSP-Hyd. To confirm that the assay conditions were capable of detecting a Hyd 
interaction I used two potential positive binding controls inferred from published 
EDD interactants: Sgg (Hay-Koren et al. 2011) and Tob (Lim et al. 2006). Although 
some background issues were encountered, both Tob and Sgg signals were increased 
upon HSP-Hyd purification (Figure 3.7 A). The expression levels of all candidate 
proteins in the lysate input control (lower panel, Figure 3.7 A) was sufficient, except 
for GlyP, which failed to express. One explanation for this is that the S2 stable cells 
have expelled the GlyP expression construct following generation of the cell line, 
resulting in S2 cells that are resistant to puromycin but no longer express the protein 
of interest. In the StrepTactin Pulldown (upper panel, Figure 3.7 A), HSP-Hyd was 
successfully pulled down, but no binding was observed with GlyP and Tudor, 
although the negative binding result with GlyP is almost certainly due to lack of its 
expression. Both APP-BP1 and Tcp1 were detected in the HSP-Hyd pulldown 
fraction, however a high level of background binding to the Streptactin resin in the 
negative S2 control (upper panel, Figure 3.7 A) suggests that both of these binding 
results are also negative. However, Armadillo was found to bind to Hyd at a level 
that was significantly above a small background binding level in the negative control, 
suggesting that Armadillo may be a bona fide Hyd binding partner (upper panel, 
Figure 3.7 A). These results therefore indicate that Hyd does not appear to interact 
with APP-BP1, Tcp1, whereas binding to GlyP could not be determined in this 
experiment. 
 
In order to verify the Armadillo:Hyd interaction in an independent experiment, I 
performed an endogenous immunoprecipitation experiment in Drosophila Clone 8 
(Cl8+) cells. Cl8+ cells were originally derived from wing imaginal discs (Currie et 
al. 1988), and, unlike S2 cells, are capable of transducing both the Hh and Wg 
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pathways (Lum et al. 2003; DasGupta et al. 2005). Hyd was successfully 
immunoprecipitated using the anti-EDD M-19 antibody (Figure 3.7 B). This 
antibody was raised against the HECT domain of EDD, but due to high sequence 
conservation between the Hyd and EDD HECT domains, the antibody is also capable 
of recognising Hyd. Both the anti-Hyd and the negative control (IgG) 
immunoprecipitated fractions were probed with an anti-Armadillo antibody, 
confirming the endogenous interaction between Armadillo and Hyd (Figure 3.7 B). 
In summary, these experiments strongly suggest that Hyd interacts with Armadillo, 
and may therefore also play a role in the Wg pathway. 
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Figure 3.7: Hyd interacts with Armadillo. (A) StrepTactin pulldown in S2 cells. S2 cells were 
transfected with APP-BP1-FLAG, Arm-FLAG, GlyP-FLAG, Tcp1-FLAG, Tudor-FLAG, Tob-FLAG, 
and Sgg-FLAG, and lysed after 48 hours. S2 cells stably expressing HSP-Hyd were lysed separately 
(non-transfected S2 cells were also lysed separately and used as a negative control). Each S2 lysate 
containing an over-expressed FLAG-tagged protein was combined 1:1 with the HSP-Hyd cell lysate, 
or the negative control lysate, and combined lysates were subjected to a StrepTactin pulldown. (B) 
anti-Hyd (M19) immunoprecipitation in S2 cells. Endogenous Hyd was immunoprecipitated with 
antti-M19, followed by Protein A agarose. Negative control = IgG. 
3.6 Phage Display approach to identify Hyd binding 
partners 
 
As an alternative, as well as complementary, approach to identify novel Hyd binding 
partners, a phage display screen using recombinant protein encoding the Hyd HECT 
domain as the bait had been carried out previously in the laboratory (Mark Ditzel). 
This yielded 50 12-mer peptides that represented potential Hyd-HECT binding 
peptides (Table 3.4).  
The phage display method utilises genetically modified bacteriophages - viruses that 
infect bacteria. A gene encoding the protein or peptide of interest (e.g. a cDNA or 
peptide library) is inserted into a phage coat protein gene (Smith 1985). The 
Hyd regulates morphogen signalling in the developing eye 
Chapter 3: Proteomic approaches to identify Hyd binding partners   133 
bacteriophage is then allowed to infect bacteria (e.g. E. coli), which results in its 
multiplication and the subsequent lysis of the bacteria. Importantly, the new 
bacteriophage particles now “display” the protein of interest as a coat protein (Smith 
1985). These phage particles, displaying a mixture of proteins from a cDNA/peptide 
library, can then be screened against a recombinant protein immobilised on a slide, 
which in this case was the recombinant Hyd-HECT fragment, containing the PABC 
and HECT domains. Unbound bacteriophages are washed off and bound 
bacteriophages are sequenced to identify the binding peptides/proteins (Kehoe & 
Kay 2005). 
To confirm the binding of these peptides to Hyd, I performed an ELISA in which the 
peptides, along with mutagenised versions of the parent peptides, were immobilised 
onto glass slides and assessed for their ability to bind recombinant Hyd protein. The 
aim of the peptide verification ELISA was to identify peptide sequences that have a 
high binding affinity for Hyd, and subsequently use bioinformatics to match these 
peptide sequences to potential novel Hyd binding partners and/or the MS hits. The 
presence of a binding peptide sequence in an existing MS hit would not only increase 
the confidence of the hit, but also provide valuable information on the location and 
nature of the interaction between Hyd and the protein of interest. 
 
Table 3.4: Phage Display Synthetic Peptide Sequences. 
Peptide 
identifier Amino Acid Sequence Mutagenised peptide sequences & identifiers 
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Peptide 





7 FQGEKIIIAILL - 
















































19 HHIIVLRLLRFG HHIIVLRAARFG (77) 
HHIIVLRLLAAG (78) 
HHIIVLRLLRFA (79) 





21 HVKKLYRNPPRA - 
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Peptide 
identifier Amino Acid Sequence Mutagenised peptide sequences & identifiers 
22 KIFIRRGILLV - 
















27 KVFLLPNPPLPT KVFLAANPPLPT (116) 
KVFLLPAAPLPT (117) 
KVFLLPNPAAPT (118) 
28 LIRGMRRGSFRF - 
29 LLHYQFILLRF - 
30 LLYIHASFIANG - 
31 LPFLHNTPPSFW - 
32 LYTALSGPKA LYTALAAPKA (141) 
LYTALSGAAA (142) 
33 NATSQRPVHIAQ - 
34 NLFISFHPVRA - 
35 PYNRYPSLLRFG PYNRYPSAARFG (80) 
PYNRYPSLLAAG (81) 
PYNRYPSLLRFA (82) 
36 QHANHQAWNNLR - 
37 QSAHSKIRSYD QSAHAAIRSYD (71) 
QSAHSKAASYD (72) 
QSAHSKIRAYD (73) 
38 RTLMYAKVVSE RTLAAAKVVSE (137) 
RTLMYAAVVSE (138) 
39 SFDNRASMIRSR SFDNRAAAIRSR (74) 
SFDNRASMAASR (75) 
SFDNRASMIRAR (76) 
40 SHLHYHVHPGLK AALHYHVHPGLK (68) 
SHAAYHVHPGLK (69) 
SHLHAHVHPGLK (70) 
41 SSHHQKILPPPS - 
42 SVSMYMKPSPRP SVSAAMKPSPRP (135) 
SVSMYAAPSPRP (136) 
43 TGRNDAAPSPIG - 
44 TQYDKRLPPHHG TQYDKRLAAHHG (97) 
TQYDKRLPPAAG (98) 
TQYDKRLPPHHA (99) 
45 TVKSVQSLKHRL - 
46 WDPSHGISSRDG - 
47 FSHELSWKPRKA - 
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Peptide 
identifier Amino Acid Sequence Mutagenised peptide sequences & identifiers 
48 AFGPDSTTPPEP - 
49 ALHPLTNRYHAT - 
50 SNFTTQMTFYTG - 
 
 
   
 
3.6.1 Purification of recombinant Hyd from bacterial cells 
 
The ELISA verification assay requires the use of purified recombinant protein at a 
concentration of 1-2 µM. The original phase display screen was carried out using the 
recombinant Hyd HECT domain, comprising of a large portion of the carboxy 
terminal of the protein (aa 2315-2885), which includes both the PABC and HECT 
domains. However, recombinant full length Hyd can also be used for binding in the 
ELISA, and this may even enhance the interaction with some peptides if other 
regions of Hyd are also involved in peptide recognition. 
 
In order to produce recombinant Hyd HECT and FL Hyd proteins, the corresponding 
GST-tagged constructs, which had already been cloned in the lab, were transformed 
into bacterial cells. Protein expression was induced using IPTG, cells were lysed, and 
the lysates were clarified by centrifugation prior to purification of the GST-tagged 
recombinant proteins using GSH sepharose (see Materials and Methods). The large 
Hyd HECT domain was detected at the expected weight of ~100 kDa in all fractions 
following IPTG induction on a silver stained gel (Figure 3.8 A). The purified 
fraction contained a relatively large amount of Hyd HECT domain, and was mostly 
free of contaminating proteins apart from a few proteins running below the Hyd 
HECT band (Figure 3.8 A). However, these bands could represent degradation 
products of the recombinant Hyd HECT protein, which retain the amino terminal 
GST tag and are therefore present in the GSH pulldown fraction. This could be due 
to the presence of contaminating proteases, or alternatively the spontaneous 
hydrolysis of the protein. Contrary to the Hyd HECT domain, full-length 
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recombinant Hyd protein was not detected by silver staining (Figure 3.8 A). The 
samples were therefore probed with the anti-M19 Hyd antibody on a Western blot, 
which is an even more sensitive detection method compared to silver staining. This 
revealed that GST-FL Hyd was successfully expressed and purified from bacterial 
cells, albeit at very low levels (Figure 3.8 B). At 319 kDa, Hyd is a very large 
protein, and it is therefore not surprising that its expression and purification from 
bacterial cells results in low protein yields. The low expression level could be due to 
misfolding and subsequent degradation of FL Hyd during and/or after protein 
expression. The expression of high levels of recombinant protein in E. coli, 
especially large proteins, commonly leads to the formation of insoluble particles 
called inclusion bodies, which consist of partially folded aggregates of the protein of 
interest. There are several methods, which could potentially increase the solubility 
and thus yield of full-length recombinant Hyd by promoting correct protein folding, 
including expression as a fusion protein, co-expression with molecular chaperones, 
and the use of multiple constructs for each protein (Peleg & Unger 2012). 
3.6.2 Verification of binding by peptide ELISA 
 
As full length Hyd was poorly expressed and produced low yields, the extended Hyd 
HECT domain, which had a much better yield, was subsequently used in the ELISA. 
To assess binding of the recombinant Hyd HECT domain to the phage display 
peptides, the relevant synthetic peptides were spotted onto glass slides (Figure 3.8 
C), along with mutagenised versions of some of the peptides, in which selected 
residues were replaced with alanine (Ala, A) (Table 3.3). The glass slides were 
incubated with the purified recombinant Hyd HECT protein and subsequently 
washed off. Retained peptide-bound Hyd HECT was detected by Western blotting. 
Two identical slides were processed in duplicate, and the binding results are shown 
in Figure 3.8 D. Binding intensity wad judged by eye, whereby white spots indicate 
no binding, black spots indicate strong binding, and varying levels of grey represent 
a scale of weak to medium binding affinity. Following visual assessment of all spots 
on both slides, and taking into account both the parent and respective mutagenised 
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peptides, five peptides in particular were found to interact with Hyd to varying 
degrees. These peptides and the accompanying mutagenised sequences are boxed and 
colour coded in Figure 3.8 C and D, and the relevant peptides numbers are 10, 14, 
23, 26 and 27 (Table 3.3). Interestingly, mutation of any of the residues in peptide 14 
results in complete abrogation of the strong binding observed with the parent peptide, 
suggesting that this peptide sequence may represent a highly conserved Hyd binding 
motif (Figure 3.8 D; yellow boxes). On the other hand, some of the peptides that 
bound the Hyd HECT protein with a medium affinity appeared to have a higher 
binding affinity towards the protein following mutation of certain residues (peptides 
23, 26 and 27; Figure 3.8 D; green, red and purple boxes, respectively). A 
comparative analysis was performed between the relevant binding level of the parent 
peptide and the mutagenised peptides (i.e. comparable, stronger, weaker or no 
binding) to determine the relative importance of individual residues for effective 
binding to the Hyd HECT domain protein. The combined results of this analysis are 
summarized in Table 3.4, where residues coloured in grey are less important for 
binding, and residues highlighted in bold are indispensable for binding.  
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Figure 3.8: Verification of Hyd HECT domain binding peptides. (A) Silver stain analysis of 
recombinant production of GST-Hyd HECT domain and full-length (FL) GST-Hyd in E.coli. GST-
tagged proteins were purified and eluted using reduced glutathione (GSH) agarose and GSH, 
respectively. (B) Immunoblot analysis of recombinant production and purification of FL GST-Hyd in 
E.coli. Black arrow indicates position of GST-Hyd. (C) GRID layout of peptide slides. Refer to Table 
3.3 for sequence information. (D) Immunoblot analysis of ELISA assay showing successful binding of 
recombinant Hyd HECT domain to peptides indicated by coloured boxes – refer to panel C for petide 
number and Table 3.3 for sequence information). Lower panel of slide corresponds to mutagenised 
peptides (corresponding wild type peptides in colour-coded boxes). Slides containing immobilised 
peptides were incubated with recombinant Hyd-HECT protein. Slides were washed to remove excess 
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protein, and probed with anti-M19 (Hyd) antibody to detect bound Hyd-HECT. Each spots represents 
one peptide identity, and each peptide was spotted in duplicate. 
 
3.6.3 Analysis of binding peptides using the protein BLAST 
algorithm 
 
In order to identify potential novel Hyd binding partners and/or any of the existing 
MS protein hits that may contain parts of the binding peptide sequences, the NCBI 
proteinBLAST algorithm was used to align the identified peptide sequences to the D. 
melanogaster proteome. Interestingly, this led to the identification of two of the MS 
hits, as well as several other proteins directly related to both Hh and Wg signaling 
(Table 3.5). The sequences of peptides 23 and 27 were part aligned with the Tudor 
and Cry-1 amino acid sequences, respectively (Table 3.5). This result increases the 
confidence level for these MS hits to be bona fide Hyd binding partners. 
Additionally, Dyrk2/smi35A, Ci, and Roadkill, which are all involved in the Hh 
pathway, were also identified (Table 3.5). Roadkill forms a key part of the E3 ligase 
complex responsible for degrading the transcriptional effector protein Ci (see 
Chapter 1, Section 1.2.4), and an interaction between Hyd and these proteins could 
indicate a potential regulatory mechanism by which Hyd negatively regulates the Hh 
pathway. Finally, the key eye-specific transcription factor Atonal (see Chapter 1, 
Section 1.2.5.2), as well as the Wg pathway proteins Frizzled and Axin (see Chapter 
1, Section 1.3.1) were also identified (Table 3.5), supporting the hypothesis that Hyd 
plays an important role in the development of the Drosophila eye by regulating more 
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Table 3.5: Peptide ELISA Results. A selection of potentially relevant protein hits from the pBLAST 
analysis using phage display peptides. 
Peptide 
identifier 




peptide vs. protein 
hit (a.a. coordinates) 
E-value 




4  VPSSPL 9                             
VPS  PL   
   461 VPSPPL 466 
 
94 
14 HETLHYLEHRSW General odorant-






1  HETLHYL  7 
        HETL    YL 
  56  HETLDYL  62 
 
1  HETLH  5                          
HETL+ 














6  HLYV  9 
HLYV 
203  HLYV  206 
 
5  GHLY  8 
GHLY 


















8  LFPP  11 
            LFPP 
   1297 LFPP  1300 
 
5  GLPL  8 
GLPL 
615  GLPL  618 
 
5  GLPLFP  10 
         G  PLFP 


























6  PNPPLP  11 
         P   PPLP 
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3  FLLPNPPLP  11 
      F  LPN      LP 
249FYLPNQALP257 
 
8  PPLPT  12 
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3.7 Discussion 
 
In an effort to identify novel Hyd binding partners that form part of a potential 
molecular mechanism in the negative regulation of Hh pathway activity and/or hh 
gene expression, I employed several complementary experimental and bioinformatic 
approaches. Firstly, in a literature-based approach, I tested the binding of Hyd to the 
EDD binding protein Dyrk2, a kinase involved in the mammalian Shh pathway. This 
revealed that, although Hyd does not interact with Dyrk2, it may interact with the 
close Dyrk2 homologue Dyrk3. Secondly, I performed a tandem affinity pulldown of 
Hyd from Drosophila S2 cells in conjunction with mass spectrometry, which 
identified 26 potential novel Hyd binding partners. Although subsequent 
bioinformatics, biochemical and peptide ELISA approaches generated some 
interesting data which identifies several potential Hyd binding partners, some of 
which are also involved in morphogen signaling, the only successfully verified 
interaction was shown between Hyd and the Wg pathway transcriptional effector 
Armadillo. 
3.7.1 Hyd and DYRK2 family kinases 
 
My results indicate that Hs Dyrk2 and Dm Dyrk2 (smi35) do not interact with Hyd, 
even though I was able to replicate the previously published interaction between 
EDD and Hs Dyrk2 (Maddika	  &	  J.	  Chen	  2009). Hs Dyrk2 negatively regulates the 
Shh pathway by phosphorylating and negatively regulating Gli protein stability, 
indicating that phosphorylation of Gli proteins by Dyrk2 contributes to the 
ubiquitylation and proteolytic processing of Gli proteins (Varjosalo	  et	  al.	  2008). In 
addition, it was shown to act as a scaffold protein, which is required for the 
formation of an E3 ubiquitin ligase complex, containing the Cul4-Roc1 family 
members DDB1 and VPRBP, and EDD. This E3 ligase complex appears to regulate 
mitotic transition by promoting the phosphorylation (requiring Dyrk2) and 
subsequent ubiquitylation (requiring EDD) and proteasomal degradation of the 
microtubule-severing enzyme katanin (Maddika	  &	  J.	  Chen	  2009). Because the 
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expression levels of transfected Dm Dyrk2-FLAG were suboptimal in S2 cells, I used 
human HEK293 cells to test the interaction between Dm Dyrk2 and Hyd instead. 
This experiment suggested that no interaction between the two proteins takes place. 
However, if the interaction is not binary, and both proteins interact as part of an E3 
ligase complex, requiring the presence of DDB1 and VPRBP, this may explain the 
negative binding result. DDB1 and VPRBP both have homologues in Drosophila 
melanogaster. As determined by the protein BLAST algorithm, the Dm DDB1 
homologue (Uniprot identifier Q9XYZ5) shares 61% sequence homology with the 
human protein, whereas the Dm VPRBP homolog, also known as protein mahjong 
(Uniprot identifier Q9W2F2), shares only 38% sequence identity with its human 
counterpart. As a result, the experiment may be improved by over-expressing Dm 
DDB1 and Dm mahjong together with Hyd and Dm Dyrk2 in HEK293 cells to assess 
whether they act as intermediate proteins required for a potential interaction between 
Hyd and Dm Dyrk2. Importantly, it is not known whether the phosphorylation of 
Gli2 by Hs Dyrk2 also requires E3 ligase complex formation, including EDD, DDB1 
and VPRBP. This would indicate that EDD contributes to the ubiquitylation and 
processing of Gli proteins in addition to the known E3 ligase protein targeting Gli, 
βTrcP (Bhatia et al. 2006). Conversely, if Dyrk2 does not act as part of an E3 ligase 
complex to phosphorylate Gli2, this would indicate that EDD is not involved in this 
process. These hypotheses could be tested using a suitable cell based assay, such as a 
luciferase reporter assay in a cell line that is capable of transducing the Hh pathway 
(e.g the Drosophila wing disc-derived cell line Clone 8), in combination with RNAi, 
to assess whether Dyrk2 regulates the Hh pathway in Drosophila, and whether this 
requires Hyd, DDB1, and mahjong. 
 
Intriguingly, the negative binding result between Hyd and Dm Dyrk2 prompted me to 
investigate the existence of other Drosophila Dyrk2 homologues, and led to the 
discovery that Dm Dyrk3 is in fact more closely related to Hs Dyrk2 than Dm Dyrk2 
(smi35) based on sequence identity. Although a binding assay with Dm Dyrk3 and 
Hyd in S2 cells proved inconclusive, the result suggested that the presence of WT 
Hyd, but not catalytic inactive Hyd (C>A), increases Dm Dyrk3 protein levels. The 
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increase in Dm Dyrk3 activity could be due to an increase in expression levels and/or 
increased protein stability, and appears to be dependent on Hyd’s E3 ligase activity. 
This raises the possibility that Hyd could increase Dm Dyrk3 protein stability 
through non-degradative ubiquitylation, analogous to the stabilization of β-catenin as 
a result of EDD ubiquitylation (Hay-­‐Koren	  et	  al.	  2011). In order to test this 
hypothesis, a ubiquitylation assay could be used to test wether Hyd can ubiquitylate 
Dyrk3, as well as assessing Dm Dyrk3 protein levels by inhibiting protein synthesis 
using cycloheximide, and testing the effect of Hyd over-expression and/or 
knockdown on Dyrk3 protein turn-over. 
 
The complementary phage display peptide ELISA screen yielded some interesting 
results, including the notion that the large carboxy terminal region of Hyd, including 
the PABC and HECT domains, binds to the peptide motif GXPLFP. Bioinformatics 
analysis identified this motif in Dm Dyrk2 (GFPLFP, see Table 3.4). Interestingly, a 
similar motif is found in Dm Dyrk3 (GHALFP), and both motifs are located in the 
respective kinase domains of Dm Dyrk2 and Dm Dyrk3. If further work were to be 
dedicated to assessing whether Hyd can interact with either of these proteins, this 
data would provide valuable hints concerning the positional nature of a possible 
interaction between Hyd and the Dyrks in Drosophila.  
3.7.2 Hyd and Glucose Homeostasis 
 
In a separate approach to identifying novel Hyd binding partners, I employed a mass 
spectrometry screen of endogenously bound proteins complexed to an amino 
terminally tagged Hyd protein that was stably expressed in S2 cells and subsequently 
pulled down using a tandem affinity purification (TAP) procedure. Although the 
peptide scores for individually identified proteins were somewhat disappointing, 
some interesting potential Hyd binding partners were identified. Among these, 
pyruvate kinase, which catalyses the last step in gluconeogenesis, and glycogen 
phosphorylase, which catalyses the first step in glycogenolysis, are both implicated 
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in glucose metabolism. Both gluconeogenesis (i.e. glucose synthesis) and 
glycogenolysis (i.e. the breakdown of glycogen into glucose building blocks) are 
processes that are important in the maintenance of blood glucose levels during 
starvation (Xiong	  et	  al.	  2011). Taken together with the fact that EDD was shown to 
ubiquitylate PEPCK1, the enzyme that regulates the first committed step of 
gluconeogenesis, in an acetylation-dependent manner, leading to its subsequent 
degaradation (W.	  Jiang	  et	  al.	  2011), suggests that Hyd/EDD is involved in 
regulating glucose homeostasis and is a target for the treatment of Type II diabetes. 
Interestingly, pyuvate kinase protein levels were also shown to be regulated by 
acetylation (Lv	  et	  al.	  2011), suggesting that it could be a ubiquitylated target of 
Hyd/EDD similar to PEPCK1. 
3.7.3 Other Hyd functions 
 
In addition, several other potential Hyd binding partners were identified in the mass 
spectrometry screen, including protein synthesis regulator eukaryotic translation 
initiation factor 2 (EiF-2), the germ cell development protein Tudor, and Ran, a 
GTP-binding protein thought to be involved in nucleo-cytoplasmic transport. Some 
of these proteins are linked to previously published work relating to EDD, which is 
encouraging. For example, it has been proposed that EDD positively regulates 
translation by ubiquitylating the translational regulator Paip2 (Yoshida	  et	  al.	  2006), 
and a possible interaction with EiF-2 could support Hyd/EDD’s role as a positive 
regulator of protein synthesis. Tudor is a large protein that plays an important role in 
the formation of primordial germ cells. A potential interaction with Hyd could 
provide insight into the mechanism behind the sterility phenotype seen in many hyd 
mutants (Mansfield	  et	  al.	  1994). Supporting this notion, Tudor was also one of the 
proteins found to contain a peptide that bound the carboxy terminal portion of Hyd in 
the phage display peptide ELISA (Table 3.4). Finally, the mass spectrometry data 
also suggests that Hyd may interact with a protein of unknown function, PERQ. 
Interestingly, it has been suggested that this protein also interacts with the negative 
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Ci regulator SuFu (Méthot & Basler 2000). This indicates a potential mechanism in 
which Hyd could negatively regulate Hh pathway activity.  
3.7.4 Hyd and Wg signaling 
 
Perhaps one of the most encouraging findings resulting from the work presented in 
this chapter is the interaction between Hyd and the Wg pathway transcriptional 
effector protein Armadillo, also known as β-catenin in humans. This is supported by 
previously published work, which showed that EDD interacts with, as well as 
ubiquitylates, β-catenin resulting in its stablilisation and nuclear accumulation (Hay-­‐
Koren	  et	  al.	  2011). This suggests that EDD is a positive regulator of Wg/Wnt 
pathway activity by promting β-catenin’s transcriptional activity. Interestingly, the 
peptide verification ELISA results also suggested that Hyd could potentially interact 
with the Wg pathway components Frizzled and Axin (see Chapter 1, Section 1.3.1). 
In light of this interesting result, which suggests that Hyd could be involved in 
regulating more than one morphogen signaling pathway, I decided to focus my 
subsequent in vivo work on investigating the role of Hyd in regulating both Hh and 
Wg signaling.
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4.1 Introduction 
 
The purpose of performing proteomics-based screens for potential Hyd binding 
partners and/or substrates was to identify novel regulators of morphogen signalling. 
More specifically, it was hoped that the function of these candidate proteins could 
shed light on the molecular mechanisms by which Hyd regulates hh expression 
and/or Hh pathway activity. However, if a protein’s function is not known, or its 
known function does not implicate it in morphogen signalling, it will not be chosen 
from a proteomics dataset. This represents the paradox of identifying a novel protein 
function from existing functional data (see Chapter 3).  
 
In order to test a given protein’s functional role in Hyd-mediated morphogen 
signalling regulation, a robust functional assay for Hyd was required, which could 
then be used to assess the functional relevance of Hyd binding partners in morphogen 
signalling (see Chapter 5). In the original work that identified Hyd as a negative 
regulator of both hh expression and Hh pathway activity, Lee et al. generated 
homozygous hyd mutant clones in the Drosophila eye-antennal disc (J. D. Lee et al. 
2002) (see Chapter 1, Section 1.4). This enabled them to assess the expression 
pattern of hh and Hh pathway-related proteins in hyd mutant clones and the 
surrounding wild type cells, and deduce a possible role for Hyd in these processes. 
To further test the hypothesis that Hyd negatively regulates hh expression and Hh 
pathway activity, and to query what other Hyd binding partners may be involved in 
facilitating or inhibiting these Hyd-mediated effects, I also used the MARCM system 
(T. Lee & Luo 2001) to generate hyd mutant clones in the eye disc. The MARCM 
technique allowed me to generate homozygous hyd mutant clones that also over-
expressed either cDNA for a novel Hyd binding partner, or RNAi to suppress the 
expression of the latter, thus providing the ideal genetic functional test for a binding 
partner’s involvement in Hyd-mediated hh expression or Hh pathway activity. This 
approach was successfully employed (see Chapter 5), however the first step was to 
confirm whether I could reproduce the previously reported effects on hh expression 
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and Hh pathway activity seen in hydmt clones (J. D. Lee et al. 2002). As a 
complementary approach, I also wanted to develop a cell-based functional test that 
could address a protein’s involvement in Hyd-mediated regulation of Hh signalling. 
The main advantage of this system would be its relative ease and speed compared to 
lengthy genetic crosses. 
 
Finally, the Hh pathway-related effects observed in hydmt clones suggest that Hyd 
may be acting to directly or indirectly regulate Ci activity (J. D. Lee et al. 2002) (see 
Chapter 1, Section 1.4). Ci activity is regulated by two E3 ubiquitin ligases 
(reviewed in (J. Jiang 2006) and see Chapter 1, Section 1.2.3 and 1.2.4). In the 
absence of Hh signal, full length Ci155 is processed to a truncated repressor form 
(Ci75) by an SCF ubiquitin ligase complex containing the F box protein Slmb (J. 
Jiang & Struhl 1998). In the presence of Hh signal, Ci155 translocates to the nucleus, 
where it is degraded by the Cul3-based E3 ubiquitin ligase Hib/Roadkill (Rdx) (Q. 
Zhang et al. 2006; Kent et al. 2006). I therefore also wanted to investigate whether 
Hyd can interact with Ci, and whether Hyd can affect Ci protein levels and/or 
ubiquitylation levels. 
 
4.2 hydK7.19 clones encode a severely truncated Hyd 
protein 
 
In the original mosaic screen for eye differentiation (J. D. Lee et al. 2002), four 
mutant alleles of hyd were discovered: hydK3.5, hydK7.19, hyd15, and hydWC461. 
However, the molecular nature of the mutations at the DNA and protein level were 
not known. The molecular characterization of these mutations could provide insight 
into the function of Hyd in the regulation of morphogen signalling in the hyperplastic 
phenotype. For example, if a particular domain carried a point mutation or was 
deleted this could help to decipher a molecular mechanism. Therefore, I wanted to 
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sequence the region of genomic DNA encoding the hyd gene for these four hyd 
mutant strains. 
Most mutant hyd alleles are homozygous lethal at or before the second instar stage 
(Mansfield et al. 1994). I therefore collected homozygous mutant hyd L1 or L2 
larvae to extract genomic DNA for sequencing. A GFP balancer chromosome was 
used to distinguish homozygous hyd mutant larvae from heterozygous animals. To 
facilitate larvae collection, male and female flies were placed in egg laying chambers 
containing grape agar plates, and were left to lay eggs in one hour-timed intervals. 
The plates were then removed and incubated at 25°C until L1 larvae emerged. 
Larvae that were homozygous for a hyd mutation were identified by the absence of a 
GFP signal under a fluorescence microscope. 
A number of L2 larvae were collected for the hydK7.19 and hydWC461 strains, although 
the ratio of GFP negative larvae to total larvae collected was significantly lower than 
expected [Figure 4.2.1; chi-square test – hydK7.19 Χ2 (2, n = 234) = 123.2, p<0.001; 
hydWC461 Χ2 (2, n = 104) = 50.7, p<0.001]. This is most likely due to some variability 
in the hyd mutant phenotype, where some larvae could experience earlier lethality 
than others. However, for the hydK3.5 and hyd15 strains, no GFP negative L1 or L2 
larvae were collected [Figure 4.2.1; chi-square test – hydK3.5 Χ2 (2, n = 83) = 83, 
p<0.001; hyd15 Χ2 (2, n = 331) = 331, p<0.001], suggesting that the mutations 
associated with these hyd alleles could be more severe and therefore result in even 
earlier lethality at the embryonic stages. In addition, the variability in total larvae 
collected for each mutant strain could also be indicative of the effect of heterozygous 
hyd mutation on reproductive health in adults. Sterility has previously been reported 
as a phenotypic feature in homozygous adult flies with some hyd alleles permissible 
only at certain temperatures (Mansfield et al. 1994). However, the total number of 
adult flies used to lay eggs was not kept constant between strains during the 
experiment, and therefore no such assumption can be made. 
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Figure 4.1: Early larval or embryonic lethality of homozygous hyd mutant animals. A GFP 
balancer chromosome was used to distinguish heterozygotes (GFP positive) from homozygotes (GFP 
negative). Crawling L2 larvae were collected, and analyzed under a fluorescence microscope.  
Because I was unable to obtain homozygous hydK3.5 and hyd15 larvae, but wanted to 
sequence the entire set of hyd alleles, I opted to sequence the adult heterozygote flies 
instead. The genotypes used for this sequence analysis are summarized in Table 4.1. 
The genomic DNA was prepared as a crude extract from single female adults. To 
increase the quality of the sequence data, the hyd gene region was amplified by PCR 
and the purified PCR product was sent for sequence analysis (see Materials and 
Methods). Some initial optimisation was required to establish a primer pair that 
would give a clean PCR product from the crude genomic extract. Due to its relatively 
large size (~13kb), the hyd gene was amplified and sequenced in two over-lapping 
parts: a 5.7kb front region starting at the transcription initiation site (ATG start 
codon), and a 6.8kb back region, which encompasses a small region of the 3’UTR 
region (see schematic in Figure 4.2 A). 
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Allele Genotype 
hydK7.19 FRT82 hydK7.19 / TM6B Tb GFP 
hydK3.5 FRT82 hydK3.5 / TM6B Tb GFP 
hyd15 hyd15 / TM6B GFP 
hydWC461 FRT82 hydWC461 / TM6B Tb GFP  
Table 4.1: hyd mutant strains used for sequencing analysis. 
Mutations were identified in the sequence data by the appearance of an obvious 
double trace in the chromatogram (Figure 4.2 B). Some mutations were confirmed 
as being known polymorphisms, silent mutations that did not result in a change of 
amino acid, or were located within intronic regions of the gene. For both the hydK7.19 
and hyd15 alleles, nonsense mutations were found early on in the protein coding 
sequence (Figure 4.2 B). The hydK7.19 allele contains a C>T nucleotide mutation in 
exon 4, resulting in an arginine (R) to STOP codon nonsense mutation. This mutation 
would theoretically produce a severely truncated Hyd protein of 27kDa that would 
only retain the amino-terminal UBA domain. The hyd15 allele theoretically produces 
a slightly less truncated Hyd protein. It contains a G>A nucleotide mutation in exon 
7, resulting in a tryptophan (W) to STOP codon nonsense mutation, which would 
result in a 54kDa Hyd protein that retains the UBA domain and a portion of the RCC 
domain.  
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Figure 4.2: Sequencing of heterozygous hyd mutant animals. (A) Schematic of the hyd gene region 
PCR strategy. (B) Sequencing data for hydK7.19 and hyd15 alleles. Nucleotide mutations are visible as a 
double trace in the chromatogram. These nonsense mutations cause the change of the respective 
amino acid to a STOP codon, resulting in truncated Hyd mutant proteins compared to the full-length 
wild type Hyd protein.  
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By contrast, no exonic mutations were found in the hydK3.5 and hydWC461 alleles. A 
single intronic mutation was found between exon 6 and exon 7 in the hydK3.5 allele, 
although the mutation is unlikely to affect mRNA splicing as it is not located at 
either intron/exon junction. However, the aforementioned results indicate that the 
hydK3.5 allele may result in very premature lethality at the embryonic stages, which 
suggests that the mutation is even more severe than the hyd15 and hydK7.19 mutations. 
One explanation for the hydK3.5 allele being more severe could be that it produces no 
Hyd protein in comparison to the truncated Hyd proteins produced by the hyd15 and 
hydK7.19 alleles. Two possible scenarios that could result in very little, or no full-
length Hyd protein being made, would be if (1) the mutation is located upstream of 
the ATG transcription site (e.g. in the promoter region) and negatively affects 
transcription, or (2) the mutation is located within the extended 3’ untranslated 
(UTR) region not covered by the PCR product and severely affects mRNA stability, 
preventing translation of the protein. In fact, it is entirely possible that the other 
alleles could also contain mutations of this nature that were not covered by the 
sequence data. This would explain why the hyd15 allele causes lethality prior to the 
L2 stage, but is less severe than the hydK7.19 mutation. Finally, a single intronic 
mutation (G>A) was found in the hydWC461 allele, which results in the change of the 
splice acceptor site at the intron/exon 13 junction from GG to AG. However, this is 
unlikely to affect mRNA splicing, as AG is in fact known to be the most favoured 
splice acceptor nucleotide composition (Moore 2000).  
In order to confirm these sequencing results, I would ideally test the presence, 
absence, or truncation of the Hyd protein by WB on protein extracts of heterozygous 
flies. However, the Hyd antibody that was routinely used in the lab (M19, Santa 
Cruz) detects the extreme carboxy terminal region of the protein. There is a 
Hyd/EDD antibody (N19, Santa Cruz) available that detects the amino terminal of 
the protein within the UBA domain. This could be used to detect the putative 
truncated mutant forms of Hyd. Unfortunately, I was not able to detect Hyd protein 
in fly lysates with either antibody, but this was most likely due to problems with 
efficient protein extraction from whole flies. Due to time constraints, I was not able 
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to optimize the use of this antibody and the lysis procedure to detect Drosophila 
Hyd. 
4.3 The hyperplastic phenotype 
 
Out of the four hyd alleles, only the hydK3.5 and hydK7.19 alleles were used to identify 
Hyd as a negative regulator of Hh signalling (J. D. Lee et al. 2002). Based on this, 
and the sequencing data, I chose the hydK7.19 allele for future work, as the molecular 
nature of the mutation was now known to me. 
4.3.1 Generation of hydmt clones in the eye-antennal (EA) disc 
using the MARCM technique 
 
Mosaic Analysis with a Repressible Cell Marker (MARCM) is an elegant genetic 
technique used in Drosophila that allows the study of labelled homozygous mutant 
cells in an otherwise unlabelled heterozygous animal (J. S. Wu & Luo 2006). This is 
particularly useful when homozygous mutations are developmentally lethal, as is the 
case with all described hyd mutations (Mansfield et al. 1994). A further advantage of 
the MARCM technique is the ability to express one or more transgenes, encoding 
either cDNA (protein over-expression) or RNAi (mRNA knockdown), in the labelled 
mutant clones (J. S. Wu & Luo 2006). This has allowed me to test the ability of a 
novel Hyd binding partner to modify the hydK7.19 phenotype (see Chapter 5).  
 
The technique relies on GAL4-mediated transcription of a positive green fluorescent 
protein (GFP) marker, as well as an optional transgene of interest, from a UAS 
promoter element, and GAL80-mediated repression of GAL4 (Figure 4.3). GAL4 is 
a yeast transcription factor that drives transcription from the Upstream Activation 
Sequence (UAS) (Fischer et al. 1988). As a result, the transcription of any sequence 
(e.g. cDNA or RNAi) that is cloned downstream of the UAS is mediated by GAL4.  
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FRT-directed mitotic recombination is used to generate homozygous hyd mutant 
clonal cells in an otherwise heterozygous hyd mutant, and therefore viable, animal.  
FLP-FRT recombination involves Flippase (FLP)-mediated recombination of 
sequences that are flanked by short Flippase Recognition Target (FRT) sites 
(Theodosiou & T. Xu 1998). For example, this can be achieved by using an FRT82B 
strain, which contains FRT sites on chromosome 3 (T. Xu & G. M. Rubin 1993), 
where the hyd gene is also located, for recombination. In order to generate 
homozygous hydK7.19 clones exclusively in the eye-antennal imaginal disc, we used 
the eyeless promoter to control FLP expression. The eyeless gene is expressed early 
on during eye development, and its expression pattern spans the entire eye region of 
the EA (eye-antennal) disc, whereas lower expression is detected in the antennal 
region, and its expression is absent from other imaginal discs (Halder et al. 1998). 
Another component of the MARCM system is GAL80, a yeast protein that blocks 
GAL4 activity by binding to its transcriptional activation domain (Suster et al. 2004). 
Importantly, the hydwt allele is physically linked to the GAL80 gene, ensuring that, 
even after FRT-directed recombination, all homozygous or heterozygous hydwt cells 
express GAL80. As a result, only homozygous hydK7.19 cells are positively marked 
by GFP and express the transgene of interest (Figure 4.3). 
 
In order to simultaneously investigate hh gene expression in hydmt clones, I also used 
the β-galactosidase gene (lacZ) enhancer trap hhP30, which I will refer to as hh-lacZ  
(J. J. Lee et al. 1992). hh-lacZ harbours an insertion of an enhancerless lacZ reporter 
into the 5’UTR of the hh gene. Thereby expression of the lacZ transgene accurately 
reflects that of the endogenous hh gene. The presence of β-galactosidase (the product 
of the lacZ gene) can be then be visualised in dissected EA imaginal discs using the 
chromogenic β-galactosidase (βgal) substrate X-gal (Adams & Sekelsky 2002), or by 
using an antibody specific for βgal and immunofluoresence. To allow clonal analysis 
of hh expression, I used a strain where the hh-lacZ enhancer trap had been 
recombined onto either an FRT82B-bearing chromosome or an FRT82B hydK7.19 
chromosome.  
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Figure 4.3: Mosaic Analysis with a Repressible Cell Marker (MARCM). (A) In cells that contain 
the GAL80 protein, GAL4-directed expression of both UAS-GFP and UAS-transgene are repressed. 
In the absence of GAL80, GAL4 can drive the expression of both GFP and the transgene (either 
cDNA or RNAi) from the UAS element, resulting in green cells. (B) Generation of homozygous 
hydmt clonal cells using MARCM. The parental genotype includes tubulin-GAL4 (resulting in 
ubiquitous expression of GAL4), UAS-GFP and UAS-transgene on one chromosome (e.g. 
Chromosome 2). The chromosome containing the hyd gene (chromosome 3) is modified by the 
insertion of FRT sites (black arrowheads) adjacent to the centromere (black circles). One of the 
heterologous chromosome arms contains the hydK7.19 allele (yellow diamond), whereas the other 
contains the hyd+ allele, adjacent to an inserted GAL80 gene (red triangle). This makes the parent cell 
heterozygous for the hyd mutation. During DNA replication, the chromosomes are duplicated, and 
site-specific mitotic recombination is directed by the Flippase (FLP) recombination enzyme at FRT 
sites. This gives rise to two types of homozygous daughter cells. One is homozygous for hydK7.19 and 
lacks GAL80 expression, therefore allowing expression of the GFP marker and the UAS-transgene by 
GAL4. The other is homozygous for hyd+ and expresses GAL80, which prevents expression of both 
UAS-GFP and UAS-transgene. Adapted from (J. S. Wu & Luo 2006). 
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4.3.2 The adult hydK7.19 phenotype 
 
The MARCM technique was successfully used to generate FRT82B control clones or 
FRT82B hydK7.19 clones in the eye. hydK7.19 mutant clones caused some subtle 
overgrowth of eye tissue, although the overgrowth was not nearly as pronounced as 
in adult eyes containing hydK3.5 mutant clones (J. D. Lee et al. 2002). Instead, a major 
feature of the hydK7.19 phenotype was the appearance of scars in the eye located at the 
margin to the head cuticle (Figure 4.4 A). There was some variability in the 
spectrum of mutant eye phenotypes, ranging from at least one scar at the less severe 
end, and multiple or very large scars in the most severe cases. The scars could be a 
result of hydK7.19 clones being eliminated relatively late in development, or they 
could also be a result of hyperplastic head tissue invading into the eye area. The eye-
antennal imaginal discs give rise to the entire adult head capsule, including the 
compound eyes, antennae, and head cuticle(Legent & Treisman 2008). Indeed, the 
head cuticle was extensively overgrown in hydK7.19 flies (Figure 4.4 B). Eye-to-eye 
measurements were taken just above the antennae of both control and hydK7.19 heads, 
and hydK7.19 heads were found to be significantly wider (p = 0.004; Figure 4.4 B).  
Hyd regulates morphogen signalling in the developing eye 
Chapter 4: The role of Hyd in morphogen expression and morphogen pathways   160 
 
Figure 4.4: The hydK7.19 adult phenotype. (A) Side view of FRT82B (control) or FRT82B hydK7.19 
compound eyes. Scale bars are 250µm. Scars are indicated by white triangles. (B) Front view of 
FRT82B (control) or FRT82B hydK7.19 heads. Scale bars are 250µm. Scars are indicated by white 
triangles. Head measurements (µm) were taken from eye-to-eye at a fixed point just above the 
antennae (n=10), and were significantly wider in FRT82B hydK7.19 animals (p = 0.004; t-test). 
The interplay between the morphogens Hh and Wg greatly contributes to 
determining the correct specification and growth of the compound eye and the head 
cuticle.  During the third instar, Wg is exclusively expressed in the lateral margins in 
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the anterior of the eye disc, where it promotes head capsule formation at the expense 
of the retinal field by antagonizing the action of Hh and Dpp (Treisman & G. M. 
Rubin 1995; C. Ma & Moses 1995). On the other hand, Hh and Dpp are expressed in 
posterior regions and the morphogenetic furrow (MF), and direct photoreceptor 
differentiation and formation of the compound eye (Royet & Finkelstein 1997). The 
invasive overgrowth of head tissue, as well scarring of the eyes, observed as a result 
of the presence of hydK7.19 clones (Figure 4.4 A) suggests that retinal cell 
specification is lost at the expense of head tissue formation, which is promoted by 
Wg signalling. This suggests that, in addition to its role in Hh signalling, Hyd could 
also negatively regulate Wg signalling. 
4.3.3 hydK7.19 clones cause overgrowth of EA discs 
 
To explain the overgrowth of head tissue and scarring in adult eyes, I proceeded to 
analyse the behaviour of clones in L3 eye-antennal discs. Indeed, hydK7.19 clones 
caused non-autonomous overgrowth of eye disc tissue, which was manifested in the 
folding and distortion of mostly non-clonal disc tissue (Figure 4.5 A). This data is in 
agreement with the non-autonomous overgrowth of wild type or heterozygous tissue 
surrounding hydK7.19 clones reported previously(J. D. Lee et al. 2002). Individual 
clusters of hydK7.19 clones had a more “rounded” morphology in some instances 
(white arrows, Figure 4.5 A), which was never observed with control clones. This 
change in morphology could indicate the premature differentiation of hydK7.19 clones 
(J. D. Lee et al. 2002). There was no obvious difference in the average number of 
hydK7.19 clones versus control clones in age-matched third instar discs, however the 
hydK7.19 clones present in the EA discs did not persist to adulthood in most cases, as 
visualised by fluorescence microscopy of adult heads and eyes containing or lacking 
GFP positive hydK7.19 clones (Figure 4.5 B). This has been reported previously for 
hydK3.5 clones (J. D. Lee et al. 2002).  hydK3.5 clones generated in a Minute genetic 
background, a mutation that confers a growth disadvantage (Morata & Ripoll 1975), 
are not eliminated and survive to adulthood, forming compound eyes that are 
drastically reduced in size, but nonetheless have correctly formed hydK7.19 ommatidia 
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(J. D. Lee et al. 2002). This suggests that hydK7.19 clones may have a growth 
disadvantage and, as a result, are eliminated by the surrounding non-clonal tissue 
through cell competition.  
 
Figure 4.5: Behaviour of hydK7.19 clones in L3 EA discs and adult heads. (A) Third instar eye-
antennal discs containing GFP-positive FRT82B (control) or FRT82B hydK7.19 clones. Anterior is to 
the left, posterior is to the right, dorsal is up, and ventral is down. White arrows indicate rounded 
morphology of hydK7.19 clones. Scale bars are 100µm. (B) Front view of FRT82B (control) or FRT82B 
hydK7.19 heads containing GFP-positive clones in the eyes (a only). Scale bars are 500µm. 
 
4.3.4 Over-expression of Hyd, but not a catalytic inactive 
mutant of Hyd, rescues the hydK7.19 phenotype 
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As discussed above, the hydK7.19 mutation results in a severe truncation of the Hyd 
protein. As a result of a nonsense mutation located immediately after the amino-
terminal UBA domain, the putative HydK7.19 mutant protein is missing the RCC, 
UBR, PABC, and the catalytic HECT domain. Any one, or a combination, of these 
domains could therefore be important in the hyperplastic phenotype. Work that had 
previously been carried out in the lab (Figure 4.6; Mark Ditzel) shows that over-
expression of a full length Hyd protein in hydK7.19 clones results in a nearly complete 
rescue of the phenotype. The eyes of rescued animals no longer harbour scars, and 
the head cuticle is reduced to a normal size (Figure 4.6). However, overexpression 
of a catalytic dead Hyd protein (Hyd C>A), in which the catalytic cysteine residue in 
the HECT domain is mutated, fails to rescue the phenotype. This suggests that Hyd’s 
ubiquitylation activity is required for its function in the hyperplastic phenotype, and 
for its function as a negative regulator of morphogen signalling. 
 
Figure 4.6: Rescue of the adult hyperplastic phenotype using Hyd transgenes. Expression of a 
UAS-Hyd wt transgene in hydK7.19 clones rescues the adult phenotype, whereas expression of a UAS-
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Hyd C>A transgene fails to rescue. The entire non-eye head area of each fly head shown was 
measured and is expressed as percentage change in pixel area with respect to the control (n=1). 
(Experiment performed, and figure provided by Mark Ditzel.) 
In order to investigate whether other Hyd domains also play crucial roles in the 
hyperplastic phenotype, I used site-directed mutagenesis to generate expression 
constructs encoding HA-tagged Hyd mutants that contained point mutations in the 
UBA, UBR and PABC domains. The point mutations were chosen on the basis of 
structural similarity to, and functional significance of the mutation of these domains 
in other proteins, and are summarized in Table 4.2. Briefly, mutation of the (i) UBA 
domain is expected to abrogate binding to ubiquitin and ubiquitylated proteins 
(Kozlov et al. 2007), (ii) UBR domain should result in defects in domain folding and 
thus function (Tasaki et al. 2005), and (iii) PABC domain should impair PAM2-
dependent protein-protein interactions (Kozlov et al. 2004) (see Chapter 1, Section 
1.4). The sequence-verified HA-tagged Hyd mutants were sub-cloned into the 
pUAST vector to allow transgenesis of Drosophila embryos, via its integration into 
the Drosophila genome. However, microinjection of embryos with the various hyd 
pUAST constructs (performed by BestGene Inc.) yielded no transformants, or 
transformants that were not expressing HA-tagged Hyd. Sequencing of the hyd 
pUAST constructs revealed they had undergone extensive recombination following 
plasmid amplification and purification. This can most probably be attributed to the 
large size of the constructs, which was in excess of 18kb. If the generation of these 
transgenic flies were to be attempted once more, I would take extra precautions by 
using recombination-deficient bacterial strains and incubate the bacteria replicating 
the constructs at lower temperatures (e.g. 20°C) to reduce recombination, and I 
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Table 4.2: Design of UBA, UBR, and PABC Hyd point mutants. 
 
4.4 Ectopic expression of morphogens by hydK7.19 
clones 
 
Next, I went on to confirm whether hydK7.19 clones over-express hh, as reported in 
Lee et al. 2002 (J. D. Lee et al. 2002), and whether this ectopic hh expression is also 
reflected in the Hh protein levels. In light of the overgrowth of head tissue in adult 
heads containing hydK7.19 clones, which, as discussed above, could be indicative of 
ectopic Wg signalling, I also investigated the effect of hyd loss on Wg morphogen 
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4.4.1 hh gene expression and Hh protein levels are elevated 
in hydK7.19 clones  
 
To investigate the levels of hh gene expression in hydK7.19 clones, the hh-lacZ 
enhancer trap was inserted into the chromosome arm containing the hyd gene, such 
that both genetic elements were inserted proximal to the FRT82B site. As a result, all 
hydK7.19 clones will harbour and express two copies of the lacZ gene under the control 
of the hh promoter. The product of lacZ gene expression is the β-galactosidase 
protein, which can be visualized as blue staining using the chromatogenic substrate 
X-gal. The levels of lacZ gene expression in hydK7.19 clones therefore accurately 
represents the levels of hh gene expression.  
 
Third instar EA discs containing control FRT82B hhlacZ clones, or FRT82B hydK7.19 
hhlacZ clones, were stained with X-gal. In control discs, hh gene expression was 
restricted to posterior regions of the eye disc, with the exception of a small area of 
expression at the lateral dorsal margin in the anterior region of the disc (Figure 4.7; 
panel a). According to previous reports, this is the characteristic hh expression 
pattern in the eye disc during the third larval instar (Cho et al. 2000) (see Chapter 1, 
Section 1.2.5). Loss of hyd in hydK7.19 hhlacZ clones had both quantitative and spatial 
consequences on hh gene expression. The overall X-gal staining, when examined by 
eye, appeared increased in posterior regions of hyd mutant discs (Figure 4.7; panels 
b-d). Additionally, ectopic hh expression was observed in anterior regions of the disc 
in some instances (Figure 4.7; panels b, e, d; arrows). These findings are in 
agreement with previous work that identifies Hyd as a negative regulator of hh 
expression (J. D. Lee et al. 2002). The expression of hh in posterior regions of the 
eye disc directs photoreceptor differentiation, which progresses as the morphogenetic 
furrow (MF) moves across the eye disc from posterior to anterior (Royet & 
Finkelstein 1997). Loss of Hyd was also reported to lead to ectopic hh expression in 
clones anterior to the furrow, which in turn lead to premature photoreceptor 
differentiation (J. D. Lee et al. 2002).  
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Figure 4.7: hhlacZ expression in X-gal-stained L3 EA discs. (A) Third instar eye-antennal discs 
containing FRT82B hhlacZ (control) or FRT82B hydK7.19 hhlacZ clones. Anterior is to the left, 
posterior is to the right, dorsal is up, and ventral is down. Black arrows indicate ectopic hhlacZ 
expression in anterior regions. Scale bars are 100µm. Location of morphogenetic furrow (MF) is 
indicated by black triangles. (B) Schematic of hhlacZ expression levels in homozygous hydK.19, 
heterozygous, and wild type clones. Only homozygous hydK.19clones are also GFP positive. A single 
copy of hhlacZ in heterozygous hydK.19 clones leads to reduced expression of hhlacZ compared to 
homozygous hydK.19 clones. 
However, one disadvantage of using X-gal staining to assess levels of hh gene 
expression in eye discs containing hydK7.19 clones, is that hh-lacZ expression is not 
exclusively restricted to hydK7.19 clones. The MARCM technique, due to the FLP-
FRT-based recombination process, will generate three different types of clones: (i) 
GFP-positive homozygous control/hydK7.19 clones that receive two copies of hh-lacZ; 
(ii) GFP-negative heterozygous control/hydK7.19 clones that receive one copy of hh-
lacZ; and (iii) GFP-negative wild-type clones that receive zero copies of hh-lacZ 
(Figure 4.7 B). As a result, the blue staining in X-gal-stained MARCM discs is due 
to hh-lacZ expressed by both homozygous and heterozygous control/hydK7.19 clones. 
Those regions lacking blue stain may either be due to cells (i) expressing hh but lack 
the hh-lacZ reporter or (ii) do not express hh but do harbour hh-lacZ. This is why hh-
lacZ expression in posterior regions of eye discs containing control clones is not 
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uniform, as not all cells have received a copy of hh-lacZ. This also means that, 
although hh-lacZ expression levels have markedly increased in eye discs containing 
hydK7.19 clones, it is not clear whether the ectoptic hh expression occurs in the 
homozygous clones or in the remaining heterozygous hh-lacZ expressing cells. 
 
In order to get around this caveat, I used immunofluorescence in conjunction with 
βgal- and Hh-N-specific antibodies to simultaneously visualize hh gene expression 
and Hh protein expression in GFP-labelled homozygous hydK7.19 hh-lacZ clones 
(Figure 4.8). In addition, as previous findings relate only to Hyd-mediated regulation 
of hh mRNA levels (J. D. Lee et al. 2002), I wanted to ensure Hh protein levels were 
also elevated in hydK7.19 clones. As expected, both hh gene expression in hydK7.19 
clones, and Hh protein expression in eye discs containing hydK7.19 clones was visibly 
elevated compared to control discs (Figure 4.8, A and B). Interestingly, Hh protein 
expression did not always co-localise with βgal staining or GFP-positive clones. This 
could be because, unlike β-gal, Hh protein is a diffusible extracellular protein. 
Furthermore, Hh staining is a cumulative representation of Hh protein produced in hh 
expressing cells – either hydK7.19 or not. Local high concentrations of Hh staining 
may also reflect physical sequestration of Hh protein by membrane-associated 
receptors, such as Ptc. Not only did loss of hyd function result in elevated Hh protein 
levels in L3 EA discs, the expression pattern of Hh protein was also notably 
disrupted, whereby ectopic high levels of Hh protein expression were observed in 
both posterior and anterior regions of the eye disc (Figure 4.8, A and B). 
 
Finally, the relative levels of hh gene expression in hydK7.19 clones versus control 
clones were quantified by measuring the average pixel intensity of the βgal signal in 
regions of interest (ROI) containing groups of GFP-identifiable clones. This was 
possible as all images were acquired at the same exposure for the βgal signal. Mean 
pixel intensity values for βgal staining were measured in groups of GFP postitive 
clones for each disc using the ImageJ software, and normalised against mean GFP 
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staining pixel intensities in the same ROI (Figure 4.8 C). This quantitative analysis 
revealed that hh expression levels were indeed significantly higher (p = 0.001) in 
hydK7.19 clones than in control clones. 
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Figure 4.8: hhlacZ and Hh expression in hydK7.19 mutant L3 EA discs. Anterior is to the left, 
posterior is to the right, dorsal is up, and ventral is down, and the morphogenetic furrow (MF) is 
marked by white triangles in all subsequent immunofluorescence (IF) images. (A) IF of FRT82B 
(control) or FRT82B hydK7.19 discs containing GFP clones (green), stained for Hh (red). (B) IF of 
FRT82B hhlacZ (control) or FRT82B hydK7.19 hhlacZ discs containing GFP clones (green), stained for 
Hh (red) and βgal (hhlacZ) (magenta). (C) Measurements of average pixel intensities in single ROIs 
containing groups of GFP-positive clones in FRT82B hhlacZ (control) discs (n=4) or FRT82B hydK7.19 
hhlacZ (n=6) (p =0.001; t-test). Normalisation was performed by dividing Bgal mean pixel intensites 
by GFP mean pixel intensities for each ROI. 
 
4.4.2 Loss of hyd in clones results in elevated Wg signaling  
 
Whilst the above results and previous reports (J. D. Lee et al. 2002) clearly show that 
loss of hyd in clones results in ectopic expression of Hh morphogen, it is not known 
whether loss of hyd can also affect Wg expression. The specification and growth of 
the head cuticle, which is normally regulated by Wg signalling (Royet & Finkelstein 
1996), is abnormally affected in adult heads containing hydK7.19 clones, where loss of 
hyd causes significant overgrowth of head tissue, often at the expense of eye tissue. 
This indicates elevated Wg signalling as a result of hyd loss, and suggests that Hyd 
could also be a regulator of Wg signaling. Further to this, Hyd protein interacts with 
Armadillo (see Chapter 3), the transcriptional effector of the Wg pathway. I 
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therefore stained L3 eye discs for Wg protein to address whether loss of hyd also 
affects Wg morphogen expression. Indeed, hydK7.19 clones cause ectopic expression 
of Wg protein, mainly in anterior regions of the eye disc (Figure 4.9), which will 
eventually give rise to the head cuticle. The Wg protein signal was visibly higher in 
images of hydK7.19 discs compared to control discs taken at the same exposure. 
Interestingly, Wg protein levels were highest in cells immediately adjacent to 
hydK7.19 clones, rather than in the clones themselves. This could reflect increased wg 
expression in hydK7.19 clones, where the secreted Wg ligand then binds and activates 
the Wg pathway in neighbouring cells. To test this, a wg-lacZ reporter could be used, 
as well as antibody staining for Wg target genes. This would have the potential to 
uncover another very interesting role for Hyd in the potential negative regulation of 
Wg signalling. However, due to time constraints, I was not able to pursue this. 
Instead, I chose to focus on investigating Hyd’s function in regulating hh expression 
and Hh pathway activity, as this was the main aim of my project.  
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Figure 4.9: Wg expression in hydK7.19 mutant L3 EA discs. IF of FRT82B (control) or FRT82B 
hydK7.19 discs containing GFP clones (green), stained for Wg (red). The morphogenetic furrow (MF) is 
marked by white triangles in all merged images. Scale bars are 250 µm. 
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4.5 Hh pathway activity in hydK7.19 mutant clones 
 
hh gene expression is up-regulated in hydK7.19 clones, leading to an increase in Hh 
protein across the eye disc. As a result of this abundance of Hh protein, one would 
expect Hh pathway activity to be up-regulated in hydK7.19 clones and/or the 
surrounding cells. Increased levels of Ci155, the full length, active form of the Hh 
pathway transcriptional effector, had previously been observed in hydK3.5 clones 
anterior to the furrow (J. D. Lee et al. 2002). However, the same effect was also seen 
in anterior hydK3.5 hh double mutant clones, suggesting that Hyd normally acts to 
reduce Ci155 levels independently of Hh activity (J. D. Lee et al. 2002). 
 
4.5.1 Loss of hyd affects Ci155 levels differentially depending 
on the location of hydK7.19 clones 
 
In order to investigate Hh pathway activity, I first stained eye discs containing 
control or hydK7.19 clones with the 2A1 anti-Ci antibody(Motzny & Holmgren 1995). 
This antibody recognizes the carboxy-terminal region of the full-length Ci155 protein, 
but not the Ci75 repressor form, which is lacking the carboxy-terminus due to 
proteolytic processing. Therefore, all Ci staining is representative of the full length, 
active form of the Ci155 protein only. 
 
The Ci155 staining pattern observed in control discs is representative of normal Ci 
expression in the eye disc at the third larval instar (Baker et al. 2009). Ci155 
expression levels are kept relatively low throughout the disc, with the exception of a 
D-V strip of concentrated Ci155 staining (Figure 4.10 A). Differentiated 
photoreceptors in the posterior half of the eye disc express hh, which activates the Hh 
pathway and leads to dpp expression in more anterior cells, thus causing a wave of 
differentiation across the disc (Royet & Finkelstein 1997). Ci and Dpp are therefore 
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highly expressed in the MF, a visible indentation that marks the front of 
differentiation(Penton et al. 1997). 
 
In eye discs containing hydK7.19 mutant clones, the dorsal-ventral (D-V) strip of Ci 
staining, which represents the MF, is visibly disrupted (Figure 4.10 A). Instead of 
forming a relatively straight line, the MF takes on an irregular path in the presence of 
hydK7.19 clones. In addition, high levels of Ci staining are no longer restricted to the 
presumed MF. This suggests that differentiation of photoreceptors from posterior to 
anterior does not occur at the same speed in different regions of the disc. Loss of hyd 
has previously been reported to cause premature photoreceptor differentiation (J. D. 
Lee et al. 2002), which could in part explain this result. 
 
Further to this, individual groups of hydK7.19 mutant clones have profound 
autonomous effects on Ci155 levels, depending on their location with respect to the 
MF. Ci155 levels are frequently reduced in clones anterior to the D-V stripe of Ci155 
staining, and sometimes in posterior clones near the MF (Figure 4.10 A, white 
arrows). This finding directly contradicts previous reports that loss of hyd in hydK3.5 
clones leads to an increase in Ci155 levels in anterior clones(J. D. Lee et al. 2002). On 
the other hand, elevated Ci155 levels were observed only in posterior clones, albeit 
less frequently (Figure 4.10 A, yellow arrow). Interestingly, the groups of clones 
that affect Ci155 levels, either positively or negatively, often had a more rounded 
morphology that was never seen in control discs. The lower Ci155 level in anterior 
clones could indicate that loss of hyd results in either the degradation of Ci155, or the 
processing to the Ci75 repressor form, which is not detected by the 2A1 antibody. 
This suggests that Hyd normally positively regulates full-length Ci155 levels in 
anterior cells, by preventing its degradation, or processing, or both. Conversely, Hyd 
appears to negatively regulate Ci155 levels in posterior cells, which could be due to 
Hyd promoting Ci155 degradation or processing instead. 
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To investigate whether increased Ci155 levels correlated with ectopic hh expression in 
posterior hydK7.19 clones, eye discs containing hydK7.19 hh-lacZ clones were double 
stained with Ci and βgal antibodies (Figure 4.10 B). Indeed, there was a strong 
correlation between high levels of Ci155 staining and high levels of hh expression in 
posterior clones (Figure 4.10 B; white arrows), suggesting that the increase in Ci155 
levels could be a direct result of autonomous Hh pathway activation. This effect was 
not observed in all eye discs containing mutant clones, which could be due to the 
variability in the severity of the phenotype already observed in adult eyes. In 
summary, Hyd appears to prevent expression of full length Ci155 ahead of the MF by 
negatively regulating hh expression, whereas it promotes or stabilizes expression of 
Ci155 in cells anterior to the furrow.  
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Figure 4.10: Ci155 and hhlacZ expression in hydK7.19 mutant L3 EA discs. (A) IF of FRT82B 
(control) or FRT82B hydK7.19 discs containing GFP clones (green), stained for Ci155 (red). (B) IF of 
FRT82B hhlacZ (control) or FRT82B hydK7.19 hhlacZ discs containing GFP clones (green), stained for 
Ci155 (red) and βgal (hhlacZ) (magenta). The morphogenetic furrow (MF) is marked by white triangles 
in all merged images. Scale bars are 250 µm. 
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4.5.2 Loss of hyd causes accumulation of Patched (Ptc) in 
hydK7.19 clones and the surrounding tissue 
 
Another indicator of Hh pathway activity is the expression of the transmembrane 
receptor for Hh ligand, Ptc. Cells expressing Ptc are responsive to Hh ligand and 
capable of transducing the Hh pathway. When Hh ligand is present and bound to Ptc 
both can be internalized, removing them from the cell surface (Martín et al. 2001). 
Importantly, ptc is also a Hh pathway target gene, and therefore Ptc expression is a 
good read-out of Hh pathway activity downstream of Ci155. 
Eye discs containing hydK7.19 clones were therefore stained for Ptc, which revealed 
high levels of ectopic Ptc expression in both anterior and posterior regions of the 
disc. hydK7.19 clones caused very pronounced non-autonomous Ptc expression in 
neighbouring cells, as well as moderate autonomous Ptc expression (Figure 4.11 A). 
It therefore appears that loss of hyd causes mainly non-autonomous ectopic Hh 
pathway activity, whilst having autonomous effects on Ci155 levels. Indeed, the 
increased non-autonomous Ptc expression suggests that these cells could have an 
increased concentration of extracellular Ptc. This could be due to the high levels of 
Hh protein expression observed in discs containing hydK7.19 clones, as well as the 
diffusible nature of the Hh ligand. 
 
Interestingly, co-staining of eye discs with Ci and Ptc antibodies revealed that both 
autonomous and non-autonomous expression of Ptc always correlated with high Ci155 
levels (Figure 4.11 B). As previously reported (J. D. Lee et al. 2002), my 
observation of Ci155 and Ptc up-regulation support the notion that Hyd negatively 
regulates Hh pathway activity both by autonomously down-regulating Ci155 levels, as 
well as non-autonomously by suppressing hh expression.  
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Figure 4.11: Ptc and Ci155 expression in hydK7.19 mutant L3 EA discs. (A) IF of FRT82B (control) 
or FRT82B hydK7.19 discs containing GFP clones (green), stained for Ptc (red). (B) IF of FRT82B 
(control) or FRT82B hydK7.19 discs containing GFP clones (green), stained for Ci155 (red) and Ptc 
(magenta). The morphogenetic furrow (MF) is marked by white triangles in all merged images. Scale 
bars are 250 µm. 
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4.6 Hyd positively regulates Hh pathway activity in 
Cl8+ cells 
 
So far, the in vivo results suggest that, depending on the location in the EA disc, Hyd 
regulates Hh pathway activity both positively and negatively. In order to help 
determine the mechanism(s) by which Hyd can regulate Hh pathway activity and hh 
gene expression, it was necessary to develop a cell culture based model system to 
reduce the complexity of the in vivo system and control for intercellular 
communication between different cell types. The advantage of an in vitro system to 
study Hyd function in these processes is the reduced complexity compared to in vivo 
studies, eliminating factors such as cell communication between different cell 
populations within a tissue. Although no Drosophila cell lines have been found to 
date that are capable of producing the Hh ligand (Celniker et al. 2009), most can be 
used to study the Hh and Wg signaling pathways (Cherbas et al. 2011).  
 
4.6.1 S2 cells transfected with exogenous Ci are capable of 
transducing the Hh pathway 
 
S2 cells are one of the most commonly used Drosophila cell lines. Gene expression 
studies, however, have revealed that they do not express the relevant components at 
adequate levels to enable them to transduce the Hh and Wg pathways (Cherbas et al. 
2011). For example, S2 cells lack the transmembrane Frizzled2 receptor for the Wg 
ligand. Similarly, Ci, which is required for Hh target gene expression, is not 
expressed in S2 cells. When Ci is provided exogenously, however, S2 cells are able 
to transduce the Hh pathway when stimulated with Hh-N ligand (Fukumoto et al. 
2001). I therefore co-transfected S2 cells with Ci and Hh-N ligand, and used a firefly 
luciferase reporter construct to measure Hh pathway activity. Two patched (ptc)-
luciferase reporter constructs were used, ptcΔ136-Luc and ptcΔ136-mut (C. H. Chen 
et al. 1999), which contained a wild-type or mutant patched promoter, respectively, 
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driving the expression of firefly luciferase. As expected, transfection of Ci led to 
reporter activation, which was increased further upon co-transfection with Hh ligand 
(Figure 4.12). The observed signal was significantly higher than in the negative 
control (ptcΔ126-mut), as well as in the absence of Ci, suggesting that transfection of 
Ci is absolutely required for the study of the Hh pathway in S2 cells. Although the S2 
cell system was optimized and worked well, I thought that the need to transfect Ci, as 
well as the inability to transduce the Wg pathway in the absence of exogenous 
Frizzled2 (which was not available in the lab), could complicate things further down 
the line. So I utilised another Drosophila cell line, Cl8+, which does not require 
exogenous components to transduce the Hh and Wg pathways(Cherbas et al. 2011). 
 
Figure 4.12: Hh pathway activation in S2 cells. S2 cells were transfected with Ci, Hh-N, and the Ptc 
luciferase reporters ptcΔ136-Luc and ptcΔ136-mut (negative control). Error bars represent standard 
deviation from three independent transfection replicates (n=3). All luciferase readings were 
normalized to renilla activity. RLU was significantly (**) enhanced in samples containing ptcΔ136-
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4.6.2 Knock down of Hyd in Cl8+ cells decreases Hh pathway 
activity 
 
Unlike S2 cells, Cl8+ cells, which are derived from third instar wing discs, express 
all the necessary components needed to transduce the Hh and Wg pathways (Cherbas 
et al. 2011). First I investigated whether transfection of Hh-N ligand into Cl8+ cells 
could also drive ptcΔ136-Luc reporter activity. Stimulation with Hh ligand yielded a 
strong signal, with minimal background in the absence of Hh and in the negative 
ptcΔ136-mut control (Figure 4.13 A). Next, I wanted to investigate what effect 
removal of Hyd would have on Hh pathway activity. Cl8+ cells were transfected 
with either dsRNA specific for EGFP (negative control), or dsRNA specific for Hyd 
(7950) (see Chapter 2, 2.2.3). As can be seen in Figure 4.13 B, the transfection of 
Hyd 7950 dsRNA results in a very good knockdown of Hyd protein in Cl8+ cells, 
whereas EGFP dsRNA has no effect on Hyd protein levels.  
 
In the presence of Hh ligand, knockdown of Hyd significantly reduces ptcΔ136-Luc 
reporter activity compared to the EGFP dsRNA-treated control (p = 0.007) (Figure 
4.13 C). This effect was reproduced in an independent experiment, whereby Hyd 
7950 dsRNA also decreased Hh pathway activity significantly compared to the 
EGFP dsRNA-treated control (p = 0.041) (Figure 4.13 D). These results suggest 
that, in the presence of Hh ligand, Hyd positively regulates Hh pathway activity in 
Cl8+ cells. 
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Figure 4.13: Hyd positively regulates Hh pathway activity in Cl8+ cells. (A) Hh pathway 
activation in Cl8+ cells. Cl8+ cells were transfected with Hh-N ligand, and the Ptc luciferase reporters 
ptcΔ136-Luc and ptcΔ136-mut (negative control). **t-test p < 0.001. (B) Knockdown of Hyd protein 
following transfection of Cl8+ cells with dsRNA. (C) Treatment with Hyd 7950 dsRNA reduces Hh 
pathway activity. Cl8+ cells were transfected with dsRNA, Hh-N, and ptcΔ136-Luc reporter. **t-test 
p = 0.007. (D) Treatment with Hyd 7950 reduces Hh pathway activity. Cl8+ cells were transfected 
with dsRNA, Hh-N, and ptcΔ136-Luc reporter. **t-test p = 0.041. All error bars represent standard 
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4.6.3 Knockdown of Hyd has no effect on Wg pathway 
activity in Cl8+ cells 
 
As my data identified Hyd’s ability to regulate Wg expression and physically interact 
with the Wg pathway transcriptional effector, Armadillo, (see Figure 4.9 and 
Chapter 3, Section 3.5.3), I also wanted to investigate whether Hyd can affect Wg 
pathway activity in Cl8+ cells. Cl8+ cells were co-transfected with Wg and a 
luciferase reporter containing 12 repeats of the TCF binding sites (dTF12) (DasGupta 
et al. 2005; Korinek et al. 1997), which are the binding sites for the Armadillo/TCF 
transcriptional activator complex controlling target gene expression in the Wg 
pathway (Behrens et al. 1996; Molenaar et al. 1996). A FOP FLASH reporter, in 
which these sites are mutated, was included as a negative control. In the absence of 
Wg ligand, both reporters produced a relatively low-level background signal. 
Induction with Wg increased the dTF12 signal, and intriguingly, completely ablated 
the background in the FOP FLASH signal (Figure 4.14 A). Additionally, the overall 
intensity of the dTF12 + Wg signal was not as high as in the Hh pathway luciferase 
assays. This could be due to non-optimal expression of the transfected Wg ligand, 
which requires CuSO4-mediated induction from a metallothionine promoter. This 
initial pilot experiment suggests that, under our experimental conditions, the Wg 
pathway reporter assays is not as robust or reliable as for the Hh pathway reporter 
assays. 
 
In the presence of Wg ligand, the dTF12 reporter activity did not change 
significantly in samples treated with Hyd 7950 dsRNA (Figure 4.14 B). 
Unfortunately, I did not have time to improve or repeat this assay. Although this 
experiment was only performed once, the results would suggest that Hyd has no 
effect on Wg pathway activity in Cl8+ cells. While this could mean that Hyd has no 
involvement in the Wg pathway in general, it could also suggest that Hyd’s 
function(s) in the Wg pathway are cell/tissue-specific, indicating that Hyd affects Wg 
signaling in the eye disc, but not in the wing disc or wing-disc derived Cl8+ cells. 
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Figure 4.14: Hyd knockdown does not affect Wg pathway activity in Cl8+ cells. (A) Wg pathway 
activation in Cl8+ cells. Cl8+ cells were transfected with Wg ligand, and the TCF luciferase reporters 
dTF12 and FOPFLASH (negative control). **t-test p = 0.002; n=3. (B) Treatment with Hyd 7950 
dsRNA has no effect on Wg pathway activity. Cl8+ cells were transfected with dsRNA, Wg, and 
dTF12 reporter. **t-test p = 0.83; n=3. All error bars represent standard deviation from three 
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4.7 Hyd interacts with Ci in Cl8+ cells but does not 
affect Ci levels 
 
Both the in vivo and in vitro data implicate Hyd in the regulation of Hh pathway 
activity, with the in vivo results clearly suggesting a role for Hyd in the regulation of 
full-length Ci155 levels and/or activity. In order to determine whether Hyd regulates 
Ci indirectly, or directly through a physical interaction, I first investigated whether 
Hyd can interact with Ci.  
 
4.7.1 Hyd interacts with Ci155 in Cl8+ cells 
 
S2 cells were co-transfected with HA-Strep Hyd and an amino-terminal (NT) HA-
tagged Ci construct (HA-Ci). Although S2 cells do not express Ci endogenously, 
they were chosen for binding assays due to their ease of transfection and handling, as 
the chances of detecting an interaction are generally higher when using over-
expressed proteins. In addition, the catalytic inactive Hyd mutant, Hyd C>A, was 
also used in these Ci binding assays; the rationale behind this being that it would be 
very hard to detect an interaction if Hyd degraded Ci.  
 
Although Ci was pulled down with both WT and C>A Hyd, the binding was weak, 
but potentially more than the background binding of Ci to the StrepTactin Sepharose 
resin (Figure 4.15 A). As assessed by measuring band intensity in ImageJ, Ci 
binding to WT Hyd was the same as background Ci binding, whereas binding to 
C>A Hyd was about 1.5x over background. Although Ci binding to WT Hyd was not 
convincing, Ci binding to C>A Hyd looked more promising and suggested that Hyd 
could be directly involved in positively regulating Ci degradation. Importantly, the 
HA tag on exogenous Ci is located at the carboxy-terminal, which means that any Ci 
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that is converted to the Ci75 repressor form cannot be detected using the HA 
antibody. Therefore, another possibility is that Hyd promotes conversion to the 
repressor form by ubiquitylation of full-length Ci155. However, the levels of Ci155 in 
the input samples appear unchanged in the presence or absence of WT and C>A Hyd 
(see Figure 4.15 A, lanes 1, 2 and 4). 
 
In a parallel approach to test Ci binding to Hyd, I also used mammalian 293 cells, as 
they are known to produce large amounts of over-expressed proteins. Drosophila 
cDNAs were cloned into mammalian expression vectors for this purpose and 
transfected into 293 cells. Following a Streptactin pull down against HSP-Hyd, Ci 
co-precipitated with WT Hyd. Importantly, no backround Ci binding was detected in 
the Ci only control (Figure 4.15 B, 3rd lane).  
 
Although the binding assays using exogenous, over-expressed proteins in S2 and 293 
cells indicate that Ci can interact with Hyd, they are not very convincing. I therefore 
performed another binding assay using Cl8+ cells, which not only express Ci and 
Hyd endogenously, but are also capable of transducing the Hh pathway. 
Additionally, my previous results showed, that knockdown of Hyd in these cells 
negatively affected Hh pathway activity, suggesting that Hyd could regulate Hh 
pathway activity in these cells by binding to Ci. I therefore immunoprecipitated 
endogenous Hyd to investigate whether it can bind to endogenous Ci. Indeed, 
endogenous Ci co-immunoprecipitated with Hyd (Figure 4.15 C). In summary, these 
results suggest that Hyd could positively regulate Hh pathway activity through 
binding Ci155.  
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Figure 4.15: Hyd interacts with Ci155. (A) StrepTactin pulldown in S2 cells. S2 cells were 
transfected with HA-Strep(HSP)-Hyd and HA-Ci constructs. (B) StrepTactin pulldown in 293 cells. 
293 cells were transfected with Drosophila HA-Strep(HSP)-Hyd and HA-Ci constructs. (C) 
Immunoprecipitation of endogenous Hyd in Cl8+ cells using the Hyd M19 antibody (Santa Cruz). 
Endogenous Ci155 was co-immunoprecipitated with Hyd, as detected using the 2A1 Ci antibody. 
Negative control = IgG. 
 
4.7.2 Knockdown of Hyd has no effect on Ci155 levels in Cl8+ 
cells 
 
So far, my data from Cl8+ cells implies that Hyd normally promotes Ci155 activity, 
which may or may not involve regulation of Ci155 stability, to positively regulate Hh 
pathway activity. I next investigated whether knockdown of Hyd affects Ci protein 
levels, both in the presence and absence of Hh ligand. However, I was only able to 
analyse full-length Ci155 protein levels, as the 2A1 Ci antibody cannot detect the Ci75 
repressor form. Loss of Hyd does not appear to affect full-length Ci155 protein levels, 
in the presence or absence of Hh ligand and therefore pathway activity (Figure 4.16). 
Although Hyd interacts with Ci155, this does not seem to affect Ci155 protein levels. 
However, Hyd could be directly or indirectly affecting the post-translational 
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modification (i.e. phosphorylation and/or ubiquitylation) of Ci, and thus regulating 
Ci155 activity independently of any effects on its expression level.  
To investigate Hyd’s potential role in Wg pathway regulation, I also looked at 
whether Hyd knockdown could affect the levels of the Wg pathway transcriptional 
effector Armadillo (Arm). Interestingly, loss of Hyd leads to slightly lower levels of 
Arm only when the Hh pathway is on (Figure 4.16, lane 6). This is in agreement 
with previous findings that identified Hyd as a positive regulator of Wg signalling 
through non-degradative ubiquitylation, and subsequent up-regulation of β-catenin 
(Hay-Koren et al. 2011). Additionally, this result also indicates cross-talk between 
the Hh and Wg pathways, which has been reported previously (J. He et al. 2006), and 
suggests that Hyd could be a key protein involved in cross-pathway signalling. 
 
Figure 4.16: Effect of Hyd knockdown on Ci155 and Arm protein levels. Cl8+ cells were 
transfected with EGFP or Hyd 7950 dsRNA and Hh-N ligand. 
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4.8 Discussion 
 
The findings presented here implicate Hyd in the regulation of both Hh and Wg 
signalling in the developing Drosophila eye and head tissues, and suggest that part of 
the molecular mechanism may involve regulation of Ci activity through physical 
interaction of Hyd with Ci. Mutant hydK7.19 clones in the EA disc express a severely 
truncated Hyd protein that lacks all carboxy-terminal domains except the UBA 
domain. These clones cause non-autonomous overgrowth of EA disc tissue, as well 
as overgrowth of head tissue in adults and scarring in adult eyes, although the clones 
themselves do not persist to adulthood. The adult phenotype is rescued completely by 
exogenously supplying a wild-type Hyd transgene, whereas a Hyd transgene 
encoding a catalytically inactive Hyd protein is unable to rescue the phenotype. 
hydK7.19 clones express significantly higher levels of hh, and cause elevated 
expression levels of both Hh and Wg ligands in EA discs. Accordingly, loss of hyd in 
the clones also affects Hh pathway activity. Loss of hyd affects Ci155 levels in 
hydK7.19 clones depending on their location with respect to the MF: Ci155 levels are 
reduced in anterior clones, but are elevated above basal levels in some posterior 
clones. Additionally, Ptc protein levels accumulate in and around hydK7.19 clones. 
Finally, Hyd positively regulates Hh pathway activity and interacts with Ci155 in 
wing-disc derived Cl8+ cells, but Hyd does not appear to affect Ci protein levels. 
 
The results clearly show that Hyd is involved in the regulation of both hh gene 
expression, as well as Hh pathway activity in the eye. hydK7.19 clones in the posterior 
region of the EA disc, which mainly gives rise to the compound eye, express high 
levels of hh, which results in both autonomous and non-autonomous elevation in Hh, 
Ci155, and Ptc protein levels. Loss of hyd in hydK7.19 clones gives rise to an adult eye 
phenotype that is chiefly characterized by scarring and roughness of the compound 
eye, but does not often feature hyperplasia of eye tissue. This suggests that Hyd 
normally negatively regulates both hh gene expression and Hh pathway activity in 
posterior regions of the disc, and that the lack of this repression leads to defects in 
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eye development. These data are mostly in agreement with previous work that 
showed ectopic expression of hh and dpp in hydK7.19 clones, however the hydK3.5 
allele used to generate clones in this study gave rise to a distinctly hyperplastic 
compound eye, which featured non-autonomous outgrowths of excessive eye tissue 
(J. D. Lee et al. 2002). One common feature between the hydK3.5 and hydK7.19 alleles is 
that both types of hydK7.19 clones seem to be eliminated in adult eyes. In the case of 
hydK3.5 clones this is stipulated to be the result of clone elimination due to cell 
competition, as hydK3.5 clones were found to have a distinct growth disadvantage 
compared to the surrounding cells (J. D. Lee et al. 2002). It is not known whether 
hydK7.19 clones are eliminated in the same way, or for different reasons, such as self-
directed apoptosis. However, one way to explain the difference in the adult eye 
phenotypes could be that hydK7.19 clones are eliminated earlier than hydK3.5 clones 
during eye development, and so the hyperplastic effects on the adult eye tissue, 
although apparent in EA discs at the third instar, are not as pronounced.  
 
Interestingly, loss of hyd in anterior hydK7.19 clones has the opposite effect on Ci155 
levels, which were clearly reduced below basal levels. This directly contradicts 
previously published results, which show that anterior hydK3.5 clones accumulate high 
levels of Ci155 (J. D. Lee et al. 2002). During normal eye development, Ci155 
expression is kept low both posterior and anterior to the MF, with the exception of a 
D-V strip of high Ci155 levels immediately posterior to the MF, where Hh signaling 
directs the differentiation of photoreceptors. However, Ci155 is regulated differently 
on either side of the furrow. In posterior regions of the eye disc, expression of the 
Cul3-based E3 ubiquitin ligase Rdx/Hib leads to ubiquitylation and subsequent 
degradation of full-length Ci155, preventing further activation of the Hh pathway in 
posterior cells. In anterior regions, expression of the E3 ubiquitin ligase Slmb 
ensures ubiquitylation of Ci155, which instead results in partial processing of the full-
length active protein to a truncated Ci75 transcriptional repressor that can no longer 
activate Hh target genes (Baker et al. 2009). A plausible theory for the differential 
Hyd-mediated regulation of Ci155 levels could therefore be that Hyd normally 
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antagonizes Slmb function in anterior cells, but potentiates Rdx/Hib function in 
posterior cells, thereby indirectly regulating Ci155 levels during eye development. 
 
This hypothesis is strengthened by the fact that Hyd can interact with Ci. Loss of 
Hyd in the wing-disc derived Cl8+ cell line results in down-regulation of the Hh 
pathway, suggesting that Hyd positively regulates Hh pathway activity in this setting. 
Of course, it must be noted that this setting represents a highly simplified model of 
Hyd’s function in regulating Hh signaling in vivo, as the complexity of 
communication between different cell types within a dynamically developing tissue 
is completely eliminated. Nevertheless, it appears that Cl8+ cells are responding to a 
loss of Hyd analogously to anterior cells in the eye disc, in which Ci155 is reduced. 
Hyd could therefore act as a positive regulator of Hh pathway activity in Cl8+ cells 
by antagonizing Slmb activity, and thus antagonising the processing of C155 to the 
Ci75 repressor form. Conversely, the Cl8+ cell luciferase results do not support a role 
for Hyd in Rdx/Hib potentiation, and thus Ci155 degradation. If Hh pathway activity 
in Cl8+ cells is due to stabilization of Ci155 levels as a result of Hyd-mediated 
antagonism of Slimb-directed Ci155 processing, one would expect Ci155 levels to be 
decreased in the absence of Hyd. However, knockdown of Hyd had no effect on Ci155 
levels in Cl8+ cells, both in the presence and absence of Hh ligand. This could be 
due to the fact that Ci155 protein is constantly replenished as a consequence of 
continuous Hh ligand stimulation, thereby masking a potential effect on Ci155 levels. 
To test this, the experiment could be improved by blocking protein translation using 
the drug cyclohexamide (CHX). It is therefore still plausible that Hyd could 
antagonize Slimb action on Ci155, for example by directly competing for Ci binding, 
preventing Slimb-mediated ubiquitylation of Ci155, and catalyzing the addition of 
ubiquitin chains that instead result in stabilization and/or activation of Ci155. This 
model is supported by the fact that the catalytic inactive Hyd transgene fails to rescue 
the phenotype, suggesting that Hyd’s ubiquitylation activity is crucial for its function 
in eye development. Additionally, EDD ubiquitylates β-catenin in the Wg pathway 
by adding K11-and K29-linked ubiquitin chains, which results in up-regulation of β-
catenin, and thus Wnt pathway activity. Hyd could therefore act in a smilar way to 
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ubiquitylate Ci. However, it remains to be determined whether Hyd can ubiquitylate 
Ci, and what the biochemical nature of these ubiquitin chains would be. 
 
Finally, the results also implicate Hyd in the regulation of Wg signaling during eye 
development. The Wg and Hh morphogens work in concert during eye development 
at the third instar to specify cells that will form part of the head cuticle and 
compound eye, respectively(Royet & Finkelstein 1996). Unlike Hh, which is mostly 
expressed in posterior regions of the eye disc, Wg expression is restricted to the 
lateral margins of the anterior eye disc(Cho et al. 2000; Treisman & G. M. Rubin 
1995). However, loss of hyd in hydK7.19 clones leads to ectopic and elevated levels of 
Wg expression throughout anterior regions of the eye disc. As a result, the head 
cuticle is overgrown in adult heads, and the scarring observed at the margins of adult 
eyes could therefore represent expanded regions of head cuticle tissue at the expense 
of the compound eye.  
 
In addition to regulating Wg expression, Hyd also interacts with the Wg pathway 
components Armadillo and Sgg (see Chapters 3 and 5), suggesting that, as for the 
Hh pathway, Hyd may regulate both Wg-ligand and -pathway activity. This is a 
novel finding in Drosophila, although EDD has previously been shown to interact 
with β-catenin, the human orthologue of Armadillo, and the kinase GSK3β (Hay-
Koren et al. 2011). 
 
The serine-threonine kinase GSK3β, also known as Shaggy in Drosophila, plays a 
key role in both the Hh and Wg signaling pathways (see Chapter 1, Sections 1.2 
and 1.3). In the Hh pathway, GSK3β/Shaggy contributes to the hyper-
phosphorylation of Ci155 (J. Jia et al. 2002), which leads to Slmb-directed processing 
of Ci155 to the Ci75 repressor form. Similarly, in the Wg pathway GSK3β/Shaggy 
phosphorylates the transcriptional effector protein β-catenin/Armadillo (S. Ikeda et 
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al. 1998), which prompts recognition and subsequent degradation of β-
catenin/Armadillo by Slimb (Aberle et al. 1997; J. Jiang & Struhl 1998). As such, 
Shaggy is a negative regulator of both the Hh and Wg pathways, and thus could be a 
key substrate for Hyd to regulate both signalling pathways.  
 
Having established that the MARCM system is a robust model to study Hyd’s 
function in hh gene regulation and Hh pathway activity, the next objective was to 
determine whether Hyd could negatively regulate Hh signalling during eye 
development by interacting with Shaggy.
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5.1 Introduction 
 
Glycogen synthase kinase 3 β (GSK3β), also known as zeste-white 3 or Shaggy 
(Sgg) in Drosophila, is a serine/threonine kinase that was initially identified as a key 
enzyme involved in insulin-mediated glycogen metabolism (reviewed in (Cohen & 
Frame 2001)). Since then, a multitude of other cellular functions of Sgg/GSK3β have 
emerged, which include its role as an antagonist of both the Wg/WNT and Hh/SHH 
signaling pathways (see Chapter 1, Sections 1.3 and 1.4). In the Hh pathway, 
Sgg/GSK3β phosphorylates the full-length transcriptional activator Ci155 (J. Jia et al. 
2002). Phosphorylated Ci155 is targeted for ubiquitylation by the E3 ubiquitin ligase 
Slimb/βTrCP, and subsequent proteolytic processing to a truncated Ci75 protein, 
which acts to inhibit the transcription of Hh target genes (Méthot & Basler 1999). 
Similarly, in the Wg pathway Sgg/GSK3β phosphorylates the transcriptional effector 
protein Armadillo/β-catenin, which prompts recognition and subsequent degradation 
of Armadillo/β-catenin by Slimb/βTrCP (Aberle et al. 1997). As such, Sgg/GSK3β is 
a negative regulator of both the Hh and Wg pathways, and thus could be the missing 
link to explain how Hyd regulates morphogen signaling. In addition to Hyd 
interacting with Armadillo (see Chapter 3), EDD interacts with the human 
homologue of Sgg, GSK3β, suggesting that Hyd also interacts with Sgg (Hay-Koren 
et al. 2011). 
 
On this basis, I propose a model in which Hyd negatively regulates both Hh and Wg 
pathway activity by interacting with Sgg (Figure 5.1). Loss of hyd up-regulates Ci155 
levels in posterior hydK7.19 clones, whereas Ci155 levels are reduced in anterior clones 
(see Chapter 4). This model would therefore only apply to posterior clones, and is 
based on the hypothesis that Hyd acts to positively regulate Sgg activity, potentially 
through non-degradative ubiquitylation. The addition of K63-linked poly-ubiquitin 
chains has previously been reported as a mechanism for kinase activation (reviewed 
in (Z. J. Chen & L. J. Sun 2009)). Conversely, in anterior hydK7.19 clones, Hyd would 
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normally be a negative regulator of Sgg, so that loss of Hyd increases Sgg activity, 
resulting in Ci155 to Ci75 processing. 
 
Figure 5.1: Hypothetical model for Hyd-mediated Hh and Wg pathway regulation through 
interaction with Sgg. Filled arrows and filled circles denote positive and negative regulation, 
respectively. 
 
The purpose of the work presented here is to determine whether Hyd can interact 
with and ubiquitylate Sgg, and whether this interaction affects Hh pathway activity. 
Binding and ubiquitylation assays in both Drosophila and human cell lines were used 
to investigate whether the interaction between the human proteins is conserved in 
Drosophila, to investigate whether Sgg/GSK3β is ubiquitylated, and what role 
Hyd/EDD plays in any potential Sgg/GSK3β ubiquitylation.  
 
To address whether the interaction has a functional consequence on Hh pathway 
activity, the MARCM technique (see Section 4.3.1) was used to either over-express 
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or knockdown Sgg in hydK7.19 clones. Since Sgg is not known to be involved in hh 
gene expression, the variation of Sgg levels is not expected to modify ectopic hh 
gene expression in hydK7.19 clones. However, Sgg may modify the hydK7.19 phenotype 
by affecting the levels of Ci155 in hydK7.19 clones. According to the model discussed 
above (Figure 5.1), only the over-expression of Sgg would be expected to rescue the 
phenotype, as this is expected to reduce ectopic Ci155 levels in posterior hydK7.19 
clones. In an attempt to increase the chances of rescue, a constitutively active SggS9A 
mutant was used as an over-expression construct in the MARCM analysis. 
Sgg/GSK3β is negatively regulated by a number of kinases, which phosphorylate 
Ser9 on its amino-terminus. The phosphorylated Ser9 residue then acts as a 
‘pseudosubstrate’, binding to the priming phosphate site and thereby blocking access 
of SGG/GSK3β substrates to the active site (see Chapter 1, Section 1.3.3.2). In the 
SggS9A mutant, Ser9 is mutated to Ala (Bourouis 2002), which would prevent 
phosphorylation and de-activation of Sgg/GSK3β through this mechanism. 
 
5.2 Hyd interacts with the protein kinase Sgg in vitro 
 
5.2.1 Hyd interacts with Sgg in S2 cells 
 
In order to investigate whether Hyd can physically interact with Sgg in vitro, I cloned 
a carboxy terminally FLAG/V5-tagged Sgg construct into the pMT Drosophila and 
pcDNA3.1 mammalian expression vectors. S2 cells were co-transfected with HSP-
Hyd and Sgg-FLAG constructs, and HSP-Hyd was pulled down using StrepTactin 
beads. A clean interaction was observed between WT Hyd and Sgg, compared to a 
Sgg only negative control. Interestingly, Sgg did not appear to interact with Hyd 
C>A, the catalytically inactive Hyd point mutant (Figure 5.2 A). The latter result is 
intriguing, and suggests that perhaps Hyd’s ubiquitylation activity is required for the 
interaction to take place. This could involve multiple possible scenarios, one of 
which would be that Hyd must first ubiquitylate Sgg before it can interact with Sgg 
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via its UBA domain binding the newly added ubiquitin moiety. Another possibility 
would be that the interaction between Hyd and Sgg is indirect, and requires the Hyd-
directed ubiquitylation of an intermediate binding partner to recruit Sgg to the 
complex. 
 
Initially, I wanted to validate that the interaction between Hyd WT and Sgg takes 
place in an independent experiment. This time, S2 cells were transfected with the 
Sgg-FLAG construct, and Sgg was immunoprecipitated using anti-FLAG agarose 
instead. Endogenous Hyd was co-immunoprecipitated with Sgg-FLAG, as detected 
using the anti-Hyd M19 antibody (Figure 5.2 B; lane 2), and the binding was clearly 
above a low level of background Hyd binding to anti-FLAG agarose (Figure 5.2 B; 
lane 1). This fully validates the interaction between Hyd and Sgg. Interestingly, the 
immunoprecipitated Sgg-FLAG protein appeared to be heavily modified, as was 
evident from very pronounced high molecular weight smearing (Figure 5.2 B; lane 
2). The chemical N-ethylmaleimide (NEM), a cysteine protease inhibitor, and thus 
inhibitor of de-ubiquitinating enzymes (DUBs), as well as a cocktail of phosphatase 
inhibitors, were added to the lysis buffer prior to immunoprecipitation. This would 
have resulted in the preservation of phosphorylation and ubiquitylation of Sgg-
FLAG, and could explain the high levels of post-translational modification observed. 
However, high molecular weight smearing is usually indicative of the addition of 
multiple ubiquitin or UBL chains, rather than the addition of a phosphate group. To 
address the possible ubiquitylation of Sgg by Hyd, I performed a series of 
ubiquitylation assays, and this will be discussed in the next section (see Section 5.3 
below). 
 
Next, I wanted to confirm whether the catalytically inactive Hyd C>A mutant was 
unable to bind Sgg. In addition to the Hyd C>A point mutant, I also included two 
other Hyd point mutants, harbouring key mutations in the PABC and UBA domains, 
respectively (these were already mentioned in Chapter 4; see Table 4.2).  
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The PABC mutant contains two point mutations: Y2509>A, and L2527>A. Based on 
structural data of the PABP protein PABC domain, which has very high homology to 
the Hyd PABC domain, this mutational combination is expected to completely 
abrogate binding to PAM2 (PABP-interacting motif 2)-containing proteins (Kozlov 
et al. 2004). As discussed in Chapter 1 (Section 1.4.1.2), the PABC domain is a 
highly conserved protein-protein interaction domain with a high affinity for proteins 
and peptides containing the 12-amino acid PAM2 motif, such as Paip1, Paip2, Erf3, 
and Tob2 (Kozlov et al. 2004). However, Sgg does not contain any PAM2 motifs, 
and so binding of Sgg to the PABC point mutant is not expected to be impaired.  
 
The UBA mutant contains a single point mutation, V166>K. Based on the structure 
of the EDD UBA domain, and the high homology between the EDD and Hyd UBA 
domains, this mutation should abrogate binding to both mono- and poly-ubiquitin 
chains (Kozlov et al. 2007). Consequently, a potentially ubiquitylated Sgg protein 
that interacts with Hyd via ubiquitin-UBA domain recognition should no longer be 
able to bind this mutant.  
 
The results from the Sgg binding assay with Hyd point mutants indicate that the 
interaction between Sgg and Hyd remains intact with all mutants (Figure 5.2 C; first 
panel). S2 cells were co-transfected with HSP-Hyd, HSP-Hyd point mutants, and 
Sgg-FLAG constructs, and Sgg was immunoprecipitated using anti-FLAG agarose. 
Although all Hyd proteins were co-immunoprecipitated with Sgg, the binding to the 
Hyd HECT and Hyd UBA point mutants was slightly stronger. However, looking at 
the Hyd potein levels in the input, it becomes evident that the transfection efficiency 
of the various Hyd constructs was extremely variable (Figure 5.2 C; third panel), 
partly explaining the difference in binding levels. The only exception in this case is 
that, although the Hyd C>A input level is lower than Hyd WT, the levels of Hyd 
C>A bound to Sgg are higher than Hyd WT. One possible explanation for this could 
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be that, assuming that Hyd ubiquitylates Sgg, the interaction between Sgg and Hyd is 
stronger prior to Sgg ubiquitylation, indicating a higher affinity of Hyd for non-
ubiquitylated Sgg. Once again, a ubiquitylation assay is necessary to test this 
hypothesis, and this will be discussed in Section 5.3 below. Importantly, this finding 
directly contradicts the previous result, which suggested that the Hyd C>A mutant is 
unable to bind Sgg (Figure 5.2 A). Although the binding assays were performed in 
completely different ways (i.e. StrepTactin pulldown versus anti-FLAG IP), this 
should theoretically not affect the end result. Unfortunately, I did not have sufficient 
time to confirm whether an interaction between Sgg and Hyd C>A takes place. In 
conclusion, the results presented in Figure 5.2 C suggest that the Sgg-Hyd 
interaction is not dependent on Hyd’s ubiquitylation activity, does not take place via 
UBA domain-ubiquitylated Sgg interaction, and, as expected, does not involve Sgg 
binding to the PABC domain in a PAM2-dependent manner.   
Hyd regulates morphogen signalling in the developing eye 
Chapter 5: Hyd regulates Hh signalling by interacting with Sgg   204 
 
Figure 5.2: Hyd interacts with Sgg in S2 cells. (A) StrepTactin pulldown in S2 cells. S2 cells were 
transfected with HA-Strep(HSP)-Hyd WT, HSP C>A catalytic inactive mutant, and Sgg FLAG 
constructs. (B) anti-FLAG immunoprecipitation in S2 cells. S2 cells were transfected with Sgg FLAG. 
Endogenous Hyd was co-immunoprecipitated with Sgg-FLAG, as detected using the the Hyd M19 
antibody (Santa Cruz). (C) anti-FLAG immunoprecipitation in S2 cells. S2 cells were transfected with 
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Sgg FLAG, and HSP-Hyd point mutants (PMs) containing mutations in the following domains: HECT 
(C>A), PABC (Y2509>A; L2527>A), and UBA (V166>K). 
 
5.2.2 Generation of Hyd deletion mutants to map the Sgg 
interaction surface on Hyd 
 
As the Hyd point mutants had proved somewhat uninformative in determining the 
nature of the Sgg-Hyd interaction, I also designed and cloned a series of Hyd 
deletion mutants (Figure 5.3 A). These were designed in a way that would allow me 
to map the approximate interaction surface for Sgg binding on Hyd relative to 
specific domains. To clone the individual Hyd deletion mutants, the original HSP-
WT Hyd construct was used as a template for PCR. Forward primers included a 
KOZAK sequence, to enhance protein expression levels, and reverse primers 
included a STOP codon to terminate protein expression prematurely in the case of all 
ΔC mutants lacking a carboxy terminal portion of the full-length Hyd protein. In 
addition all primers included appropriate restriction enzyme sites to allow cloning 
into both the pMT Drosophila expression vector, as well as the pGEX vector for 
expression of recombinant GST-tagged proteins in bacterial cells. This is an 
important design feature, as it is still unknown whether the interaction between SGG 
and Hyd is direct, or occurs indirectly via an intermediate protein in a multi-protein 
complex. 
 
Only three of the deletion mutants were successfully cloned (Many thanks to 
Katharina Krauskopf; Erasmus project student summer 2012), and their expected size 
was confirmed to be correct through an expression test in S2 cells, although 
expression levels were sub-optimal (Figure 5.3 B). Unfortunately, I did not have 
time to test the binding between Sgg and the Hyd deletion mutants. However, future 
experiments would address this by mapping the interaction surface through binding 
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assays in S2 cells, as well as using recombinant Hyd protein and deletion mutants to 
investigate whether the interaction between Sgg and Hyd is binary or not.  
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Figure 5.3: Generation of Hyd deletion mutants. (A) Schematic of all Hyd deletions mutants. 
Given names and amino acid coordinates are indicated to the left of each deletion mutant. (B) 
Expression of HSP-Hyd pMT deletion mutant constructs in S2 cells: HSP-ΔN1 Hyd, HSP-RCC + 
UBR Hyd, and HSP-ΔC2 Hyd. The expected molecular weight of each deletion mutant is indicated on 
the left. 
 
5.3 Sgg/GSK3β is ubiquitylated in Drosophila and 
human cells 
 
My results so far indicate that Hyd interacts with Shaggy, although it is unclear 
whether the interaction is direct or occurs indirectly through an intermediate binding 
partner. As Hyd is an E3 ubiquitin ligase, my next question was to address whether 
Hyd can also ubiquitylate Shaggy, and whether this affects steady-state levels of the 
Shaggy protein as a result of Hyd-mediated Shaggy degradation. 
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5.3.1 Hyd does not affect Sgg protein levels 
 
As discussed above in Section 5.2.1, SGG appears to be post-translationally modified 
(Figure 5.2 B). The nature of the high molecular weight smearing of Sgg suggested 
that the modification was likely to consist of mono- and poly- ubiquitin chains. If this 
is indeed correct, and if Hyd is the respective E3 ubiquitin ligase, one of the possible 
outcomes of Hyd-mediated Sgg ubiquitylation could be its degradation. Therefore, as 
an initial investigation, I monitored Sgg protein levels in the presence and absence of 
endogenous Hyd protein in Cl8+ cells. Treatment of Cl8+ cells with dsRNA 
targeting either EGFP (control) or Hyd did not affect SGG protein levels (Figure 
5.4).  
 
When the Hh pathway is activated by Hh ligand binding to the Ptc receptor, a 
sequence of intracellular signaling events leads to inhibition of Sgg. It is possible that 
Hh pathway activation results in removal, i.e. degradation, of Sgg to prevent Ci155 
phosphorylation. I therefore also tested whether Sgg protein levels are affected by 
dsRNA-mediated Hyd knockdown in the presence of Hh-N ligand. However, 
removal of Hyd had no effect on endogenous Sgg protein levels, regardless of 
whether the Hh pathway was on or off (Fig. 5.4). This suggests that, although Hyd 
may still be involved in ubiquitylating Sgg, Hyd does not appear to direct the 
degradation of Sgg.  
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Figure 5.4: Hyd knockdown has no effect on Sgg protein levels. Cl8+ cells were transfected with 
EGFP dsRNA (control) or Hyd 7950 dsRNA, and Hh-N ligand. Endogenous Hyd and Shaggy protein 
levels in cell lysates were monitored 48 hours post-transfection by probing with anti-M19 (Hyd) and 
anti-Sgg antibodies, respectively. Tubulin = loading control. 
 
5.3.1 Sgg is ubiquitylated in S2 cells 
 
To investigate the nature of the Sgg post-translational modification, and whether the 
high molecular weight modifications can, at least in part, be attributed to the addition 
of ubiquitin chains, I performed a ubiquitylation assay. To preserve protein 
ubiquitylation, this assay involves transfection of a His6-tagged ubiquitin construct, 
and denaturing cell lysis using a lysis buffer containing 6M Guanidinium 
hydrochloride. A pulldown of all cellular proteins that have been conjugated with 
His6-ubiquitin is then performed using Ni2+ agarose beads (see Chapter 2, Section 
2.4.5). Using an antibody specific for the protein of interest, the presence or absence 
of this protein (i.e. Sgg) in the pulldown fraction, and thus its ubiquitylation state, 
can then be determined. 
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To determine whether Sgg was ubiquitylated, HEK293 cells were co-transfected with 
Drosophila Sgg-FLAG and His6-ubiquitin constructs. In addition, two positive 
controls were included to ascertain that the assay was working correctly. One of the 
positive controls was Myb-FLAG, a Drosophila transcription factor that, when co-
transfected with His-ubiquitin, was previously found to be heavily ubiquitylated 
(personal observation). The other positive control was the catalytically inactive 
apoptotic effector caspase drICE-FLAG (C>A), which is ubiquitylated by co-
transfected E3 ubiquitin ligase DIAP1(Ditzel et al. 2008). The catalytically inactive 
caspase (drICE-FLAG C>A) was used in this case, as transfection of an active 
caspase would lead to apoptosis of cells. Both positive controls, Myb-FLAG and 
drICE-FLAG, were ubiquitylated (denoted by * and **, respectively, in Figure 5.5 
A; upper panel), indicating that the assay can successfully detect protein 
ubiquitylation. As a result, it was confirmed that over-expressed Sgg-FLAG is also 
heavily ubiquitylated in HEK293 cells (Figure 5.5 A; upper panel, lane 3). 
 
Sgg-FLAG was also co-transfected with HSP-Hyd WT or HSP-Hyd C>A, to 
determine whether over-expression of Hyd leads to an increase in Sgg-FLAG 
ubiquitylation. This would identify Sgg as a potential Hyd substrate. Unexpectedly, 
however, over-expression of Hyd WT drastically reduced Sgg-FLAG ubiquitylation 
(Figure 5.5 A; upper panel, lane 1, compared to lane 3), while over-expression of 
Hyd C>A resulted in a very slight reduction of Sgg-FLAG ubiquitylation (Figure 5.5 
A; upper panel, lane 2, compared to lane 3). The lack of Sgg-FLAG in the Ni2+ 
pulldown fraction in the presence of Hyd WT could be a result of Hyd-mediated 
ubiquitylation and subsequent degradation of Sgg. However, no significant changes 
in Sgg-FLAG protein levels as a result of Hyd WT expression were detected in the 
input (Figure 5.5 A; third panel, lane 1). Instead, WT Hyd expression levels were 
noticeably lower in the presence of Sgg-FLAG, compared to Hyd WT expressed on 
its own (Figure 5.5 A; lowest panel, lane 1, compared to lane 4). This raises the 
possibility that SGG could instead regulate Hyd protein stability, for example, 
through phosphorylation and in a similar mechanism to Sgg-mediated Ci155 
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regulation. Alternatively, Hyd could indirectly regulate SGG ubiquitylation by 
modulating the activity of another E3 ubiquitin ligase involved in Sgg ubiquitylation. 
 
Interestingly, the Ni2+ pulldown fraction was also probed with the anti-HA antibody, 
revealing that both HSP-Hyd WT and HSP-Hyd C>A are themselves ubiquitylated 
(Figure 5.5 A; second panel, lanes 1, 2 and 4). This could be a result of auto-
ubiquitylation, which has been previously reported to occur for HECT E3 ubiquitin 
ligases (Mouchantaf et al. 2006), and would presumably be mediated by endogenous 
Hyd following dimerisation with HSP-Hyd C>A. On the other hand, the 
ubiquitylation of Hyd could also be mediated by another E3 ubiquitin ligase.  
The experiment was repeated to address whether over-expression of Hyd WT 
reduces Sgg-FLAG ubiquitylation. Unfortunately, I was unable to reproduce this 
result, as, in this experiment, Sgg-FLAG ubiquitylation levels, although slightly 
reduced, were not significantly affected by over-expression of HSP-Hyd WT or 
HSP-Hyd C>A (Figure 5.5 B; upper panel, compare lanes 1, 2 and 3). Similarly, 
variable levels of Hyd WT in the input no longer appeared to be dependent on the 
presence or absence of Sgg (Figure 5.5 B; lower panel, compare lanes 1 and 4). 
 
Due to inconclusive results when overexpressing Hyd and assessing any changes in 
overexpressed Sgg ubiquitylation levels, I decided to also investigate the effect of 
Hyd knockdown on endogenous Sgg ubiquitylation. Based on the previous 
experiments, this would test the hypothesis that Hyd decreases Sgg ubiquitylation to 
potentially prevent its degradation. If this were the case, one would expect Sgg 
ubiquitylation to increase in the absence of Hyd. Over-expressed Sgg-FLAG was co-
transfected with His-ubiquitin into S2 cells as a positive control and directly 
compared with endogenous Sgg ubiquitylation. However, no ubiquitylation of 
endogenous Sgg could be detected in S2 cells (Figure 5.5 C). The Sgg-specific band 
detected in the pulldown fraction was present in the negative control lacking His-
ubiquitin, as well as in all the other samples, suggesting that endogenous Sgg was 
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simply bound to the Ni2+ resin non-specifically (Figure 5.5 A; upper panel, compare 
lane 1 to all others). Although endogenous Hyd was successfully knocked down, no 
endogenous Sgg ubiquitylation was detected under these circumstances either 
(Figure 5.5 A; upper panel, lane 4).  
 
The fact that no endogenous Sgg ubiquitylation could be detected raised the question 
of whether the ubiquitylation seen on Sgg-FLAG, although much weaker than in 
HEK293 cells, could be an artifact or cell-type specific. Unlike HEK293 cells, S2 
cells are incapable of transducing the Hh pathway, due to not expressing the 
transcriptional effector protein Ci. This could explain why Sgg ubiquitylation was 
much lower, or non-detectable in the case of endogenous SGG, in S2 cells. Although 
the Drosophila Cl8+ cell line is capable of transducing both the Hh and Wg 
pathways (see Chapter 4, Section 4.6), I have to date not been successful in carrying 
out large-scale transfections on these cells. The transfection efficiency, as assessed 
by transfection of a GFP construct into Cl8+ cells, and subsequent fluorescence 
microscopy, was 5-10 % at best, which is not sufficient to carry out a ubiquitylation 
assay. Due to the comparable ease of working with HEK293 cells, I therefore 
decided to shift to a mammalian setting to investigate whether the human Sgg 
orthologue, GSK3β, is also ubiquitylated, and the potential role of the mammalian 
Hyd orthologue, EDD, in this mechanism.    
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Figure 5.5: Sgg is ubiquitylated. HEK293 and S2 cells were subjected to denaturing lysis and a Ni2+ 
pulldown of all His-ubiquitin-conjugated proteins. (A) Sgg-FLAG ubiquitylation in HEK293 cells. 
HEK293 cells were transfected with varying combinations of His-ubiquitin, Sgg-FLAG, and HSP-
Hyd over-expression constructs. Positive controls were: *Myb-FLAG co-transfected with His-
ubiquitin (note no input samples shown); **FLAG-drICE C>A and nude DIAP1 co-transfected with 
His-ubiquitin. (B) Sgg-FLAG ubiquitylation in HEK293 cells. HEK293 cells were transfected with 
varying combinations of his-ubiquitin, Sgg-FLAG, and HSP-Hyd over-expression constructs. The 
positive control (*) was: FLAG-drICE C>A and nude DIAP1 co-transfected with His-ubiquitin. (C) 
Endogenous Sgg ubiquitylation in S2 cells. S2 cells were transfected with varying combinations of 
dsRNA (EGFP control or targeting Hyd), and His-ubiquitin and HSP-Hyd over-expression constructs. 
The positive control (lane 7) was: Sgg-FLAG co-transfected with His-ubiquitin. 
 
5.3.2 EDD negatively regulates GSK3β ubiquitylation in 293 
cells 
	  
Initially, to investigate whether GSK3β is also ubiquitylated, HEK293 cells were co-
transfected with HA-tagged GSK3β and His-ubiquitin constructs. As expected, 
GSK3β was also heavily ubiquitylated in HEK293 cells (Figure 5.6 A; upper panel, 
lane 3). Further to this, expression of HSP-EDD WT and HSP-EDD C>A resulted in 
a small reduction of GSK3β ubiquitylation levels (Figure 5.6 A; lanes 1 & 2, 
compared to lane 3). This result is in agreement with a similar reduction of Sgg-
FLAG ubiquitylation seen in HEK293 cells in the presence of HSP-Hyd (Figure 5.5 
A & B). Interestingly, HSP-EDD C>A was also found to be ubiquitylated (Figure 
5.6 A; upper panel, red arrow, lane 2), which, as discussed above, could indicate 
auto-ubiquitylation by endogenous Hyd/EDD, or ubiquitylation by another E3 
ubiquitin ligase. 
 
Next, I tested whether endogenous GSK3β is ubiquitylated in HEK293 cells, and 
whether the presence or absence of EDD can alter the ubiquitylation state of GSK3β. 
HEK293 cells were transfected with varying combinations of His-ubiquitin, control 
or EDD siRNA, or HSP-EDD constructs. Indeed, endogenous GSK3β was 
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ubiquitylated compared to a negative control lacking His-ubiquitin, although 
endogenous GSK3β ubiquitylation levels were markedly reduced compared to over-
expressed HA-GSK3β ubiquitylation levels (Figure 5.6 B; upper panel, compare 
lanes 1, 2, and 9). Importantly, siRNA-mediated knockdown of endogenous EDD 
resulted in a significant increase of endogenous GSK3β ubiquitylation levels (Figure 
5.6 B; upper and lower panels, lane 4), although this had no effect on steady-state 
levels of GSK3β in the input (Figure 5.6 B; middle panel, lane 4). Over-expression 
of EDD did not appear to have any significant effects on endogenous GSK3β 
ubiquitylation (Figure 5.6 B; upper panel, lanes 5-8). Contrary to what one would 
expect, in this case removal of an E3 ubiquitin ligase increases ubiquitylation, 
suggesting that EDD does not promote GSK3β high molecular weight ubiquitylaion. 
Instead, this result suggests that perhaps EDD is involved in regulating the addition 
of ubiquitin onto, or promoting its removal from, GSK3β. In the former scenario 
EDD may be involved in suppressing the activity of an additional E3 involved in 
GSK3β regulation, while EDD-mediated recruitment of a deubiquitylase could 
explain the latter. In addition, the fact that EDD does not appear to affect steady-state 
levels of GSK3β suggests that the nature of the GSK3β ubiquitylation affected by 
EDD is more likely to play a role in GSK3β’s activity, rather than its degradation. 
 
As the experiment was performed only once, it was repeated in order to confirm the 
effect of EDD knockdown on endogenous GSK3β ubiquitylation levels. However, 
although removal of EDD resulted in a slight increase of GSK3β ubiquitylation 
(Figure 5.6 C; upper panel, lane 4), I was not able to reproduce the same level of 
GSK3β ubiquitylation increase over baseline levels seen in the previous experiment. 
Therefore, although this is a very interesting result that could provide insight into the 
mechanism by which Hyd/EDD could regulate SGG/GSK3β activity, the results do 
not conclusively support a role for EDD in altering the GSK3β ubiquitylation state. 
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In conclusion, the results presented here show that both Sgg and GSK3β are 
ubiquitylated. They also suggest that Hyd does not affect Sgg protein expression 
levels, and that Hyd/EDD is not likely to be directly involved in ubiquitylating 
SGG/GSK3β. However, Hyd/EDD may be involved in indirectly regulating protein 
ubiquitylation, and thus perhaps the activity, of SGG/GSK3β indirectly through 
interaction with another E3 ubiquitin ligase or DUB. 
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Figure 5.6: Effect of EDD over-expression or knockdown on GSK3β ubiquitylation. HEK293 
cells were subjected to denaturing lysis and a Ni2+ pulldown of all His-ubiquitin-conjugated proteins. 
(A) HA-GSK3β ubiquitylation in HEK293 cells. HEK293 cells were transfected with varying 
combinations of His-ubiquitin, HSP-EDD, and HA GSK3β over-expression constructs. (B) 
Endogenous GSK3β ubiquitylation in HEK293 cells. HEK293 cells were transfected with varying 
combinations of siRNA (scrambled, and targeting EDD or EDD 3’UTR), and His-ubiquitin, HSP-
EDD, or HA GSK3β over-expression constructs. Asterisk (*) on lane 2 indicates a loading problem 
with the input samples for that lane, which were accidentally lost during loading, thus explaining 
lower levels of endogenous GSK3β and EDD input in this sample. Please note: this does not affect the 
pulldown sample. (C) Endogenous GSK3β ubiquitylation in HEK293 cells. HEK293 cells were 
transfected with varying combinations of siRNA (scrambled, and targeting EDD or EDD 3’UTR).  
 
5.4 Variation in Sgg levels and activity in vivo 
rescues the adult hydK7.19 phenotype 
 
The results presented so far have focused on the use of biochemistry, in the form of 
binding and ubiquitylation assays, to attempt to gain insight into the potential 
mechanism of Hyd-mediated Sgg regulation. These results indicate that an 
interaction between Hyd and Sgg takes place, and that Hyd is likely to play a role in 
Sgg regulation, possibly through modifying Sgg ubiquitylation. However, it is not 
known what the functional consequence of this interaction is in vivo. Therefore, I 
decided to address this by using the MARCM system to query whether Sgg can 
modify the hydK7.19 phenotype in the eye, which has already been extensively 
described in Chapter 4.  
 
As described in Section 4.3.1, MARCM is a genetic technique that allows the tissue-
specific generation of hydK7.19 clones, which can also over-express any GAL4-
regulated transgene. These transgenes can include over-expression constructs, as well 
as sequences encoding shRNAs that target specific mRNAs for degradation. To 
assess whether Sgg can modify the hydK7.19 phenotype in the eye, I chose two sgg 
transgenes to co-express in hydK7.19 clones: UAS-sggS9A and UAS-sggRNAi. The UAS-
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sggS9A transgene expresses a constitutively active Sgg kinase, which can no longer be 
inactivated by phosphorylation due to the mutation of Ser9 to Ala (Bourouis 2002). 
The second transgene, UAS-sggRNAi, encodes an inverted repeat, which specifically 
targets sgg mRNA for degradation and thus results in knockdown of endogenous Sgg 
protein levels in hydK7.19 clones. According to the hypothesis discussed in the 
introduction to this chapter (see Figure 5.1), Hyd could negatively regulate Hh 
and/or Wg pathway activity by enhancing Sgg activity. Therefore, loss of Hyd would 
reduce Sgg activity, and over-expression of a constitutively active Sgg kinase would 
be expected to rescue the phenotype. Similarly, RNAi-mediated knockdown of sgg in 
hydK7.19 clones would be expected to have the opposite effect, failing to rescue the 
phenotype, or possibly even exacerbating it.  
 
5.4.1 Effect of Sgg protein levels and activity on the adult eye 
phenotype 
 
MARCM was used to generate hydK7.19 clones in eye-antennal discs, which were 
either over-expressing SggS9A, or were deficient in endogenous Sgg protein. The 
adult flies were then assessed for both eye and head phenotypes. To control for any 
Hyd-independent effects of Sgg over-expression and knockdown, clones solely 
expressing SggS9A or sggRNAi only were also generated. As would be expected 
according to the hypothesis that Hyd positively regulates Sgg activity, over-
expression of SggS9A in hydK7.19 clones can rescue the hydK7.19 eye phenotype (Figure 
5.7 A; panel c). Intriguingly, however, knockdown of endogenous Sgg protein in 
hydK7.19 clones also rescues the phenotype (Figure 5.7 A; panel e). In both cases, a 
complete rescue occurred in 50% of all adult flies analysed (n=10), in which eyes 
resembled those of control animals. Further to this, by analyzing adult eyes of over-
expression-only controls, it was confirmed that neither over-expression of SggS9A or 
sggRNAi alone, in otherwise wild-type clones, had any visible effects on adult eyes 
(Figure 5.7 A; panels d and f). These results suggest a strong and complex genetic 
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interaction between sgg and hyd. In addition, epistatically, Sgg function lies 
downstream of, or in a parallel pathway to, Hyd.  
 
As mentioned before, the hydK7.19 phenotype varies in severity from individual to 
individual (see Chapter 4). To quantify the extent of rescue seen in adult eyes, the 
incidence of scars, being a major feature in the hydK7.19 mutant phenotype, was noted 
in all examined flies (n=10 per genotype) (Figure 5.7 B). These results confirmed 
the results of the visual analysis outlined above. The average number of scars in 
hydK7.19 animals was 2.3, with the total number of scars per eye ranging from one in 
mild cases to five in the most severe cases (Figure 5.7 B; b). Rescued hydK7.19 
animals had an average number of 0.7 scars, if expressing UAS-sggS9A (p = 0.005), 
and 1.1 scars, if expressing UAS-sggRNAi (p = 0.05). For both genotypes, the 
maximum number of scars never exceeded three (Figure 5.7 B; c and d). No scars 
were observed in any of the control flies, with the exception of a single UAS-sggRNAi-
expressing fly, which had one scar (Figure 5.7 B; f). 
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Figure 5.7: Modification of Sgg levels and activity recues the adult hydmt eye phenotype. (A) Side 
view of compound eyes containing the following genotypes of clones: a - FRT82B (control), b - 
FRT82B hydK7.19, c – UAS-sggS9A; FRT82B hydK7.19, d - UAS-sggS9A; FRT82B, e - UAS-sggRNAi; 
FRT82B hydK7.19, f - UAS-sggRNAi; FRT82B. Scale bars are 250µm. (B) Incidence of scars in adult 
eyes. Scars were counted in adult eyes containing clones with genotypes a-f (detailed above). Black 
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squares indicate average number of scars; lines indicate range, starting from minimum number, and 
ending at maximum number of scars. n=10 (per genotype). *t-test genotype b versus c, p = 0.005; *t-
test genotype b versus e, p = 0.05. 
 
5.4.2 Effect of Sgg protein levels and activity on the hydK7.19 
head phenotype 
 
As discussed in Chapter 4, the presence of hydK7.19 clones in EA discs not only results 
in scarring of the compound eye, but also causes a significant increase in the amount 
of non-eye head tissue in adults (Section 4.3.2). It was argued that this is more 
closely linked to effects on Wg pathway activity, whereas the compound eye 
phenotype is more likely to be dependent on Hh pathway activity (see Chapter 1, 
Sections 1.2.5 and 1.3.4). Because Sgg is a key regulator of both pathways, the 
expression of SggS9A in hydK7.19 clones was also expected to affect head size. Indeed, 
expression of both UAS-sggS9A and UAS-sggRNAi transgenes in hydK7.19 clones 
reduced the amount of non-eye head tissue (Figure 5.8 A; panels c and e), although 
the effects were not found to be significant when quantified (Figure 5.8 B; t-test b 
versus c, p = 0.1; t-test b versus e, p = 0.15). This suggests that the functional 
consequence of the Hyd-Sgg interaction is likely to affect both Hh (eye effects) and 
Wg (head capsule effects) pathway activity. The results were quantified by 
measuring the eye-to-eye distance of non-eye head tissue at a fixed point (Figure 5.8 
B). Interestingly, this suggests that SggS9A clones significantly reduce the amount of 
non-eye head tissue compared to control animals containing wild-type clones (p = 
0.03) (Figure 5.8 B; compare d and a). From a molecular point of view, over-
expression of Sgg would suppress Wg pathway activity and thus the growth and 
development of head tissue, which could explain this result. 
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Figure 5.8: Modification of Sgg levels and activity recues the adult hydmt head phenotype. (A) 
Front view of adult heads containing the following genotypes of clones: a - FRT82B (control), b - 
FRT82B hydK7.19, c – UAS-sggS9A; FRT82B hydK7.19, d - UAS-sggS9A; FRT82B, e - UAS-sggRNAi; 
FRT82B hydK7.19, f - UAS-ssggRNAi; FRT82B. Scale bars are 250µm. (B) Head measurements (µm) 
were taken from eye-to-eye at a fixed point just above the antennae, and were significantly wider in 
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FRT82B hydK7.19 animals (**p = 0.004; t-test), and significantly lower in UAS-sggS9A; FRT82B 
animals (*p = 0.03; t-test) compared to FRT82B control animals. Genotypes are indicated a-f, and 
were as described in (A). n=10 (per genotype).  
 
5.4.3 Effect of Sgg protein levels and activity on survival of 
GFP clones to adulthood 
 
In Chapter 4, I showed that, although there was no obvious difference in the number 
of hydK7.19 clones versus control clones in age-matched third instar discs, the hydK7.19 
clones present in the EA discs did not persist to adulthood in most cases (Section 
4.3.4, Figure 4.5 B and Figure 5.9 panels b1 and b2). This has been reported 
previously for hydK3.5 clones (J. D. Lee et al. 2002). hydK3.5 clones generated in a 
Minute genetic background, a mutation that confers a growth disadvantage (Morata 
& Ripoll 1975), are not eliminated and survive to adulthood, forming compound eyes 
that are drastically reduced in size, but nonetheless have correctly formed hydK7.19 
ommatidia (J. D. Lee et al. 2002). This suggests that hydK7.19 clones may have a 
growth disadvantage (i.e. reduced fitness) and, as a result, are eliminated by the 
surrounding non-clonal tissue through cell competition.  
To assess whether over-expression or knockdown of Sgg in hydK7.19 clones affects or 
rescues their reduced fitness, adult heads and eyes containing GFP positive clones of 
the respective genotypes were imaged using a fluorescence microscope (Figure 5.9). 
Although over-expression of UAS-sggS9A in hydK7.19 clones rescues the adult eye 
phenotype as judged by the obvious reduction in scarring and head size (Figures 5.7 
and 5.8), UAS-sggS9A; FRT hydK7.19 clones were completely absent from the adult 
head (Figure 5.9; panel c). This suggests that over-expression of UAS-sggS9A in 
addition to loss of hyd reduces the fitness of clones even further than in hydK7.19 
clones alone. Importantly, the fitness of UAS-sggS9A–only clones was not 
significantly affected as they were readily detected in adult heads (Figure 5.9; panel 
d). On the other hand, UAS-sggRNAi; FRT hydK7.19 clones survived to adulthood 
(Figure 5.9; panel e), and this also resulted in rescue of the scarring and increased 
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head size seen in animals containing hydK7.19 clones (Figures 5.7 and 5.8). Similarly, 
UAS-sggRNAi clones were also present in adult eyes (Figure 5.9; panel f). Taken 
together, these results suggest that the knockdown of endogenous Sgg in hydK7.19 
clones reverses the reduced fitness of hydK7.19 clones compared to the surrounding 
wild type cells, and that therefore a functional interaction takes place between hyd 
and sgg.  
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Figure 5.9: Effect of Sgg on clone survival. Front view of adult heads showing eyes containing 
GFP-positive clones with the following genotypes of clones: a - FRT82B (control), b1 and b2 - 
FRT82B hydK7.19, c – UAS-sggS9A; FRT82B hydK7.19, d - UAS-sggS9A; FRT82B, e - UAS-sggRNAi; 
FRT82B hydK7.19, f - UAS-sggRNAi; FRT82B. Scale bars are 500µm. n = 4; representative image taken 
for each genotype. 
 
5.5 Effect of Sgg levels and activity on morphogen 
expression in third instar EA discs 
 
The expression of both UAS-sggS9A and UAS-sggRNAi in hydK7.19 clones in EA discs 
ultimately leads to the rescue of the adult eye and head phenotypes. However, the 
molecular mechanism by which this rescue occurs is unknown. However, we do 
know that a major feature of the hydK7.19 phenotype is the ectopic expression of the 
morphogens Hh and Wg due to the presence of hydK7.19 clones in third instar EA 
discs (see Chapter 4, Section 4.4). Since both of these morphogens play crucial 
roles in directing the growth and differentiation of head and eye tissue, I investigated 
the effect of Sgg over-expression or knockdown in hydK7.19 clones on ectopic 
morphogen expression. 
 
5.5.1 Sgg and hh gene expression 
 
Although Sgg is known to be involved in regulating Hh pathway activity (J. Jia et al. 
2002), a potential involvement in regulating hh ligand expression has not been 
reported. Therefore, the expression of the constitutively active Sgg kinase, or 
knockdown of sgg, in clones was not expected to affect the ectopic expression of hh 
by hydK7.19 clones. Surprisingly, however, both over-expression and knockdown of 
sgg appeared to affect hh gene expression levels in L3 EA discs. 
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Posterior hydK7.19; hh-lacZ clones express high levels of hhlacZ compared to control 
clones, and some anterior mutant clones also ectopically express hhlacZ (see Section 
4.4 and Figure 5.10 A). 40% of discs containing UAS-sggS9A; hydK7.19 hhlacZ clones 
displayed lower levels of hhlacZ expression compared to discs containing hydK7.19 
hhlacZ clones (Figure 5.10). Quantitative analysis, in which the intensity of B-gal 
staining was measured in groups of GFP-positive clones and compared across 
genotypes, confirmed that the maximum level of hhlacZ expression in UAS-sggS9A; 
hydK7.19 hhlacZ clones, although still high in some cases, was generally lower than in 
hydK7.19 hhlacZ clones (Figure 5.10). The wide range of hhlacZ expression levels 
observed indicates some variability in the phenotype, as well as variability in the 
extent of the rescue of ectopic hhlacZ expression. Further to this, over-expression of 
UAS-SggS9A alone can also lead to increased levels of hhlacZ expression (Figure 
5.10 A). Again, quantitative analysis revealed that, on average, UAS-sggS9A; FRT 
hhlacZ clones expressed higher levels of hhlacZ compared to FRT hhlacZ control 
clones (Figure 5.10). 
 
Interestingly, knockdown of sgg in UAS-sggRNAi; hydK7.19 hhlacZ clones also rescues 
ectopic hhlacZ expression in posterior clones in about 50% of cases (Figure 5.10). 
However, anterior UAS-sggRNAi; hydK7.19 hhlacZ clones express high levels of ectopic 
hh, and this phenomenon is generally more frequent and widespread than in discs 
containing hydK7.19 hhlacZ clones (Figure 5.10). Finally, UAS-sggRNAi; FRT hhlacZ 
clones alone express lower levels of hhlacZ in posterior regions, which in some cases 
drop below the levels seen in control discs (Figure 5.10). However, the notable 
ectopic hhlacZ expression in anterior clones remains in UAS-sggRNAi; FRT hhlacZ 
clones, even though these carry no mutation in the hyd gene (Figure 5.10). 
 
Contrary to what was expected, these results suggest that Sgg is involved in the 
regulation of hh gene expression. The expression of a constitutively active Sgg 
kinase leads to increased hhlacZ expression in posterior regions, whereas knockdown 
Hyd regulates morphogen signalling in the developing eye 
Chapter 5: Hyd regulates Hh signalling by interacting with Sgg   229 
of Sgg leads to ectopic hhlacZ expression in anterior regions of the disc. This 
suggests that Sgg has opposite effects on hh gene expression depending on the spatial 
localization of a cell within the disc. It therefore appears that Sgg positively regulates 
hh expression in posterior cells, but negatively regulates hh expression in anterior 
clones. This notion is supported by the fact that (i) the expression of SggS9A in 
hydK7.19 clones rescues hhlacZ expression in anterior clones, and that (ii) knockdown 
of sgg in hydK7.19 clones results in a partial to full rescue of abnormal hhlacZ 
expression in posterior cells, but not in anterior cells. However, if Sgg is a positive 
regulator of hh expression, it is not clear why over-expression of SggS9A in hydK7.19 
clones can sometimes also rescue high hhlacZ levels in posterior cells. This could 
possibly reflect a variation in the hyd phenotype itself. 
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Figure 5.10: Effect of Sgg on hhlacZ expression L3 EA discs. Anterior is to the left, posterior is to 
the right, dorsal is up, and ventral is down in all subsequent immunofluorescence (IF) images. (A) IF 
of L3 EA discs containing GFP clones (green), stained for hhlacZ (blue). White arrows indicate 
ectopic hhlacZ expression in anterior clones. The morphogenetic furrow (MF) is marked by white 
triangles in all merged images. Scale bars are 250 µm. (B) Measurements of maximum pixel 
intensities in single ROIs containing groups of posterior GFP-positive clones in L3 EA discs. T-test 
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was performed on genotypes in brackets. n = 8. (C) Measurements of maximum pixel intensities in 
single ROIs containing groups of anterior GFP-positive clones in L3 EA discs. T-test was performed 
on genotypes in brackets. n = 8. 
 
5.5.2 Sgg and Hh morphogen expression 
 
Next, I used an antibody specific for Hh-N (Gallet et al. 2003), the Hh protein ligand 
that is secreted by hh expressing cells, to determine whether, as would be expected, 
Sgg has the same effects on Hh protein expression levels. Although one would 
expect this to reproduce the hhlacZ data, it is important to note that the Hh protein, 
unlike the hhlacZ-derived β-gal protein, can diffuse across the disc and bind to 
neighbouring cells displaying its receptor Ptc. Therefore, increased levels of Hh 
staining could be indicative of both high levels of Hh expression, as well as high 
levels of Ptc and Hh pathway activity. 
 
All genotypes displayed elevated expression patterns of Hh staining compared to 
control discs (Figure 5.11). In addition to a higher level of all over Hh staining, these 
discs also had regions of localized high intensity Hh staining in clones (Figure 5.11). 
A notable exception to this trend, were discs containing UAS-sggS9A clones, which 
had levels of Hh protein comparable to levels in control discs (Figure 5.11). This 
was unexpected, because UAS-sggS9A clones were found to express increased levels 
of hhlacZ in posterior cells (Section 5.5.1). One possible explanation for this could 
be that over-expression of SggS9A in these discs leads to down-regulation of the Hh 
pathway and decreased expression of ptc, which is then no longer displayed on the 
cell surface. Any secreted Hh protein therefore has no target to bind to and may 
subsequently be degraded, potentially explaining the low levels of Hh staining 
observed in these discs. 
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Overall, these results indicate that the increased Hh staining seen in the remaining 
discs is most probably a result of the mis-regulation of both hh gene expression and 
Hh pathway activity. 
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Figure 5.11: Effect of Sgg on Hh expression in L3 EA discs. (A) IF of L3 EA discs containing GFP 
clones (green), stained for Hh-N (red). Arrows indicate ectopic Hh expression in and around clones. 
The morphogenetic furrow (MF) is marked by white triangles in all merged images. Scale bars are 
250 µm. (B) Measurements of average maximum pixel intensities in L3 EA discs. T-test was 
performed on genotypes in brackets. n = 7. 
5.5.3 Sgg and Wg morphogen expression 
 
Finally, I also investigated whether over-expression of SggS9A could affect the high 
autonomous and non-autonomous Wg levels previously seen in discs containing 
hydK7.19 clones (Section 4.4 and Figure 5.12). However, expression of SggS9A in 
hydK7.19 clones did not appear to alter the elevated Wg expression levels seen in discs 
containing hydK7.19 clones alone (Figure 5.12). This was further supported by 
quantitative analysis of the pixel intensity, which also suggested that expression of 
SggS9A fails to rescue ectopic Wg expression in discs containing hydK7.19 clones 
(Figure 5.12). Further to this, no significant change in Wg protein levels was 
detected in discs containing UAS-sggS9A clones (Figure 5.12). This suggests that, 
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although previous results implicate Sgg in the regulation of Hh expression, Sgg does 
not appear to be involved in the regulation of Wg expression. 
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Figure 5.12: Effect of Sgg on Wg expression in L3 EA discs. (A) IF of L3 EA discs containing GFP 
clones (green), stained for Wg (red). White arrows indicate ectopic Wg expression in and around 
clones. The morphogenetic furrow (MF) is marked by white triangles in all merged images. Scale bars 
are 250 µm. (B) Measurements of average maximum pixel intensities in L3 EA discs. T-test was 
performed on genotypes in brackets. n = 4. 
5.6 Effect of Sgg levels and activity on Hh pathway 
activity 
 
As discussed in Chapter 4, loss of Hyd results in de-regulation of Hh pathway 
activity in third instar EA discs, which manifests as ectopic Ci155 and Ptc expression 
in hydK7.19 clones. Sgg is a key regulator of Ci155 activity, directing the processing of 
the active Ci155 protein to the Ci75 repressor protein. The results presented here so far 
clearly indicate that both a physical and functional interaction takes place between 
Hyd and Sgg. It is therefore likely that the rescue of the hydK7.19 phenotype by 
modifying Sgg levels and/or activity is, at least in part, a result of a direct effect on 
Ci155 protein levels. I therefore assessed the effects of Sgg over-expression and sgg 
knockdown on Ci155 and Ptc expression in hydK7.19 clones.   
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Loss of hyd results in elevated Ci155 expression levels in posterior clones, whereas 
anterior clones have reduced Ci155 expression levels (Figure 5.13 A, yellow and 
white arrows, respectively). Over-expression of sggS9A in hydK7.19 clones rescued the 
phenotype in 30-40% of cases. In a rescued disc, the characteristic D-V stripe of 
Ci155 staining was no longer disrupted or irregular, and the incidence of ectopic Ci155 
expression was greatly reduced (Data not shown). However, in the majority of discs 
(~60%) containing UAS-sggS9A; FRT hydK7.19 clones, Ci155 expression was not 
rescued or only partially rescued. More specifically, these discs still had disrupted 
and/or an irregular D-V stripe pattern of Ci155 staining, as well as some anterior and 
posterior clones ectopically expressing low or high levels of Ci155, respectively 
(Figure 5.13 A, white and yellow arrows, respectively). On the other hand, over-
expression of SggS9A in wild-type clones has no significant effect on the normal Ci155 
staining pattern, apart from low Ci155 expression levels in some anterior clones 
(Figure 5.13 A, white arrow). 
 
My previous results suggested Sgg to be a positive regulator of hh gene expression, 
as over-expression of SggS9A resulted in high hhlacZ expression levels in posterior 
regions of the eye disc. This is a common feature with the hydK7.19 phenotype, in 
which posterior hydK7.19 clones also express high levels of hhlacZ (Section 5.5). I 
therefore wondered whether there could be a correlation between ectopic hh 
expression and Ci155 levels in clones. Indeed, double staining for β-gal and Ci155 
revealed that high Ci155 levels in posterior hydK7.19 clones frequently correlated with 
high hhlacZ expression levels in the same clones (Figure 5.13 B, white arrow).  
 
This could indicate that high levels of Ci155 in posterior hydK7.19 clones are a direct 
result of ectopic hh expression in the same cells, suggesting that the Hh pathway is 
activated autonomously. Conversely, in UAS-sggS9A; hydK7.19 clones high hhlacZ 
expression in posterior clones does not generally correlate with Ci155 levels. 
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Although, in some cases, high hh expression in posterior clones correlates with low 
levels of Ci155 levels (Figure 5.13 B, white arrow). This negative correlation between 
hhlacZ and Ci155 levels is the opposite trend to the positive correlation seen in 
hydK7.19 clones. This suggests that over-expression of SggS9A reverses the high levels 
of Ci155, resulting from induction of the Hh pathway by ectopic Hh ligand 
production, through conversion of the Ci155 activator protein to the Ci75 repressor 
protein, which is not detectable with the Ci antibody that was used. In other words, 
the rescue of the hydK7.19 phenotype by over-expression of SggS9A could be, in part, 
due to increased processing, and thus reduced levels of Ci155 in posterior regions of 
the disc. 
 
However, as mentioned above, only a small proportion (~30%) of discs containing 
UAS-sggS9A; hydK7.19 clones display a rescue of ectopic Ci155 expression in posterior 
clones. In the majority of cases, posterior UAS-sggS9A; hydK7.19 clones still express 
high levels of Ci155, with no significant differences detectable when compared to 
hydK7.19 clones (Figure 5.14, yellow arrows). However, the incidence of low Ci155 
expression, seen in anterior hydK7.19 clones, is significantly reduced in anterior UAS-
sggS9A; hydK7.19 clones (Figure 5.14, white arrow). In addition, double staining for 
Ci155 and Ptc confirmed that high or low levels of Ci155 co-localised with high or low 
Ptc protein levels, respectively. This suggests that the Hh pathway was ectopically 
activated in posterior UAS-sggS9A; hydK7.19 clones and hydK7.19 clones, and down-
regulated in anterior hydK7.19 clones. 
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Figure 5.13: Effect of Sgg on Ci155 and hhlacZ expression L3 EA discs. The morphogenetic furrow 
(MF) is marked by white triangles in all merged images. Scale bars are 250 µm. (A) IF of L3 EA discs 
containing GFP clones (green), stained for Ci155 (red). Arrows indicate ectopic Ci155 expression in 
anterior (white) and posterior (yellow) clones. (B) IF of L3 EA discs containing GFP clones (green), 
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stained for Ci155 (red) and hhlacZ (blue). White arrows indicate clones in which Ci155 and hhlacZ 
expression are correlated.  
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Figure 5.14: Effect of Sgg on Ptc and Ci155 expression L3 EA discs. IF of L3 EA discs containing 
GFP clones (green), stained for Ptc (blue) and Ci155 (red). Arrows indicate anterior (white) and 
posterior (yellow) clones in which ectopic Ci155 and Ptc expression are correlated. The morphogenetic 
furrow (MF) is marked by white triangles in all merged images. Scale bars are 250 µm. 
 
5.6.1 Effect of Sgg knockdown on Hh pathway activity 
 
The RNAi-mediated knockdown of endogenous sgg in hydK7.19 clones had a much 
more pronounced and consistent effect on the ectopic Ci155 expression profile in 
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hydK7.19 clones than over-expression of SggS9A. In the vast majority of discs 
examined, anterior UAS-sggRNAi; hydK7.19 clones no longer expressed low levels of 
Ci155, but instead markedly over-expressed Ci155 (Figure 5.13 A, white arrows). On 
the other hand, the behaviour of posterior clones remained unchanged. Both posterior 
hydK7.19 and UAS-sggRNAi; hydK7.19 clones over-expressed Ci155 (Figure 5.13 A, 
yellow arrows). Interestingly, UAS-sggRNAi clones exhibited the same ectopic Ci155 
expression pattern, with both anterior and posterior clones expressing high levels of 
Ci155 (Figure 5.13 A, white and yellow arrows, respectively). 
 
Further to this, in both anterior UAS-sggRNAi; hydK7.19 and UAS-sggRNAi clones, high 
levels of Ci155 expression were positively correlated with high levels of ectopic 
hhlacZ expression (Figure 5.13 B, white arrows). As discussed in the previous 
section, Sgg appears to be a negative regulator of hh expression in anterior regions of 
the eye disc (Section 5.5). This suggests that the high Ci155 levels seen in anterior 
clones expressing RNAi against sgg could be a result of increased autonomous Hh 
pathway activation as a result of increased hh expression in the absence of Sgg. On 
the other hand, no correlation between high Ci155 expression and hhlacZ expression 
was detected in posterior clones, suggesting that increased Ci155 levels in these clones 
were not related to Hh ligand expression. Instead, it is more likely that the absence of 
Sgg in these cells prevents the conversion of Ci155 to Ci75 in these clones, resulting in 
an accumulation of Ci155. 
 
Finally, in both anterior- and posterior UAS-sggRNAi; hydK7.19 and -UAS-sggRNAi 
clones increased Ci155 levels were positively correlated with high Ptc levels (Figure 
5.14, white and yellow arrows, respectively). This suggests that, regardless of the 
underlying cause of Ci155 accumulation in anterior and posterior clones, the 
downstream effect is the increased activation of the Hh pathway in both cases. 
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In an effort to elucidate the mechanism by which Hyd negatively regulates Hh 
pathway activity, I applied both in vitro and in vivo methods to establish whether Sgg 
interacts with Hyd, and what the molecular and functional consequences of this 
interaction are. 
 
Hyd interacts with Sgg in S2 cells, which suggests that the interaction is conserved 
between Drosophila and humans. The interaction between the human orthologue of 
Hyd, EDD, and GSK3β in HEK293 cells has been reported previously (Hay-­‐Koren	  
et	  al.	  2011). This is encouraging, as it increases the likelihood of conservation of a 
possible Hyd/EDD-mediated regulation mechanism of Hh/SHH pathway activity 
involving Sgg/GSK3β in mammalian cells. De-regulation of SHH pathway activity 
occurs in a wide range of human tumours (reviewed in (L.	  L.	  Rubin	  &	  de	  Sauvage	  
2006)), and this result strengthens the notion that EDD would be a good therapeutic 
target. The interaction between EDD and GSK3β is binary (Hay-­‐Koren	  et	  al.	  2011), 
and although I did not confirm that this is the case in Drosophila cells also, I tried to 
map the interaction surface for Sgg on Hyd. This revealed that Sgg binding does not 
occur via the recognition of ubiquitin or a PAM2 motif by the UBA and PABC 
domains, respectively. Nor does the interaction require the catalytic cysteine residue 
in the HECT domain of Hyd to be present, suggesting that the binding does not occur 
through this residue. It also suggests that Hyd’s ubiquitylation activity is not 
required. However, S2 cells express endogenous Hyd, which could ubiquitylate Sgg 
prior to exogenous Hyd C>A binding. This could explain the contradictory results I 
obtained with Sgg binding to the Hyd C>A mutant. In future, the binding assay 
should be carried out using recombinant proteins to determine whether the 
interaction is direct in Drosophila, and whether the Hyd C>A mutant can bind Sgg in 
the absence of endogenous Hyd. 
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Both Sgg and GSK3β were found to be ubiquitylated, but my results do not support 
the hypothesis that Hyd/EDD is the E3 ubiquitin ligase responsible for Sgg/GSK3β 
ubiquitylation. Although Sgg ubiquitylation has not been reported before, GSK3β is 
ubiquitylated and subsequently degraded by the HECT E3 ubiquitin ligase Smurf2 in 
mouse chondrocytes, leading to increased Wnt signalling (Q.	  Wu	  et	  al.	  2009). In S2 
cells, Hyd did not affect Sgg ubiquitylation or Sgg levels, suggesting that Hyd does 
not ubiquitylate or degrade Sgg. However, loss of EDD in HEK293 cells increased 
endogenous GSK3β ubiquitylation, which implies that EDD instead antagonizes 
GSK3β ubiquitylation. This result was not confirmed in S2 cells. However, S2 cells, 
unlike HEK293 cells do not express the necessary components to transduce the Hh 
and Wg signaling pathways, and this may explain the discrepancy between these 
results. Although EDD does not appear to ubiquitylate GSK3β, it does seem to 
prevent the ubiquitylation of GSK3β.  
 
Since ubiquitylation can have many non-degradative outcomes (see Chapter 1, 
Section 1.1.5.2), EDD could thereby affect GSK3β function independently of 
changes to its half-life. Over-expression of EDD in HEK293 cells increases the 
nuclear localization of GSK3β	  (Hay-­‐Koren	  et	  al.	  2011), and its nuclear 
translocation may be regulated by ubiquitylation. This would enable the nuclear 
phosphorylation of a particular subset of GSK3β substrates, such as GLI-family 
members (the human Ci homologues). Identification of GSK3β’s ubiquitylation sites, 
specifically those occurring upon EDD RNAi, would allow the creation of non-
ubiquitylatable mutants. Various mutants of Sgg/GSK3β, in which all or a sub-set of 
lysine residues are mutated to alanine, could then be used to determine whether the 
nuclear uptake of Sgg/GSK3β is dependent on ubiquitylation. 
 
To complement the in vitro work, I also successfully used the MARCM technique to 
vary Sgg levels and activity in hydK7.19 clones in Drosophila eye-antennal discs. This 
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significantly modified the adult hydK7.19 hyperplastic phenotype, suggesting that there 
is also a functional interaction between the two proteins in vivo. Intriguingly, both 
over-expression and RNAi-mediated knockdown of Sgg in hydK7.19 clones led to a 
complete rescue of tissue hyperplasia of the eye and head. While hydK3.5/hh double 
mutant clones lead to a partial suppression of the hyperplastic phenotype, the 
generation of hydK3.5/hh double mutant clones expressing UAS-Ci75 resulted in a 
complete rescue (J.	  D.	  Lee	  et	  al.	  2002). This suggests that both ectopic hh expression 
and ectopic Hh pathway activation must be rectified in hyd mutant clones to reverse 
the phenotype. My results clearly indicate that Hyd and Sgg regulate both hh 
expression and Hh pathway activity. However, it is also possible that Sgg modifies 
the hydK7.19 phenotype through effects on Wg signalling. 
 
Most of the hydK7.19 clones in the adult eye are eliminated, suggesting that the loss of 
hyd may confer a growth disadvantage (see Chapter 4), and the over-expression of 
SggS9A in hydK7.19 clones also lead to their elimination prior to adulthood. In a 
previous study, hydK7.19 clones that were generated in a minute background formed 
adult eyes which were reduced in size, and it was stipulated that hydK7.19 clones 
exhibit a growth disadvantage, leading to their elimination through competition with 
WT cells (J.	  D.	  Lee	  et	  al.	  2002). To investigate whether the expression of SggS9A in 
hydK7.19 cells further reduces the fitness of clones, suggesting that Hyd and Sgg 
function in the same or parallel pathways, these clones could also be generated in a 
minute background. If so, it would be expected that UAS-SggS9A; hydK7.19 clones 
generate even smaller or no adult eyes. Further to this, experiments to address 
whether the elimination of hydK7.19 and UAS-sggS9A; hydK7.19 clones occurs through 
apoptosis could be carried out. This can be achieved by Terminal deoxynucleotidyl 
transferase dUTP nick end labeling (TUNEL staining) to detect DNA fragmentation 
following apoptosis, or staining for active caspase-3, or genetically, by generating 
clones that over-express a caspase inhibitor (e.g. p35), to see whether clones can now 
survive to adulthood. On the other hand, knockdown of endogenous sgg in hydK7.19 
clones also rescued the hyperplastic phenotype, but these clones were not eliminated. 
This suggests that an alternate molecular rather than cellular compensation 
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mechanism is involved, which is most likely attributed to the role of Sgg in 
regulating the Hh and Wg pathways. 
 
Although my original aim was to determine whether the interaction between Hyd and 
Sgg affects Hh pathway activity in vivo, my results somewhat surprisingly revealed 
that Sgg also affects hh gene expression. Over-expression of SggS9A reduces ectopic 
hh expression in posterior hydK7.19 clones, whereas posterior SggS9A clones alone 
express high ectopic levels of hh. Conversely, knockdown of Sgg results in ectopic 
hh expression in anterior SggRNAi; hydK7.19 and SggRNAi clones, whereas this has no 
effect on posterior hydK7.19 clones, but leads to a reduction in hh expression in 
posterior SggRNAi clones (Figure 5.15 A). This suggests that Sgg regulates hh gene 
expression, which has not been reported before. Based on these results, I propose a 
model in which Sgg negatively regulates hh expression in anterior regions of the eye 
disc, as a result of activation by Hyd; whereas Sgg positively regulates hh expression 
in posterior regions, antagonizing the action of Hyd in a separate mechanism (Figure 
5.15 B). In the anterior compartment of the EA disc, Ci75 represses hh gene 
expression (Domínguez et al. 1996; Méthot & Basler 1999). Therefore, Sgg could 
negatively regulate hh expression in anterior cells simply by promoting the 
processing of Ci155 to Ci75. This process, in turn, could be potentiated by Hyd 
through positive regulation of Sgg activity. On the other hand, in the posterior EA 
disc compartment, hh expression is not regulated by Ci, but instead, the transcripton 
factor Pointed, a downstream target of the Egfr/Ras pathway, positively regulates hh 
expression (Rogers et al. 2005). Sgg and Hyd could therefore be acting through 
Pointed to positively and negatively regulate hh expression, respectively, in these 
cells. It would be interesting to determine whether Sgg or Hyd can interact with 
Pointed, and whether any potential interactions would involve phosphorylation 
and/or ubiquitylation to regulate Pointed transcriptional activity. 
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Finally, as expected and reported previously in wing disc sgg- clones (J.	  Jia	  et	  al.	  
2002), RNAi-mediated loss of Sgg also increases the level of Ci155 in both anterior 
and posterior clones (Figure 5.15 A). As such, knockdown of Sgg in hydK7.19 clones 
has no effect on ectopic posterior Ci155 expression, but reverses the low Ci155 
expression seen in anterior hydK7.19 clones (Figure 5.15 A). This would suggest that 
only the prevention of low Ci155 and low Hh pathway activity in anterior clones leads 
to a rescue in SggRNAi; hydK7.19 animals (Figure 5.15 C).  
 
However, on the basis of these results, it is not possible to determine how exactly 
modification of Hh pathway activity and Ci155 levels leads to a rescue of the 
hyperplastic phenotype following Sgg knockdown. Surprisingly, over-expression of 
SggS9A had no significant effect on Ci155 levels in both SggS9A; hydK7.19 and hydK7.19 
clones (Figure 5.15 A). This may be because the RNAi-mediated knockdown of 
endogenous sgg could be more efficient than the over-expression of a sgg transgene. 
Alternatively, protein over-expression can also result in contradictory effects, due to 
a phenomenon called squelching (Natesan et al. 1997), which occurs when over-
expressed proteins compete for a limiting pool of endogenous downstream 
targets/substrates, resulting in minimal change in downstream effects. 
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Figure 5.15: Summary of Ci155 and hh expression in EA discs containing hydK7.19, SggS9A, and 
SggRNAi clones. The morphogenetic furrow (MF) is marked by a double line. A = anterior, P = 
posterior. (A) Summary of ectopic autonomous hh and Ci155 expression in clones. (B) Model for the 
molecular mechanism of hh gene regulation in anterior and posterior regions of the eye disc. In 
anterior regions, Hyd negatively regulates hh expression by positively regulating Sgg, which in turn 
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down-regulates hh expression. In posterior regions, Hyd negatively regulates hh expression 
independently of affecting Sgg activity, whereas Sgg positively regulates hh expression independently 
of Hyd. (C) Model for the molecular mechanism of Ci155 regulation in anterior and posterior regions 
of the eye disc. In anterior regions, Hyd downregulates Ci155 levels by activating Sgg, resulting in 
increased processing of Ci155 to Ci75. Conversely, in posterior regions, Hyd downregulates Ci155 levels 
independently of Sgg in a mechanism that is not dependent on processing of Ci155 to Ci75.
Hyd regulates morphogen signalling in the developing eye 





















Hyd regulates morphogen signalling in the developing eye 
Chapter 6: Discussion   256 
6.1 Summary 
 
Hyd is a putative E3 ubiquitin ligase and tumour suppressor protein that negatively 
regulates Hh signalling in the developing Drosophila eye. Hh signalling comprises 
both hh gene expression and the subsequent activation of the Hh pathway, and Hyd 
regulates both processes by independent, yet unknown, mechanisms (J. D. Lee et al. 
2002). Mutations in Hh pathway components are linked to several human tumours 
(L. L. Rubin & de Sauvage 2006; Scales & de Sauvage 2009). However, recent 
findings suggest that over-expression of the SHH ligand by either the tumour 
epithelium or the surrounding stromal cells is much more prevalent in cancer (Fan et 
al. 2004; Yauch et al. 2008; Dierks et al. 2007; Hegde et al. 2008).  As a result, Hyd 
and its highly conserved human homologue EDD, along with the putative regulatory 
pathways governing morphogen expression, represent potential targets for the design 
of novel cancer therapeutics. This is especially important since drugs correcting the 
cause of SHH expression in human tumours are not available. Numerous functional 
links to morphogen signalling, including the SHH and WNT pathways have been 
demonstrated for EDD (see Chapter 1, Sections 1.4.2.3 and 1.4.2.5), suggesting that 
Hyd’s role in negatively regulating morphogen signalling is likely to be conserved in 
humans.  
 
The aims of this project were to identify novel Hyd binding partners and/or 
ubiquitylated substrates that could be involved in putative molecular mechanisms 
regulating hh expression, or in the regulation of Hh pathway activity and possibly 
other morphogen signalling pathways. More specifically, this involved multiple 
objectives, including the use of mass spectrometry, bioinformatics and 
binding/ubiquitylation assays to identify new binding partners, followed by the 
further investigation of the functional relevance of the interacting proteins in 
morphogen signalling using a Drosophila eye in vivo model. 
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The results presented in this thesis support a significant role for Hyd in the regulation 
of both Hh and Wg signalling. Tandem affinity purification of exogenous Hyd from 
Drosophila S2 cells and subsequent mass spectrometric analysis of the complexed 
material revealed several putative novel binding partners, including Armadillo (Hs β-
catenin), Ran and the SuFu interacting protein of unknown function, PERQ. Binding 
assays demonstrated that Hyd, unlike EDD, does not bind to the Hh pathway kinase 
Dyrk2, but may bind the close homologue Dyrk3 in Drosophila. In addition, binding 
assays also confirmed the interaction between Hyd and Armadillo, and showed that 
Hyd interacts with Shaggy (Hs GSK3β) and Ci (Hs GLI). This revealed that Hyd not 
only interacts with the kinase Shaggy, which is a major regulator in both the Hh and 
Wg pathways, but also interacts with the transcriptional effector proteins Ci and 
Armadillo, responsible for the activation of gene transcription in the Hh and Wg 
pathways, respectively. Although the results show that Shaggy and GSK3β are 
ubiquitylated, which has been reported previously for GSK3β (Q. Wu et al. 2009), 
they do not support a role for Hyd in mediating Shaggy ubiquitylation. Instead, my 
findings suggest that EDD inhibits GSK3β ubiquitylation. Taken together, these 
results place Hyd firmly in the regulation of Hh and Wg pathway activity at or below 
the level of Ci and Armadillo phosphorylation by GSK3β, providing a starting point 
for future investigation of the molecular mechanism underlying Hyd’s function in the 
regulation of these pathways.  
 
I subsequently employed a suitable Drosophila in vivo model designed to assess the 
functional significance of the interaction between Hyd and Shaggy, and its effects on 
hh expression and Hh pathway activity. This model utilized the MARCM technique 
to generate hyd mutant clones in the larval eye antennal imaginal disc, allowing me 
to assess the spatial expression of morphogens and morphogen pathway components 
during eye development, as well as the developmental effects on the adult eye and 
head tissue. The technique further allowed me to knockdown endogenous sgg or 
over-express an exogenous Shaggy protein in hyd mutant clones through the 
simultaneous use of different transgenes. 
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The generation of homozygous hyd mutant clones bearing the previously used 
hydK7.19 allele resulted in elevated hh and full-length Ci155 expression in posterior 
clones, non-autonomous disc tissue overgrowth, and scarring of adult eyes, all of 
which confirm previous reports of hyd mutations in eye disc clones (J. D. Lee et al. 
2002). Conversely, I found that Ci155 levels were reduced in anterior hyd mutant 
clones, which directly contradicts previous findings where a different hyd mutant 
allele, hydK3.5, was used (J. D. Lee et al. 2002). In addition, hyd mutant clones 
resulted in mis-expression of Wg protein across the eye disc, as well as significantly 
increased head tissue in adults, an area known to be regulated by Wg signaling at the 
retinal boundary during eye disc development (Legent & Treisman 2008). 
 
Interestingly, over-expression of exogenous Shaggy protein in hyd mutant clones 
rescued the adult phenotype, resulting in the elimination of eye scarring, reduced 
head size, as well as significantly reducing hh over-expression in posterior hyd 
mutant clones. Conversely, over-expression of Shaggy in anterior hyd mutant clones 
resulted in elevated hh expression, suggesting that Shaggy may be a novel regulator 
of hh expression with dual roles in both the positive and negative regulation of hh 
expression depending on the spatial location of eye disc cells.  
 
My sequencing results showed that the hydK7.19 allele contains a pre-mature stop 
codon, which in theory would result in the expression of a severely truncated Hyd 
protein lacking all functional domains apart from the UBA domain. Furthermore, 
while a full-length Hyd transgene rescues the phenotype when expressed in hyd 
mutant clones, a catalytically inactive transgene fails to rescue the phenotype, 
suggesting that Hyd’s E3 ligase activity is crucial for its function in regulating Hh 
signaling. These findings are in agreement with recent work, which showed that 
Hyd’s E3 ligase activity is essential for its role in regulating Hh signalling (Wang et 
al. 2014). 
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Finally, I utilized a wing-disc derived Drosophila cell line (Cl8+) in conjunction 
with a ptc-luciferase reporter to demonstrate that knockdown of endogenous Hyd 
results in down-regulation of Hh pathway activity, suggesting that Hyd positively 
regulates Hh pathway activity in this setting.  
 
6.1.1 Hyd function in regulating Hh signaling 
 
My results support a role for Hyd in the regulation of both hh expression and Hh 
pathway activity. While some of my findings are in agreement with previously 
published data in the literature, others represent a novel contribution to the field and 
point to intriguing new mechanisms of action for Hyd in these processes. Although 
previous findings suggest that Hyd is a negative regulator of Hh pathway activity (J.	  
D.	  Lee	  et	  al.	  2002), my results suggest that Hyd can both positively and negatively 
regulate the Hh pathway by affecting full length Ci155 levels in the eye-antennal disc, 
and by positively regulating ptc gene expression levels in wing-disc derived 
Drosophila cultured cells. Hyd’s dual role in Hh pathway regulation may be tissue- 
and/or cell type dependent, which may suggest that Hyd employs different effector 
proteins and mechanisms for different outcomes on Hh pathway activity. 
Interestingly, this notion is supported by recent work, which showed that Hyd can 
differentially regulate the transcriptional output of the Hh pathway in wing disc cells 
(Wang et al. 2014). Furthermore, the interactions between Hyd and Ci and Hyd (Hs 
EDD) and Shaggy (Hs GSK3β), which have previously been reported (Wang et al. 
2014; Hay-Koren et al. 2011), further suggest that Hyd is involved in regulating Ci 
levels and or activity to regulate pathway activity. In the eye-antennal disc, hyd 
mutant clones anterior to the morphogenetic furrow exhibit reduced Ci155 levels in 
the region where Ci155 is mainly regulated by Slimb-mediated proteolytic processing 
to Ci75. Interestingly, over-expression of Shaggy in these cells had no effect on Ci155 
levels, whereas knockdown of endogenous Shaggy protein expression rescued Ci155 
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levels. As Shaggy is known to promote the processing of Ci155 to Ci75 (J. Jia et al. 
2002), Hyd may prevent Ci155 processing by inhibiting shaggy activity, or interfering 
with Slimb action and/or binding to Ci155. However, knockdown of hyd in Cl8+ cells 
did not appear to affect Ci155 levels. Moreover, recent findings suggest that Hyd does 
not affect Ci155 stability, but rather that it acts as a transcriptional co-activator upon 
Ci155 binding to target promoters (Wang et al. 2014).   
 
Further to this, the mass spectrometry results suggest that Hyd, via its interaction 
with PERQ, could indirectly interact with Sufu, a Ci155 negative regulator. Sufu 
antagonises the transcription of Hh target genes by both preventing the translocation 
of Ci155 (Hs Gli) into the nucleus (Kogerman et al. 1999; Ding et al. 1999; Wang et 
al. 2000; Méthot & Basler 2000), and by recruiting the SAP18-mSin3-histone 
deacetylase co-repressor complex to Hh target gene promoters (Cheng & Bishop 
2002). Hyd and EDD contain nuclear localisation signals and, as a result, were found 
to localise mostly to the nucleus (Mansfield et al. 1994; Hay-Koren et al. 2011). One 
possible mechanism of action for Hyd in Hh pathway regulation could therefore be 
the regulation of the nuclear translocation of Ci155. This would incidentally affect 
both Hh pathway activity and Ci155 levels, as nuclear Ci155 activates Hh target gene 
transcription, but is also subject to degradation by Rdx. For instance, Hyd could 
oppose the negative regulation of Ci by Sufu by competing for the Sufu binding site 
on Ci155, and thus facilitating nuclear import. The putative Hyd binding partner Ran, 
as determined by mass spectrometry, may also be involved in this process, as it is 
essential for the transport of proteins through the nuclear pore complex (Izaurralde & 
Adam 1998). In this model of Hyd-mediated Ci155 nuclear import, Hyd would bind 
Ci155, preventing an intraction with SuFu, whilst also recruiting Ran to Ci155 to 
initiate nuclear import. Alternatively, Hyd ubiquitylation of Ci155 could prevent 
binding by Sufu. Interestingly, recent insights into the mechanism of Ci155/Gli 
nuclear translocation show that Ds Transportin (Trn) and Hs Importin β1 (Impβ1) 
positively regulate Ci155/GLI nuclear import. Mechanistically, the two proteins may 
compete with Sufu for binding to the nuclear localisation sequence (NLS) at the 
amino-terminal of Ci155/GLI (Shi et al. 2014; Szczepny et al. 2014). Therefore, future 
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work should address whether Hyd and EDD are involved in this process, and also 
whether this would involve Hyd-mediated ubiquitylation of Ci155, Sufu, Ran, or 
Trn/Impβ1. 
 
Finally, the results presented here suggest that Shaggy may have a positive role in 
promoting hh gene expression. From the in vivo experiments, the relationship 
between Hyd and Shaggy mediated regulation of hh gene expression, if any, as well 
as the molecular mechanism, are not clear and would require further investigation 
(see Section 5.7 and Section 6.1.2). 
6.1.2 Hyd function in regulating Wg signaling 
 
Although the main focus of my work was to investigate the role of Hyd in Hh 
signalling, my results also suggest that Hyd negatively regulates Wg signalling in the 
developing Drosophila eye and head tissues. While the in vivo work demonstrated 
that Hyd negatively regulates Wg protein expression, the data from binding assays 
also suggest that Hyd engages in the Wg pathway by interacting with both Shaggy 
(Hs GSK3β) and Armadillo (Hs β-catenin). As discussed above in relation to Ci, Hyd 
may have a similar effect on the nuclear translocation of Armadillo. There have been 
conflicting reports of EDD’s role in β-catenin nuclear translocation and WNT 
pathway regulation, suggesting that EDD can act both as a positive (Hay-Koren et al. 
2011) and negative (Ohshima et al. 2007) regulator of these processes. The HECT E3 
ubiquitin ligase Smurf2 ubiquitylates and degrades GSK3β, which leads to increased 
WNT signalling in mouse chondrocytes (Q. Wu et al. 2009). Since my results 
suggest that EDD antagonises the ubiquitylation of GSK3β, EDD could differentially 
regulate WNT signalling by (i) preventing the degradation of GSK3β, potentially by 
antagonizing Smurf-mediated ubiquitylation of GSK3β, and thus down-regulating β-
catenin levels, and (ii) ubiquitylating and up-regulating β-catenin, as suggested 
previously (Hay-Koren et al. 2011). 
 
Hyd regulates morphogen signalling in the developing eye 
Chapter 6: Discussion   262 
 
 
6.2 Future Perspectives 
 
As well as providing new insights into Hyd’s function, the work presented in this 
thesis raises some interesting questions concerning its molecular mechanism in 
morphogen signalling. As a result, there are a number of experiments that 
immediately follow on from this work, some of which I have not been able to carry 
out in the time available. 
6.2.1 How does Hyd regulate hh expression? 
 
In order to investigate the molecular mechanism behind Hyd-mediated regulation of 
hh gene expression, and the potential involvement of Shaggy, I would use a more 
simplified approach to study this process in a cultured cell line model. This would 
eliminate the complexity of interactions between different cell types that may 
contribute to hh expression patterns in the eye disc. Unfortunately, according to data 
generated by the modENCODE Fly Transcriptome Project (Celniker et al. 2009), 
there are currently no Drosophila cell lines available that express hh. However, there 
are a number of human cancer cell lines, such as the breast cancer cell line MCF-7 
(Cui et al. 2010), which over-express SHH. It would be interesting to analyse the 
SHH expression profile in these cells by quantitative real-time PCR (qRT-PCR) and 
Western blotting in the presence and absence of EDD. This would involve the 
knockdown of endogenous EDD, preferably using an RNAi construct that targets the 
3’UTR region of the EDD mRNA to allow simultaneous expression of exogenous 
wild type or catalytic inactive (C>A) EDD. These experiments would address 
whether EDD is involved in regulating shh expression in human cells, and whether 
this process involves EDD’s E3 ligase activity. Additionally, the potential role of 
GSK3β in regulating Shh expression could also be investigated in this setting using 
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RNAi, over-expression, or the use of lithium chloride, a specific GSK3β inhibitor 
(Klein & Melton 1996; Stambolic et al. 1996). 
 
An alternative approach would be to use Chromatin Immunoprecipitation (ChIP) to 
investigate whether Hyd/EDD and Shaggy/GSK3β can bind to the enhancer regions 
and/or promoter region of the hh and Shh genes. For example, Hyd could bind DNA 
directly through its putative DNA-binding RCC domain, and both Hyd and Sgg 
could be localised to DNA and regulate the activity of transcription factors, 
epigenetic regulators and histones through ubiquitylation or phosphorylation, 
respectively. Briefly, ChIP involves the cross-linking of protein and any bound 
DNA/chromatin using formaldehyde, followed by shearing of the DNA/chromatin 
into ~500 bp fragments by sonication, and subsequent immunoprecipitation of 
specific proteins and sequencing of the associated DNA. This could be performed 
with EDD and GSK3β in the aforementioned MCF-7 breast cancer cell line, as well 
as with Hyd and Shaggy in eye-antennal imaginal discs, as specific antibodies are 
available for all of these proteins (see Chapter 2, Materials and Methods). 
6.2.2 How does Hyd regulate Hh pathway activity? 
 
Although the absence of hh-expressing Drosophila cell lines makes the study of the 
regulation of hh gene expression difficult, it is ideal for the purposes of studying 
Hyd’s role in regulating Hh pathway activity, as it effectively uncouples the two 
processes. Both L3 wing disc derived Cl8+ cells and embryonic derived S2R+ cells 
are capable of transducing the Hh pathway when stimulated with exogenous Hh-N 
protein (Cherbas et al. 2011; Lum et al. 2003). They therefore represent a much 
better model to study the molecular mechanism by which Hyd regulates Hh pathway 
activity as they are much more likely to express the protein components involved in 
these putative regulatory pathways. Table 6.1 summarises the specific Hh pathway 
components that could interact with Hyd to regulate Hh pathway activity, and their 
expression levels in the S2, S2R+ and Cl8+ cell lines. 
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Table 6.1: Expression of Hh signalling components in commonly used Drosophila cell lines. 
Cell Line and Expression Level 
Gene 
S2 S2R+ Cl8+ 
Hh Absent Absent Absent 
Ci Absent Absent Medium 
Sgg Medium Medium Medium 
Sufu Medium Low Low 
Slmb Medium Medium Medium 
Rdx Medium Medium Medium 
 
The expression levels of Hh pathway components shown in Table 6.1 suggest that 
Cl8+ cells are the best model system for studying Hh pathway activity. Therefore, I 
would use Cl8+ cells to perform the following experiments to address Hyd’s function 
in regulating Hh pathway activity and Ci activity and/or location: 
• Immunofluorescence with Cl8+ cells to investigate the effect of Hyd over-
expression or knockdown on Ci location in the cell. The Ci antibody (rat Ci 
2A1, Developmental Studies Hybridoma Bank) that I used in all experiments 
presented in this thesis recognises the carboxy terminal portion of full-length 
Ci, and so only recognises Ci155 and not Ci75. Therefore, I would use this 
antibody in conjunction with another Ci antibody (dl-20) that recognises the 
amino terminal of Ci, and thus would recognise both Ci155 and Ci75 (available 
from Santa Cruz). Additionally, RNAi-mediated knockdown of other 
components known to affect Ci155 localisation, such as Sufu, can be 
incorporated into these experiments. 
• Drosophila L3 eye antennal disc immunofluorescence staining of hyd mutant 
clones to determine the expression levels of more proteins using the 
following additional antibodies: Sgg, SggS9A, Sufu, Ci amino-terminal 
antibody (dl-20), Rdx, Slmb and Dyrk3. 
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• Luciferase assays with Cl8+ cells to investigate the effects on Hh pathway 
activity of knocking down Shaggy, Sufu, Roadkill, Slimb, and Ci in 
combination with knockdown or over-expression of Hyd and/or different Hyd 
mutant proteins. 
• Further binding and ubiquitylation assays to determine whether Hyd interacts 
with and ubiquitylates Sufu, Transportin, PERQ, Dyrk3, Ran, Roadkill and 
Slimb. 
• Ubiquitylation assays to determine whether Hyd affects Ci ubiquitylation. 
This would involve ubiquitylation assays with Hyd and Ci in the presence 
and absence of Roadkill and Slimb.    
• In vitro binding assays to determine whether the interactions between Hyd 
and Ci/Shaggy are binary. 
• Repeating the TAP mass spectrometry experiment with either Cl8+ cells or 
eye discs expressing HSP-Hyd in order to target more Hyd interacting 
partners that are involved in Hh signalling. 
6.2.3 How does Hyd regulate Wg signalling? 
 
Finally, some of my data suggests that Hyd regulates Wg signalling, and this would 
also be an interesting project to pursue. I would use the above-mentioned methods 
for Hh signalling to investigate both Hyd-mediated regulation of wg expression and 
Wg pathway activity in Cl8+ cells and L3 eye-antennal discs. In addition, I would 
also use binding and ubiquitylation assays to further characterise the interaction 
between Hyd and Armadillo, as well as the role of Shaggy in mediating this 
interaction, and the resulting effect on Armadillo nuclear localisation. The TOPflash 
luciferase reporter for Wg pathway activity has previously been used successfully in 
Cl8+ cells (DasGupta et al. 2005), and altering the levels of Hyd by RNAi-mediated 
knockdown or over-expression would be a good starting point to investigate Hyd’s 
role in Wg pathway regulation. 
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